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Abstract
The chromatography steps dominate the Downstream Processing (DSP) costs of a new
biopharmaceutical, which has propelled the biopharmaceutical industry to invest a lot
of effort on their improvement in order to reduce the costs of the biopharmaceutical
production. Liquid chromatography (LC) is currently the core technique within the
DSP strategy for the purification of biopharmaceuticals. Although single-column batch
chromatography is simpler to operate than continuous (multicolumn) chromatography,
the latter has many advantages over the former, including improved purity, yield, and
productivity.
The main objective of this thesis is the development of a new chromatographic plat-
form based on a novel single-column device that mimics the operation of multicolumn
chromatography through ingenious management and recycling of the mixed fractions
exiting the chromatographic column. The platform shares the benefits of the Simulated-
Moving-Bed (SMB) technology. However, the newly developed process uses only a single
chromatographic column.
The conceptual design of the set-up and its mathematical model were successfully
established. The laboratory prototype was built focusing on a simple, compact, and
versatile design with small footprint. The binary separation of nucleosides by reversed-
phase chromatography was experimentally realized as proof of concept of the new system.
An effort was made in 3D manufacturing of flow distributors and internals to ensure the
proper operation of the recycle device and the improvement of its efficiency. A second
case study—the capture step of monoclonal antibodies by affinity chromatography on
protein A—was successfully used as a demonstration of the applicability of the newly
developed process.
The new system offers a more compact, less expensive, and simpler-to-operate alter-
native to multicolumn SMB chromatography. Depending on the efficiency of the recycle
device, the single-column process can achieve the same purities as the analogous SMB
unit while keeping the specific productivity constant. Moreover, the single-column chro-
matograph can be easily integrated into the existing downstream processing platforms of
complex biopharmaceuticals.
Keywords: Biomolecules Separation/Purification, Continuous Chromatography, Simu-
lated Moving Bed, Single-column with Recycle Lag.
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Resumo
As etapas cromatográficas inseridas no trem de purificação a jusante da bioreação domi-
nam largamente os custos dessa componente do processo de produção de um biofármaco,
o que tem levado a indústria biofarmacêutica a investir esforços na sua melhoria a fim
de reduzir os custos globais de produção. A cromatografia líquida é atualmente a téc-
nica principal para a purificação de produtos biofarmacêuticos. Embora a cromatografia
descontínua monocoluna seja mais simples de operar do que a cromatografia contínua
multicoluna, a última apresenta muitas vantagens sobre a primeira, incluindo pureza
mais elevada e melhorias de rendimento e produtividade.
O objetivo principal desta tese é o desenvolvimento de uma plataforma cromatográfica
baseada num novo processo monocoluna capaz de mimetizar a operação da cromatogra-
fia multicoluna em contracorrente simulada por meio de um dispositivo engenhoso de
gestão e reciclo das frações do efluente da coluna cromatográfica. Apesar da plataforma
desenvolvida utilizar apenas uma única coluna cromatográfica, ela partilha os benefícios
dos chamados processos de Leito Móvel Simulado (LMS). Este último é a realização física
do conceito de cromatografia sólido-líquido em contracorrente.
O desenho conceptual da instalação e o seu modelo matemático foram estabelecidos
com sucesso. O respetivo protótipo laboratorial foi construído visando a minimização
de equipamento, simplicidade, versatilidade e volume, sem, no entanto, limitar a ampla
variedade mimetizável de processos multicoluna LMS e suas variantes. Procedeu-se ao de-
senho e dimensionamento do ciclo de operação de uma separação binária de nucleosídeos
por cromatografia em fase reversa como prova de conceito do novo sistema e validou-se o
processo experimentalmente. Desenharam-se e fabricaram-se diversos distribuidores de
fluxo e dispersores internos através de impressão 3D para garantir a operação adequada
do dispositivo de reciclo e melhoria de sua eficiência. O passo de captura de anticorpos
monoclonais por cromatografia de afinidade com proteína A foi o segundo caso de estudo
ao qual foi aplicado o novo processo, demonstrando a sua aplicabilidade.
O novo cromatógrafo de coluna única com atraso no reciclo oferece uma alternativa
mais compacta, barata e simples de operar do que a cromatografia LMS multicoluna.
Dependendo da eficiência do dispositivo de reciclo, o novo processo pode alcançar as
mesmas purezas da unidade LMS análoga, mantendo a produtividade específica cons-
tante. Para além disso, ele pode ser facilmente integrado nas plataformas existentes de
purificação de biofármacos complexos.
Palavras-chave: Separação/Purificação de Biomoléculas, Cromatografia Contínua, Leito
Móvel Simulado, Monocoluna com Atraso no Reciclo.
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Research Purpose
1.1 Motivation
The biopharmaceutical industry emerged from the merger of the pharmaceutical industry
with the biotechnology industry in the 1990s [55]. Traditionally, while the pharmaceutical
industry produced and marketed drugs through chemical synthesis, biotech companies
developed therapies manufactured in or extracted from living organisms such as yeast,
bacteria, plant or mammalian cells. These therapies, or biologics, have offered potent
therapeutic options for many diseases that had no available treatment, or had treatment
with limited efficacy. In 2016, seven of the top ten best-selling drugs in the world were
biologics [55].
Monoclonal antibodies (mAbs) are one of the most important medical products of
biopharmaceutical industrial manufacturing [96]. mAbs are specific agents applied with
a high degree of efficacy for the treatment of a wide variety of cancers [240, 263], for
treatment of organ rejection response [167], as well as for reduction of the symptoms of
various autoimmune diseases, such as multiple sclerosis [79], among several other crucial
functions in the area of medical treatments.
The synthesis and applications of peptides are gaining increasing popularity as a
result of the developments in biotechnology and bioengineering areas and for a number of
research purposes including cancer diagnosis and treatment, antibiotic drug development,
epitope mapping, production of antibodies, and vaccine design [49]. The use of synthetic
peptides approved by the health authorities for vaccine, for cancer, and in drug delivery
systems is increasing with these developments.
In the struggle for health costs control, the huge cost of biological products, including
mAbs and peptides, is an issue that has been explored and discussed extensively [38].
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The production of biopharmaceuticals can be divided into two main steps: the Up-
stream processing (UPS) part—the initial stage of a bioprocess—mainly comprising the
bioreaction in the case of mAbs and solid-phase synthesis in the case of synthetic peptides,
up to the stage where the biomolecules of interest are produced, and the Downstream
processing (DSP) part, where the (bio)reaction bulk is processed to meet the purity and
quality requirements. For years, the former received much more investments to develop-
ment of production technologies.
The DSP has a majority share in the total cost of manufacturing biopharmaceuticals,
mainly due to the presence of chromatographic processes in some of its stages [229].
The predominant obstacles faced by the production of new bioproducts include cost
reduction, through improving process economics and efficiency, and meeting the quality
criteria for Food and Drug Administration (FDA) approval, which have been increasingly
demanding [229]. Because of that, the biopharmaceutical economy started to demand an
evolution in DSP, in order to reduce the costs of the production process while aiming, at
the same time, to develop more efficient equipment with respect to productivity, recovery,
yield, ease of handling and automation, and qualified products in terms of purity.
Liquid Chromatography (LC) is currently the core technique for purification of bio-
pharmaceuticals, and its use is often integrated vertically within the DSP strategy, as it
easily fits into the early capture stage as well as into the final purification phase.
Single-column batch chromatography, which because of its simplicity is routinely
used by industry, isolates the pure fraction of the product peak. In this process purity is
achieved at the expense of yield because the impure side fractions, containing valuable
product, must be discarded.
Multicolumn continuous chromatography, whose most efficient implementation is
based on the Simulated Moving Bed (SMB) concept, captures the side fractions by internal
recycling until the entire product has been extracted while new feed and fresh eluent (or
desorbent) are continuously or cyclically injected. This not only gives significantly higher
yields of purer product, but also enables to process more feed and thereby increase overall
throughput.
A SMB unit typically consists of a circular train of chromatographic columns divided
into a number of sections (the standard configuration uses four sections). A section or
zone is defined as one or more columns connected in series without any side streams in
between; sections are separated by inlet and/or outlet streams. For example, the standard
four-zone SMB has two inlet streams—fresh feed and fresh eluent (or desorbent)—and
two outlets—raffinate and extract. Section I is contained between the eluent inlet and the
extract outlet; section II is located between the extract outlet and the feed inlet; section III
is placed between the feed inlet and the raffinate outlet; and section IV is located between
the raffinate outlet and the eluent inlet.
There are already several published works on SMB processes with less than four
sections, such as three [230, 281, 284] and two [21, 128, 129, 160, 227, 228] sections.
Around 2003–2004 Abunasser and Wankat [6, 7] proposed a one-column SMB analog,
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but their system did not fully exploited the analogy with the multicolumn system.
In 2005, a new idea of mimicking the operation of continuous multicolumn chro-
matography with a single column was put forward [17, 176]. The concept was called
“one-column analog of continuous chromatography.” This single-column chromatograph
crave to imitate the operation of the multicolumn process with the same specific produc-
tivity (feed processed per unit time per resin volume) or, equivalently, absolute produc-
tivity (feed processed per unit time) divided by the number of columns. However, very
little has been raised about this idea, particularly from the viewpoint of experimental
realization.
Working with the limiting case of one-column chromatography is advantageous be-
cause only one column has to be (re)packed, switching from one mixture to another would
be easier and take less time than with a multicolumn system, less equipment is involved
and the pressure drop and solvent consumption are reduced.
Thus, in an effort to produce high-quality biopharmaceuticals at a lower cost and
using a simpler set-up, the main objective of this PhD thesis is to develop a new chro-
matographic platform based on the “one-column analog of continuous chromatography”
concept: a novel single-column device that mimics the operation of continuous multicol-
umn chromatography through ingenious management and recycling of mixed fractions,
reaching values of purity and recovery equal to or greater than multicolumn systems.
1.2 Objective and Justification
The main aim of this work is to develop and describe the most efficient way of mimicking
the behavior and performance of continuous multicolumn chromatography with just a
single-column apparatus. In order to achieve this, four specific objectives were traced:
• To establish the conceptual design of set-up, its mathematical model and assemble
the laboratory prototype;
• To perform experimental validation, mimicking an already validated multicolumn
system;
• To optimize the set-up using 3D printing technology;
• To apply the newly-developed system to another case study aiming at comparing
the results with a different multicolumn chromatographic system.
The work plan was divided into four steps according to the specific objectives out-
lined.
The first task consisted of the conceptual design of the new chromatographic pro-
cess, the mathematical description of its time-dependent behavior and performance, and
construction of a laboratory prototype.
3
CHAPTER 1. RESEARCH PURPOSE
Reducing the number of chromatographic columns in a LC process is of intense in-
terest in biopharmaceutical DSP, due to the reduction of costs and simplification of the
production platform. Based on the approach proposed in 2005 [176] by the research
group in which this project was developed, the idea of a single-column chromatographic
system was explored by experimentally realizing a recycle device with a moving piston,
to be implemented in line with the chromatographic column, so that the mixed fractions
leaving the column can be directed to the recycle device. The latter has the function of
collecting, storing, and re-injecting the mixed fractions with a delay in time, in which
the fluid outlet maintains the same order of the piston input. The piston is expected to
achieve a dispersive plug-flow behavior therein.
For reasons of efficiency, simplicity, and cost, the laboratory prototype should be as
compact as possible, with a small number of equipment involved, with the challenge of
minimizing the extra volumes in the system and operating with optimal pressure values.
The possibility of automation brings agility to the operation, and online monitoring is
crucial for the development of modern techniques in the competitive biopharmaceutical
production market.
The second specific objective, which served to guide the second stage of the thesis,
was the validation of the laboratory prototype. For this purpose, the laboratory prototype
was tested on the binary separation of nucleosides by reversed-phase chromatography
under linear adsorption conditions in an open-loop configuration. These experimental
considerations were taken from literature [228] as a convenient model separation problem.
The experimental results were compared with simulations, performed in the dynamic
process simulation software gPROMS, considering two different limiting behaviors of the
moving-piston device with recycle lag: perfectly stirred tank and dispersed plug-flow. It
was envisaged that each nucleoside would be recovered in a distinct fraction with a high
degree of purity and recovery besides low solvent consumption, and the experimental
concentration profile curve would be similar to the plug-flow simulation curve.
To bring the piston model closer to the desired one, 3D printing technology was widely
approached for production of different distributor configurations for the inner workings
of the piston. The most appropriate 3D form was used together with the complete system
for the chromatographic separation of guanosine and uridine nucleosides.
The application of the newly developed chromatographic process to another case
study is fundamental to prove its intended purpose. With this aim in mind the proposed
physical realization of Single-Column Chromatography with Recycle Lag, representing
the fourth stage of the thesis plan, was applied to the capture step of mAbs by affinity
chromatography on Protein A (PrA) resin, as an analog of the commercial Twin-Column
CaptureSMB process [29, 30], which in turn is a simplified instance of the more general
Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) process [155, 179,
180, 182].
This separation is considerably more complicated than that of nucleosides. mAbs and
their derivatives are of increasing interest in the drug industry due to their important
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application in the treatment of complex diseases. On the other hand, the capture step of
mAbs from a clarified bioreaction bulk is challenging due to the presence of very similar
impurities, with similar adsorption properties to the target product [253]. Besides this,
PrA is an extremely expensive resin, thirty times more expensive than most ion-exchange
resins [123]; this increases the manufacturing costs of mAb-derived bioproducts and thus
provides a gigantic advantage to a system operated with the limiting case of only one
chromatographic column.
The simulated concentration profiles were simulated in gPROMS for the new system.
Also for evaluation purposes, it was aimed at attaining values of specific productivity,
purity and recovery as good as those obtained with the continuous multicolumn processes
discussed above.
1.3 Thesis Content
In addition to this Chapter, the contents of this thesis is as follows:
Chapter 2 Introduction
In this chapter the literature review is presented covering the main important sub-
jects for understanding the work developed in this thesis. The main topics covered
are: Biopharmaceutical Industry, Products and Processes; Chromatography; Continuous
Multicolumn Countercurrent Chromatographic Processes; and Monocolumn Processes
Similar to SMB.
Chapter 3 Single-column Analog with Recycle Lag
Chapter 3 is based on the concept of a single-column analog that mimics Contin-
uous Multicolumn Chromatography, developed in 2005 by the research group of
Prof. Paulo Mota (same group in which this thesis is inserted), and proposes the
conceptual design for its prototype, the corresponding mathematical model, as well
as the conditions for assembly of the laboratory prototype.
Chapter 4 Separation of Nucleosides by Reversed-phase
This chapter, as well as the ones that follow, are structured as Introduction and
Objectives, wherein it is expressed a brief approach on the main subject and the
objective of the work in question; Materials and Methods; Results and Discussions;
and, finally, Conclusions.
After construction of the laboratory prototype, this chapter aims to validate the
apparatus created and assembled. For this purpose, the binary separation of uri-
dine and guanosine nucleosides by reversed-phase, originally processed by semi-
continuous two-column chromatography in open-loop configuration, is used as
reference. This process is then mimicked by the single-column system. Before the
experiments, the characterization of the stationary phase, adsorption isotherms,
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column dynamic behaviour and recycle device is made. The experimental results of
this case study for each mode of operation are compared with the simulated results
generated through gPROMS software.
Chapter 5 Improvements of Plug-flow Operation in the Recycle Device
Chapter 5 is responsible for presenting new fluid distributor configurations—pieces
that compose part of the recycle device in the new set-up, printed using two dif-
ferent 3D technologies: Stereolithography (SLA) and Fused Deposition Modeling
(FDM). The fluid concentration profile is analyzed for each printed configuration
and the one with the best result is used to reproduce the nucleosides separation
experiments.
Chapter 6 mAb Capture on Protein A
Still in order to prove the efficacy of the single-column system created within this
thesis, in chapter 6 the single-column system is applied to another case study that
uses a more complicated separation than the case of nucleosides: the purification
of a monoclonal antibody, mimicking the commercial Twin-Column CaptureSMB
process. The simulated results are compared with the simulations in gPROMS for
the Twin-Column system.
Chapter 7 Final Considerations and Perspectives
This final chapter presents an overview of the main conclusions of the work devel-
oped in the thesis and suggestions for future research that can still be approached
for the developed chromatographic system.
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Introduction
2.1 Biopharmaceutical Industry, Products and Processes
2.1.1 Biopharma Market Overview
The Biopharma sector is the leading growth sector within the pharmaceutical industry,
accounting for about 40% of overall pharmaceutical market. This sector has been expe-
riencing rapid growth of 15% per year, with global revenues now reaching 200 billion
dollars annually [157].
Rapid growth is happening all over the world and is accompanied by fierce competi-
tion. Developing countries are the fastest growing in the manufacture and marketing of
biopharmaceuticals. China and India are some of the countries that have been following
this wave of growth in the biopharmaceutical area, betting on mammalian cell culture
platforms, recombinant proteins and even monoclonal antibodies. Although these poten-
tial countries are developing countries, each has approximately 10–11% of the total liters
capacity of bioreactors across the globe, indicating that they are gaining maturity in their
technical expertise [157]. Vietnam and Cuba are some of the other developing countries
that are starting to gain space in the manufacturing process of this sector.
Despite this, the United States and Europe are still the largest facility holders, with
the United States dominating 35.3% and Europe 30.2% of total concentration of global
biopharmaceutical manufacturing, while China and India add up a little more than 19%
of biopharmaceutical production worldwide [214].
2.1.2 Challenges and Opportunities
Biopharmaceutical has long been considered one of the most sophisticated and elegant
gains of modern science. Its impressive potential for market growth brings opportunities
7
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and challenges, driving this industry for the exploration of Research and Development
(R&D) work objectifying new strategies, technologies and operational approaches. R&D
refers to creative investigative activities driven by an enterprise for innovation, introduc-
tion and improvement of its products and procedures, with the purpose of developing
new knowledges or improving existing ones.
From the opportunity of development of ever more complex and efficient materials
for healthcare application, arises the capability of biopharmaceuticals to treat previously
intractable diseases. As a consequence, the greater number of diseases with treatment or
complete cure leads to an increase in the acceptance and reliability of biopharmaceuticals
by the population, in addition to increased marked demand, impelling the growth of this
market.
The limitations of this glamorous industry are presented in different forms. The
facilities are costly to manage, with processes having long duration, low yields, expensive
raw materials and a highly qualified team to operate them due to complexity of manage
these set-ups. All of this results in very costly installations. Large-scale biotechnology
manufacturing facilities, for example, require $200 million to $500 million to build,
and can take 4–5 years to build, compared to the cost of small molecule scale, ranging
$30 million–$100 million [198].
In addition, and not least, the bioprocessing industry has rigid regulators involved in
most decisions to ensure high-end bioproducts. As a consequence, changes occur slowly.
Maybe these are some reasons companies prefer to focus on one or a few platforms to
apply to as many products as possible.
The FDA1 is the agency responsible for protecting the public health by ensuring that
human and veterinary drugs and biological products intended for human use are safe
and effective. New drugs and biologics must receive FDA approval before companies can
market them. Some examples of biological products are therapeutic proteins, vaccines
and cellular therapies. Manufacturers must prove that they are able to produce the
drug in accordance with federal quality standards. The FDA does not test or develop
the products, its experts analyse the results of laboratory clinical trials performed by
the manufacturers. If the agency grants approval it means that the known risks of the
product to the intended use are outweighed by their benefits [75].
The biopharmaceutical field has changed a lot over the last fifteen years. In the early
2000s, biopharmaceutical facilities operated at elevated levels of capacity utilization
rates due to high demand and tight production capacity. The so-called “capacity crunch”
was a major concern of this branch of industry in face of significant capacity shortages.
In 2003, the capacity utilization rate was 79% overall compared with up to 63% overall
in 2018 [217]. It is much healthier to operate at a lower capacity utilization rate, but still
higher than 50%, than to operate at very big rates. When this rate approaches or exceeds
1FDA is an agency within the U.S. Department of Health and Human Services. The core functions of
the agency are to oversee Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory
Operations and Policy, and Operations. For more information please visit: https://www.fda.gov.
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80%, process facilities tend to become a bottleneck and bioprocessing is limited.
The rigid rules of quality that companies must comply result in a meticulous pro-
duction process, in which the purity of the material of interest is one of the factors
of extreme importance. Since 2018, the main bottleneck factor has been “facility con-
straints” [217], highlighting the fact that a new phase of industry capacity expansion
is emerging. Downstream operations are where most bottlenecks now occur, which re-
quires increasing research for the development of better continuous and better overall
downstream purification technologies.
Innovative technologies come and go over the years. An example of this is transgenic
animals, for in-vivo manufacture of recombinant proteins, which is, at present, an rela-
tively rejected bioprocess area. This same area was considered the apex of interest in the
early 2000s. Recently, on the other hand, cellular and gene therapies, involving even both
technologies (genetically-modified cells), have been presented as the next big topic for
biopharmaceutical manufacturing [217]. Cell therapy Provenge, for example, is used for
the treatment of cancer, while gene therapies offers even more magnificent promises of
regenerative medicine and disease remission [198].
2.1.3 Bioproducts
Biopharmaceuticals are only part of the pharmaceutical industry products. In the 1980s,
the term “biopharmaceuticals” appeared to refer to human health products generated
through modern biological methods using engineered organisms, distinguishing these
products from traditional biological products extracted directly from natural biological
sources. [102].
Biopharmaceuticals are complex molecular structures with high molecular weight,
200- to 1000- fold higher than traditional medicines; moreover, because of their size and
sensitivity, they are primarily absorbed by the lymphatic system. While the chemical
and natural medicines have low molecular weight and simple structure, because they
are made up of simple molecules with well-defined physical chemical properties. These
molecules from chemical synthesis are easily absorbed by the blood through the capillar-
ies [12, 220].
A wide range of biopharmaceutical products with different application functions are
already part of healthcare, and with each passing year the number of new products only
increases. Currently, biopharmaceuticals account for 60% of the new drugs approved by
the FDA [28].
The composition of biopharmaceuticals can be grouped into different classes accord-
ing to their nature (Figure 2.1), being nucleic acids, peptides, or proteins [270]. Cell-
based systems can also be contemplated as biopharmaceuticals for applications in cell
therapy [235]. Biopharmaceutical products include, but are not limited to, purified pro-
teins, recombinant proteins, natural and synthetic peptides, recombinant hormones, re-
combinant enzymes, growth factors, cell and gene therapies, vaccines and monoclonal
9
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PEPTIDE PROTEIN
Vaccines
Hormones
siRNA
Aptamers
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Thrombolytes
…
Figure 2.1: Diagram of biopharmaceuticals classes divided into groups according to their
nature. Within nucleic acids there are siRNAs and aptamers [28]. In the protein group
there are the enzymes, growth factors, monoclonal antibodies, anticoagulants, among
others. Hormones can be divided between peptides or proteins. Vaccines can be divided
into all groups.
antibodies.
Complex biomolecules undergo a purification process before usage in patients, with
specific physicochemical properties and biological activity. Growth factors, for exam-
ple, are used to treat cardiovascular diseases, or for bone tissue regeneration at clinical
level [28].
Many of the molecules used to prevent diseases are inserted in the vaccines group.
Prophylactic vaccines are made from peptides, DNA, or recombinant proteins [213].
Hepatitis B surface antigen, for example, is a protein-based vaccine used against hep-
atitis B [277].
Another important class of biopharmaceuticals are the therapeutic proteins, that have
been targeting a great diversity of diseases for 30 years, representing one of the most
promising drug families [191]. This variety of therapeutic proteins is dominated by
mAbs [267]. Therefore, recombinant therapeutic proteins, including mAbs, constitute
the most mature class of biopharmaceuticals, with the highest number of approved prod-
ucts. From 2003 to 2017, the number of recombinant therapeutics approved by FDA
increased by approximately 400% [215, 216]. FDA set a record in 2017 for the number
and percentage of approved biopharmaceuticals being recombinant-based, there were
31 approvals, representing 93% of the total biopharmaceutical products approved. In
2003, there were 18 approvals and 69% for recombinant products. For the production of
therapeutic proteins, the most common expression system have been and continues to be
Chinese hamster ovary (CHO) cells [271].
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Figure 2.2: Monoclonal antibody structure. An immunoglobulin protein consists of two
proteins, the light and heavy chains, linked through disulphide bonds. Each chain has a
constant region(Fc) and a variable region(Fab). The antigen-recognizing part is located
in the variable region.
2.1.3.1 Monoclonal Antibodies
Immune processes are divided into two types: adaptive and innate [164, 203]. While
innate immunity recognizes targets common in any micro-organism structure, such as
double-stranded DNA, adaptive immunity recognizes an antigen by its specific epitope.
An epitope is a segment recognized by the T-cells and B-cells, the principal cells of the
adaptive immune system. Both of these receptors are able to recognize a specific target
of a micro-organism, usually a segment of an extracellular protein.
mAbs are complex molecules, produced by B-cells, that are specific to epitopes on
antigens. Once the cells are labelled by the antibodies, the latter conduct other cells of
the immune system to destroy those tagged substances [189]. Because of the ability to
recognize specific molecules present on the surface of the cell or in organism fluids, mAbs
affect the functions of this target cell without damage the rest of body’s cells.
mAbs are made of polypeptide chains and have high molecular weight. They are
Y-shaped proteins and are composed of a fixed and a variable part (Figure 2.2). It is
the variable region that characterizes antibody specificity and, therefore, where antigen-
antibody interactions occur. The constant region is the one that will determine which
of the 5 existing classes the antibody belongs to: immunoglobulin (Ig)M, IgD, IgG, IgA,
or IgE.
mAbs have revolutionized the field of research and medicine, due to its ability to be
produced in large quantity and its high specificity. These molecules are one of the most
structurally and functionally complex classes among protein-based biopharmaceuticals.
Mostly used to prevent and treat cancer (e.g., breast, colorectal and gastric cancers),
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infectious, inflammatory, and autoimmune diseases (e.g., rheumatoid arthritis, multiple
sclerosis), and transplant rejection, mAbs can be applied in multiple areas of medicine.
In this way, they can identify or destroy tumor cells, activate or reduce physiological
functions, stimulate or turn off receptors, stop pathological processes, and inactivate
enzymes [189].
In addition, antibodies do not have valuable functions only for clinical utilization, but
are also widely used for scientific research tools, such as Enzyme-linked immunosorbent
assay (ELISA) [256], Western blot (WB) [39] and flow cytometry techniques; and acting
as markers for diagnostic tests, being used, for example, to quantify a desired specific
protein found in an immersion medium.
The commercialization of the first therapeutic mAb product occurred in 1986, the
Orthoclone OKT3, approved for use in the prevention of kidney transplant rejection [71].
Since then, the commercialization of this class of biopharmaceuticals has only been grow-
ing. Therapeutic drugs based on monoclonal antibodies are the class of biotherapeutics
most produced today. The annual production demanded by the marked for an approved
mAb is 10–100 kilograms, using bioreactor batch sizes up to 20,000 liters [187].
By 2016, the FDA had already approved more than 50 mAbs for the treatment of a
variety diseases, and another 50 were in phase three clinical trials [219]. Of these products
already approved and manufactured, only three are produced in E.coli while all others
are produced in mammalian cells [71].
The first approved biosimilar mAbs in Europe, Inflectra and Remsima [71], are in-
cluded in the list of approved mAbs. They are biosimilar versions of the blockbuster
mAb Remicade. A single supplier, Celltrion, is responsible for the manufacture of the
bulk mAb used for the production of these biosimilars, although they are considered
two different products, since the final drug for each is manufactured by a separate entity
and two different manufactures are responsible by the final batch release of the products.
In addition, each product has undergone separate European Marketing Authorization
Applications.
The brilliant success of this class of drugs comes at a price. In 2013, global sales
revenue for all mAb products accounted for approximately half of total sales of biophar-
maceuticals, reaching close to $75 billion [71].
In addition to the continued growth in sales of mAb products already approved, there
are still more than 300 products from this class in development [208], with the potential
to come to approval, leading to the belief that not only sales of mAs will continue to grow
in the coming years, but will also boost sales of biopharmaceutical products in general.
About three to six new mAb products are approved each year in Europe and/or the
United States. Along these lines, approximately 70 mAb products are expected to be on
the market by 2020, with worldwide sales approaching $125 billion [71, 233].
Approximately 26% of mAb products entering Phase II human clinical trials in recent
years will reach market approval with an average time of seven years between the com-
mencement of Phase II clinical trials until approval [63, 205], based on the review of the
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historical success and turnover rates (i.e., time taken for a product to change from one
stage of development to another).
Global sales of mAbs have been growing faster than other biopharmaceuticals in
recent years, since their approval rate is also much higher than these other products. To
get an idea, from 2008 to 2013 the growth in sales of mAbs jumped from $39 billion to
$75 billion, an increase of 90% [71]. On the other hand, sales of the other recombinant
protein therapies increased only 26% over the same period.
There are some factors that contribute to the growth of the mAb market. The emer-
gence of new targets, from the rapid advancement of our understanding of disease at the
molecular level, is one of the drivers of continued interest in developing new antibody
products. The fastest route to a clinical proof-of-concept to activate, inhibit or block
these new targets is usually provided by the mAb product. The risk of unexpected safety
problems in human clinical trials is lower than in other types of therapeutic products,
since their production uses efficient platforms and the antibodies are generally well tol-
erated and highly specific. Thus, mAbs are almost always the first product candidates to
reach the stage of clinical trials for these new targets. And then, if proof-of-concept of
these products succeed, they are already advanced to commercialization, presenting the
“first-to-market” advantage [71].
The amplification of the world pharmaceutical market, due to the increase and aging
of the world population and the rising standard of living in emerging markets, is also an
important factor driving sales of mAbs [168].
Furthermore, the need for large-scale and cost-effective supply requires the market
to develop new technologies for the production of mAbs, allowing for a noticeable im-
provement in process efficiency and reducing actual manufacturing costs [44, 92, 267].
As a consequence, this represents a great benefit to society as these products have the
increasing opportunity to be inserted in more cost-sensitive markets.
2.1.4 Bioprocess Flow
Biopharmaceutical processes must be integrated processes designed to provide the quan-
tity and quality of the required product utilizing as few steps as possible and in the
most cost effective manner. Modern bioprocesses are diverse, with specialized designs, to
suit different types of consumers and their products. The production process of biotech
products, with application in the pharmaceutical field, is divided into two main steps:
upstream (USP) and downstream (DSP) processing as demonstrated in Figure 2.3.
2.1.4.1 Upstream Processing
UPS is the initial phase of the bioprocess, where cells grow within bioreactors until
they reach the desired density [188]. As shown in Figure 2.3, this step contains all the
tasks related to the development of the inoculum (thawed cells introduced to the media),
such as preparation of the media, cell culture, and bioreactor bulk collection. Thus, the
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Figure 2.3: Simplified Bioprocess Flow diagram. UPS covers the development stages of
the inoculum, represented by preparation of the medium, cell culture, and collection of
the bioreaction bulk. The DSP covers all the steps for recovery and purification of the
target product and subsequent shipment to the market, containing the stages of solid-
liquid separation, concentration, purification, formulation and filling. The stages of a
bioprocess may vary according to the host organism used and the desired product.
main purpose of UPS is to promote the environment necessary for cells to produce the
biomolecule of interest.
The media is prepared by ensuring proper nutrition for the cells to grow and express
the target product. Before introducing the cells, it is necessary to make sure the media
is homogenous. In addition, the media is subjected to measurement of some parameters,
such as pH, ions concentration (conductivity), glucose level and particle concentration
measurement (osmolality) to assure the perfect cellular development.
The fermentation process/cell culture is monitored and its end is based on the quan-
tity and quality of the product accumulated in the bioreactor. When the number of cells
begins to decrease faster, i.e. when they begin to die, it is the indicator that the highest
quantity of high quality product has been achieved in the bioreactor [267]. During the
cell culture, gases and temperature are controlled to guarantee maximum cell growth.
After cell culture, the bulk is withdrawn from the bioreactor containing the product
of interest and a diversity of other components. This target product can be excreted by
the cell, being an extracellular production (usually it is the case of mammalian cells), or
it can be an intracellular production (usually it happens with cells of bacteria), needing
cell lysis to be able to release and then harvest the desired biomolecule [199].
2.1.4.2 Downstream Processing
DSP is an essential step in the manufacture of biopharmaceuticals, and refers to the
recovery and purification of these products. The cell mass coming from the upstream is
processed to meet the requirements of purity and quality (e.g. stability and activity of
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the bioproduct). The main steps taken by DSP are harvest, concentration, purification,
formulation and filling [187]. Because biotech products vary in size and nature, different
principles of separation are required to isolate (recover) and purify the products.
Harvest is considered the transition stage between UPS and DSP. It is the primary
recovery, where the cells and large debris are separated from the medium containing the
target product. Centrifugation is one of the commonly used procedures for harvest, in
which cells and some larger debris are separated from the mixture and are discarded,
since they are the biggest components of the medium and suffer the effect of gravity more
intensely than the rest of mix. Another procedure, that is applied generally in sequence,
is the filtration, using size exclusion principle, to remove more debris. Harvest methods
may change depending on the host organism used.
After solid-liquid separation, the clarified is concentrated by methods such as evapo-
ration, ultrafiltration, adsorption, precipitation, among others, to reduce the volume of
sample to be purified.
In sequence, the purification stage occurs and it is extremely important for biopro-
cesses. It has the function of removing compounds that may cause a safety risk for
patients, supply risk, performance alteration of purification resins/membranes or dam-
age/alteration of product. Therewith, the final drug must be free of incompletely ex-
pressed product, aggregates of the target product, or remnants of cell lysis. Endotoxins,
host cell proteins, proteolytic enzymes, cellular DNA and other nucleic acids, virus, cell
debris, lipids and proteases are some of the impurities and contaminants that affect the
quality of the bioproduct [126].
To maintain the activity and stability of the product, the formulation step is applied,
by concentrating the sample with removing most of the water (e.g., freeze-drying, spray
drying), or crystallization by addition of salts.
Proteins are highly susceptible to loss of biological activity, so they deserve special
attention in the formulation step. To prolong the life of the protein, some stabilizers are
added for protein formulation, such as salts (ammonium sulfate, sodium chloride), sugars
(sucrose, lactose), polyhydric alcohols (glycerol) and polymers (polyethylene glycol). The
protein formulation may be in the form of dry powder, suspensions or solutions.
Lastly, in the filling phase the formulated product is packaged and sent to the market
for consumers.
2.1.4.3 Processing of Monoclonal Antibody
mAbs became the dominant product class within the biopharmaceutical market and, as
the biopharmaceutical industry matures, the number and types of diseases that will be
treated with monoclonal antibody products will only increase. This demand for mAbs has
as consequence the requirement of a significant improvement in design and optimization
methods and processes for the manufacture of this type of product, not only to make
the production process faster and more cost-effective for industry, but also to facilitate
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Figure 2.4: Typical integrated process for a mAb. USP usually occurs in perfusion biore-
actors, whereas in DSP, purification is divided into capture and two polishing steps.
Recovery is commonly performed together with a first purification by the capture chro-
matographic process. Purification, also called polishing steps, are generally covered by
CEX chromatography (binding and elute mode) and AEX chromatography (flowthrough
mode), respectively. To concentrate the solution, ultra/diafiltration procedures are re-
peated between different stages of the DSP. An additional step, the viral inactivation,
is necessary to improve the purification. Variations may occur to the process described
above.
world-wide access to the product in terms of cost-benefit in both developed and more
cost-sensitive countries.
For mAb-based drug category, the most common class of biotherapeutics produced
today, the conventional industrial production takes place via well-defined batch platform
operations, separated into USP and DSP [87]. In the USP phase the process runs in
large-scale fed-batch bioreactors, while in the DSP part the harvest and purification are
performed in sub-stages through sequences of complementary chomatographic methods.
Concentration steps, performed by ultrafiltration and diafiltration, may also occur more
than once in DSP, interspersed with the usual chromatographic operations [44, 187]. In
addition, there is a virus inactivation step [92, 267] to ensure the high level of purity and
no risks for human health. The complete process schematic [123, 249] can be seen in
Figure 2.4.
For the continuous production of therapeutic proteins, the USP presents two alterna-
tives: chemostat and perfusion bioreactor [94, 151, 276], both with continuous mode of
operation in terms of constant medium exchange. Their schematic setups are showed
in Figure 2.5. The striking difference between the two is that the output flow in the
chemostat is the same as the contents of the bioreactor, including cells, target proteins
and metabolites [113], while at the perfusion set-up, a cell retention device is added,
which removes only by-products from the bioreactor, which are the target proteins and
metabolites, and holds the cells in, allowing process intensification and increased viable
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Figure 2.5: Apparatus of chemostat (left-top) and perfusion bioreactors (right-top). In
the bottom, the graph compares their performance to cultures of Chinese hamster ovary
(CHO) cells via viable cell density profiles. For CHO cultures, much lower viable cells
densities are achieved with the chemostat than with perfusion operation, explained by
the low division rate of mammalian cells. Source: [267].
cell densities. Cultures with a high rate of cell division, as typically occurs with microbial
production systems, chemostat is used, while mammalian cells, which have a lower rate
of cell division than the former, are applied at the perfusion setup [267].
Cell retention devices, used in the perfusion bioreactor, use the separation method
based on cell size or cell density, and may be filter devices, centrifuges, gravity settlers to
acoustic wave separators [51, 152, 268]. However, the devices in focus nowadays employ
tangential flow, which are the Alternating tangential flow (ATF) filtration and Tangential
flow filtration (TFF) systems, both using hollow fiber filter modules for cell retention.
When comparing the two systems, a comparative study [57] showed that TFF device
could achieve higher viable cell density than ATF. In contrast, the ATF operation reduces
the probability of filter-fouling, as it induces a self-cleaning of the hollow fibers [40].
In another research [135] it was reported that the ATF device has significantly lower
maximum shear stress, but on the other hand, almost no protein retention compared to
the TFF.
An analysis of suitable cell specific perfusion rates is required for the appropriate
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design and development of the mammalian cell perfusion process. A robust and stable
operating process is the key to better integration with downstream processing for the
development of an end-to-end integrated production stream, and these conditions are
guaranteed by defining suitable operating set points (flow rates, viable cell density, and
medium composition) [267].
The mAbs are in mixtures of different molecules themselves, exhibiting a wide het-
erogeneity, due to degradation processes and post-translational modifications. So there
are different glycoforms, lysine variants, deamidated variants, etc. mAb purification is a
challenging task, due to the presence of impurities very similar to the target product and
consequently with very similar adsorption properties [253]. Besides that, their purifica-
tion is generically characterized by a center-cut separation, in which the pure fraction of
mAbs is eluted between two others composed by weakly adsorbing impurities (W) and
strongly adsorbing impurities (S). Thus, improved separation methods are required to
achieve good purity and yield in the purification process [178].
In DSP the primary separation of bioproduct and cellular debris from the bulk of
the bioreactor occurs at the capture, or recovery stage, usually performed on protein A
resin [267]. This stage is also a purification phase. The aim is to isolate the product by
removing all microparticles and colloidal materials, in addition to removing most of the
water, medium growth supplements, solutes from small molecules, proteolytic enzymes
and other degradative elements by concentrating the product. In short, the goal is to
isolate, concentrate and stabilize the target bioproducts [88]. Depending on the method
used for capture, the recovery phase can reach 95% purity [187].
Then, mAbs undergo a first polishing step, or intermediate purification, to remove
most of the bulk contaminants (impurities) [88], such as host cell proteins and accidental
viruses, even as other contaminants from other materials of the process, for example,
leached ligand from the capture resin (generally free protein A) which may be bound or
co-eluted with the desired therapeutic.
Finally, a second polishing step, or final purification, is employed to remove trace
contaminants and impurities (such as inactive or unwanted isoforms) or closely related
substances (fragments or other chemical modifications of the bioproduct, like improperly
combined or unfolded polypeptide chains) to achieve final purity [88]. Although this
stage is a more meticulous phase, both the intermediate and final polishing phases assist
in the removal of viruses, accidental or endogenous, and remaining traces of endotoxins,
DNA and host cell proteins.
In brief, while capture is used to concentrate the antibody from the sample taken
from the bioreactor outlet employing Protein A affinity chromatography using pH step
elution with the positive effect of significantly decreasing the levels of process-related
impurities (e.g., DNA), the two polishing phases aim at the removal of process- and
product-related impurities (e.g., aggregates) using two chromatographic methods such
as Cation exchange (CEX) and Anion exchange (AEX) [267]. There are two types of
purification mode: bind/elute mode, where the target product as it passes through the
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stationary phase is then retained by the medium, and the flow-through mode, in which
the target product flows through the medium and the impurities are retained by the
stationary phase. In the mAb case CEX acts in bind/elute mode, whereas AEX acts in
flow-through mode [123].
An alternative method for the mAb capture step has been extensively studied and
successfully applied in recent years—the Multicolumn Countercurrent Solvent Gradient
Purification (MCSGP) [155, 179, 180, 182]. This process allows the separation of charge
variants of the mAb with high yield and purity using a cost-effective cation exchange
adsorbent. Using MCSGP, the specific activity of the drug may be increased by removing
less active charge variants [178].
Yields and purities higher than 90% can be obtained with this procedure applied for
mAb purification [180, 250], and comparing to batch operation for the same purity values,
MCSGP achieves considerably higher yields [179]. Steinebach et al. [250] has recently
shown, for example, that for a purity of 92% in a procedure for isolation of the main
charge isoform of a mAb, a two-column MCSGP process (with 5 cm length each) achieved
94% yield after 5 cycles, while batch operation under the same parameters and using a
5 cm column obtained 50% of yield, while with a 10 cm column 85% yield was reached.
At the conventional mAb producing process (protein A affinity chromatography and
two polishing steps, cation- and anion-exchange chromatography), charge variants of the
mAb remain in the final product. Due to the increasingly stringent requirements related
to product heterogeneity imposed by regulatory authorities, the MCSGP has gained no-
toriety due to its ability to remove these variants in a preparative production with small
and economically viable units [253].
In addition, although protein A affinity chromatography, applied in the mAbs capture
phase, produces mAbs with high yield and purity, and with short process development
times, the high cost of the affinity resin dominates the overall costs of downstream pro-
cessing. Thus, although the CEX stationary phase is less selective than protein A, this
disadvantage is outweighed by a higher process efficiency. This increased efficiency of
the MCSGP is attributable to the countercurrent movement of the stationary phase with
the mobile phase and the internal recycle [180].
On the other hand, the use of cost-effective non-affinity resins in batch chromatogra-
phy provides a higher Host cell protein (HCP) content in the final product. Therefore,
the use of the continuous MCSGP process is favored, since it bypasses this drawback of
conventional non-affinity batch chromatography, while using a much cheaper resin than
Protein A. Ströhlein et al. [253] showed that MCSGP is very competitive with the capture
step using protein A, achieving yield of 95%, and HCP content in the eluted product
stream between 146-625 ppm, whereas at protein A capture phase is in the order of about
2000 ppm. To achieve the final specifications, a polishing step is generally added to the
process using a multimodal resin.
Accordingly, for mAb purification a two-step system consisting of cation-exchange
MCSGP capture step and multimodal batch chromatography polishing step may replace
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Protein A
CEX
(bind-elute)
AEX
(flow through)
MCSGP
CEX
Multi-Modal
AEX
(bind-elute)
Figure 2.6: Schematic of three-step and two-step processes for monoclonal antibodies
purification. The conventional sequence of chromatography steps is composed by Pro-
tein A affinity chromatography as capture phase and, as polishing phases, the cation-
exchange chromatography in bind-elute mode and anion-exchange chromatography in
flow through mode. The developed two-step downstream processing has the cation-
exchange MCSGP process as capture step, and a multi-modal chromatography using AEX
in bind-elute mode as polishing step.
the state-of-the-art three-step scheme which includes Protein A, cation-exchange, and
anion-exchange, as drawn in Figure 2.6
In another study, Müller-Späth et al. [180] in collaboration with Merk-Serono2 made
an economic comparison between the two-step process and the batch protein A-based
three-step process for mAb purification. The calculations took into consideration ma-
terial costs, overhead costs and capital costs. As result, the case study manifested that
downstream costs of the MCSGP-based process were 25 % lower than the protein A-based
process, which was predominantly caused by material costs that were 50% lower. The
study also showed that the cost gap between the two processes increases as the mAb titers
increase, which the latter appears as a current trend in upstream process development.
2.1.4.4 Upstream versus Downstream Processing
The challenge of the biopharmaceutical industry focuses on ensuring optimized, robust
and high-yield processes with bioproducts of a high level of purity and efficacy, but with
2Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company focused on
biopharmaceuticals, located in Darmstadt-Germany, and a brand and division of Merck. More information
at: http://www.merckserono.com .
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full attention to the costs derived from the production process.
Bioprocessing lines undergo switch-overs, maintenance, installation and validation
of new equipments, training of personnel and cleaning and sterilization of stainless steel
facilities, requiring a necessary downtime. Recent studies show that DSP still fights
to keep up with USP improvements, so downtime with upstream versus downstream
equipment is normal [217].
DSP, especially purification, continues to be the productivity limiter. The manufactur-
ing cost of therapeutic antibodies, for example, have a considerable percentage assumed
by the DSP chromatographic steps [229]. This is the main reason for the growing fasci-
nation and recent technology advances in continuous purification, which can solve many
downstream bottlenecks [157]. This interest has not only promoted technological ad-
vances that point to the transition from batch to continuous processing in many industrial
cases, as the conversion of batch manufacturing to continuous manufacturing has already
resulted in a significant intensification of the process for a variety of industries [267].
The benefits of continuous process are not few. It offers reduced equipment size,
steady state operation, low cycle times, high volumetric productivity, more homogeneous
product quality, and improved controllability, and, as importantly, reduced economic
costs [152, 210, 272, 280].
2.2 Chromatography
2.2.1 Principle of Operation
The history of chromatography began in 1903 and since then has had an important task in
several different fields [43]. Chromatography is a separation and purification technique
used to isolate, enrich and separate a target compound of interest from other compounds
of a sample. Therefore, chromatography is a reliable way to identify and quantify com-
pounds and an extraordinary way to produce pure, high quality compounds [60]. In
summary, the purpose of applying chromatography is to achieve satisfactory separations
in an appropriate time interval.
In the chromatographic method, the complex mixture is dissolved in a fluid (mobile
phase), which traverses through another material held by a porous support (stationary
phase). The various components of the mixture cross the stationary phase with different
migration speeds, causing the separation of these constituents. Therefore, the factor
responsible for separation of the components of the mixture is the differential interactions
that these components possess with two phases: the mobile phase and the stationary
phase [103]. Occasional differences in the velocity of passage through the stationary phase
imply in differential retention on the stationary phase, thus changing the separation [246].
To wash out a compound through a column the elution process is carried out, where
a suitable solvent is injected into the column. This solvent has a stronger interaction
with the component to be eluted than the interaction between the component and the
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Table 2.1: Terms commonly used in liquid chromatography. Adapted from [141].
Term Definition
Mobile phase or carrier Solution or solvent moving through the column.
Stationary phase or adsorbent Substance attached to a support that stays fixed inside
the column.
Analyte Complex mixture whose individual components have
to be separated and analysed.
Eluent Fluid entering the column to assist in the dragging
components of interest.
Eluate Fluid exiting the column and being collected for quan-
titative and qualitative analysis.
Elution The process of washing out a compound through a
column using a suitable solvent.
stationary phase. Table 2.1 shows a brief definition of the main terms used in liquid
chromatography.
Figure 2.7 illustrates the functional principle of chromatography, showing an example
of feed injection, in a previously packed chromatographic column, of a mixture containing
two major components, A and B. The purpose of this process is to promote a binary
separation. The curves inside the column show the concentration of each component as
a function of the length (L) of the column at x-axis. Thus, it is noted that by placing the
mixture to run through the column, constituent A has a higher velocity, and therefore
crosses the column more rapidly, due to its lesser interaction with the stationary phase
material (called raffinate). Accordingly, component B, which adheres more strongly to the
stationary phase (called extract), travels more slowly compared to A, that has a weaker
adhesion. With this, A is the first component to be collected at the output of the column.
Next, component B is collected at a further fraction of the output of the column. At the
end of the process, the eluate has two practically pure compounds separated and collected
at different time intervals, due to their different retention times. Retention time is the
amount of time a compound spends on the column after it has been injected.
The principle of separation of different constituents of the feed mixture is determined
by the differential affinities, or strength of adhesion, of the various components towards
the stationary and mobile phase, in which the affinity is decreed by two conditions: ad-
sorption and solubility [141], the adsorption being the phenomenon that measures the
degree and the manner in which the component attaches to the stationary phase, while
solubility is the property of how well a component dissolves in the mobile phase. Thus,
the higher the adsorption to the stationary phase, the slower the molecule moves through
the column. On the other hand, the higher the solubility in the mobile phase, the faster
the molecule moves through the column. These two factors, adsorption and solubility,
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𝑥 = 0 𝑥 = 𝐿
FEED
A+B
A : Raffinate
B : Extract
B
A
B
A
𝑡1 𝑡2 𝑡3 𝑡4
Figure 2.7: Operating principle of chromatography. A feed solution, in this case binary
mixture, consisting of A and B, is injected into the chromatographic column. Concentra-
tion profiles are plotted as the compounds pass through the column length. It is possible
to observe that the affinity of the B component for the stationary phase present in the
column is more pronounced than the affinity of A, therefore its retention time is longer
than that for A. The chromatogram shows the concentration profiles, or the detection
of the separated components, at the exit of the column. Since A is the least retained
component in the column, it is called raffinate, and will be the first component collected
at the output of the column, while B receives the extract nomenclature and will be the
last component to be presented at the chromatogram.
simultaneously interfere with the rates at which each component moves through the col-
umn and both can be manipulated by choosing the appropriate stationary and mobile
phases.
Nowadays, chromatography is the main tool employed for purifying biopharmaceu-
ticals [44], thanks to some advantages over other unit operations. To begin with, chro-
matography offers high separation efficiencies, enabling the use of mixtures with very
similar molecular properties. A second factor is the high capacity of chromatographic
adsorbents, allowing the capture of biomolecules from diluted solutions, which results
in rapid product concentration or almost complete removal of contaminants present at
low concentrations. Finally, chromatography can be employed in a nearly closed system
and chromatographic media can be easily regenerated.
On the other hand, the restrictions imposed by the biopharmaceutical industry makes
the scale-up of chromatographic processes a difficult achievement, making it a disad-
vantage for chromatography. However, this impasse can be solved and optimal columns
for large-scale can be developed through the manipulation of engineering tools in con-
junction with appropriate measurements [44]. For example, although there are still
no products with such a demand, there are already adequate and viable (technically
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and economically) chromatographic processes for the purification of proteins of 20 ton-
s/year [140], showing that this unit operation is promising in view of the rapid growth of
the biopharmaceuticals popularity.
Chromatography can have two different functions: preparative/production or analyt-
ical. While the purpose of preparative (or production) chromatography is the recovery
of purified products, in analytical chromatography the main focus is to gain information
about identification, purity and composition [206].
2.2.2 Types of Chromatography
Chromatography is attributed to a huge variety of applications, for qualitative and quan-
titative analysis, thanks to the several existing types of this method, defined by the mode
of interaction of the various components with the mobile phase and stationary phase
used. Regarding the mobile phase, the chromatography is categorized into two types, as
shown in table 2.2. If the mobile phase is liquid it is called Liquid chromatography (LC),
if it is gas then it is termed Gas Chromatography (GC); if the mobile phase is whole or
partially a supercritical fluid then it is termed supercritical fluid chromatography.
Additionally, table 2.3 explains the main varieties of liquid chromatographic tech-
niques commonly used, based on the specificity of the stationary phase.
2.2.2.1 Size Exclusion Chromatography (SEC)
Size Exclusion Chromatography (SEC), also called Gel Filtration (GF), is the simplest
of all chromatography techniques. It is a highly flexible and multifunctional separation
technique that uses as separation principle the different molecular weights as the sample
passes through the resin [62]. In this method there is not any interaction, physical or
chemical, between the analyte and the stationary phase, in other words, the molecules
do not bind to the chromatographic resin, unlike the other types of chromatography, and
consequently the composition of the buffer does not directly affect the final separation,
or the resolution (i.e. the degree of separation between peaks) [109]. This implies a
significant advantage of the SEC, where conditions may vary to suit the type of sample
or requirements for further purification analysis or storage without altering the separa-
tion. In addition, since the composition of the buffer does not affect the final separation,
SEC can be performed immediately after IEX, HIC, or AC. This technique is suitable
for molecules sensitive to pH change, metal ion concentration and cofactors, or harsh
environmental conditions, and can be operated within a wide temperature range (usually
between 4-30 °C), covering the prerequisites for most of the experiments.
As shown in Figure 2.8, the SEC resin is constituted by a porous matrix of inert
spherical particles [60]. The bed after being packed with the resin is equilibrated with
buffer, which fills the pores of the matrix and the space between the particles. The liquid
inside the pores, or stationary phase, is in equilibrium with the liquid (mobile phase)
outside the particles. Larger molecules than the largest pores in the matrix can not enter
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High molecular weight
Intermediate molecular weight
Low molecular weight
Figure 2.8: Separation principle of SEC. Biomolecules with higher size pass through the
inter-particle spaces of the stationary phase and elute first, while smaller biomolecules
enter inside the pores of the chromatographic media taking longer to elute.
the matrix, so they are the first molecules to exit the column having very low retention
times, once they pass directly through the column. Next, the molecules with partial access
to the matrix pores are eluted. Finally, the small molecules that have full access to the
pores of the matrix are harvested at the exit of the column. Therefore, elution from the
column occurs in decreasing order of size, and since there is no adsorption of molecules in
the SEC, the elution is isocratic, i.e., the composition of the buffer remains the same during
separation. However, at the end of the separation a washing step is usually proceeded
using running buffer to remove molecules that may have been retained in the column at
a nonideal behaviour, when interactions between the resin and the biomolecules occur,
and to prepare for the next experiment.
A greater homogeneity in the distribution of the matrix grains inside the column,
i.e. a smaller difference between the interparticular spaces, implies a greater uniformity
with which the fluid crosses the column, and therefore increases the efficiency of this
method [196].
The most regularly used SEC resins are based on agarose or silica [109], but there are
also matrices from other materials such as dextran and polyacrylamide [62, 196].
Lastly, SEC is sectioned according to three main applications [109]:
i) Preparative SEC: Applied to isolate one or more components (such as proteins and
enzymes, polysaccharides, nucleic acids, virus particles and other biological macro-
molecules) of a complex mixture.
ii) Analytical SEC: Apllied to evaluate the quality of the sample or to study the prop-
erties of a biomolecule, e.g. to determine molecular weights of the molecule. This
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approach can also be used for rapid purity checks and screening.
iii) Desalting and buffer exchange: Approach to decrease salt concentrations. Applied
to prepare samples for storage or for other chromatography techniques and assays.
2.2.2.2 Ion Exchange Chromatography (IEX)
Ion Exchange Chromatography (IEX) has as separation principle the electrostatic inter-
actions between groups of charged biomolecules and the matrix [60]. The chromatogra-
phy media has an ionic charge opposite to the biomolecule to be separated. Therefore,
what characterizes the affinity between the biomolecule and the column are the ionic
bonds. Since the molecules vary their charge properties, the degree of interaction with
the charged matrix will be determined according to differences in overall charge, charge
density, and surface charge distribution.
The chromatographic matrix can be porous or non-porous. The choice of the matrix
is made by analyzing the degree of resolution, binding capacity and desired flow rate for
the separation. Modern IEX media use polymer and agarose-based matrices to meet the
requirements of high bonding capacity, chemical and physical stability, and to generate
media with particle sizes satisfactory for a wide variety of applications [108]. The matrix
surface is then replaced by functional groups. There are two types of IEX, according to
the ion exchange media used, or, to be more specific, according to the functional groups
that are linked to this matrix, determining the charge of the medium [131]:
i) Anion exchange chromatography: The matrix is positively charged, and adsorbs
negatively charged biomolecules. Examples of functional groups: Quaternary am-
monium (Q), Diethylaminoethyl (DEAE).
ii) Cation exchange chromatography: The matrix is negatively charged, and adsorbs
positively charged biomolecules. Examples of functional groups: Sulfopropyl (SP),
Methyl sulfonate (S).
Figure 2.9 shows the separation principle of IEX, separating biomolecules according
to differences in their net surface charge. This procedure arose in 1960 and is one of
the most commonly used tools for purifying proteins, peptides, nucleic acids, and other
charged biomolecules. Such a technique is highly suitable for use in any of the steps
of biomolecule purification (capture, intermediate purification and polishing steps), in
addition, it is a mechanism used from micro-scale purification and analysis to purification
of kilograms of product. This is because the IEX technique offers valuable qualities such
as high resolution, group separations with high loading capacity, as well as being able to
separate molecules that have only minimal differences in their charge properties, such as
two proteins differing by one charged amino acid [108].
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Figure 2.9: Separation principle of IEX. The adsorbent has positively (AEX) or negatively
(CEX) charged functional groups. Biomolecules with opposite charge of the stationary
phase bind to the functional groups, while the biomolecules with the same stationary
phase charge flow through the column. In this case, AEX is illustrated.
To separate the components from the column matrix and elute out from the column,
the pH or concentration of ion salts are changed, thus changing the ionic strength (ions
concentration) of the buffer solution [134].
2.2.2.3 Affinity Chromatography (AC)
Affinity Chromatography (AC) uses as separation methodology the biorecognition (ligand
specificity), i.e. highly specific biological interaction between the analyte molecule and
the immobilized molecule present on the stationary phase (ligand) [265]. Thus, as seen in
the Figure 2.10, a affinity ligand capable to make a complex with a specific biomolecule
attaches to the chromatographic matrix (agarose, dextran, polyacrylamide, cellulose, etc.)
to create a stationary phase [60]. Then, the specific protein present in the mobile phase
binds to the stationary phase, remaining retained inside the column, while other compo-
nents cross the column.
This method provides high resolution, high selectivity and high capacity. In addi-
tion, it generally exhibits very high purities and recoveries of the active substance [265].
As an advantage over other chromatography techniques, it is the only one that allows
the purification of biomolecules based on their biological function and individual chem-
ical structure. As a consequence, purities that would be time-consuming, difficult or
even infeasible using other techniques can easily be performed with affinity chromatog-
raphy [110].
This type of chromatography can be utilized whenever a appropriate ligand is avail-
able for the target biomolecule, and is applied to isolate existing pure molecules at low
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Ligand
Specific target
Spacer arms
Figure 2.10: Separation principle of AC. The chromatographic media has a ligand specific
to one biomolecule, and spacer arms to promote the bond between the matrix and the
ligand. The specific biomolecules become attached as they pass through the column,
while other biomolecules are collected at the output of the column.
concentration in large sample volumes, to eliminate contaminants and to separate active
biomolecules from functionally different or denatured forms [110]. AC is required for
the capture or intermediate step in a purification protocol of hormones, enzymes, nu-
cleic acids, antibodies, and specific proteins [278], wherein the molecule(s) of interest is
collected in a purified and concentrated form.
Biological interactions between the biomolecule of interest and the ligand is a con-
sequence of Van der Waals forces, electrostatic or hydrophobic interactions, and/or hy-
drogen bonding [110]. The biomolecule that is attached to the ligand within the column
will only be detached when the ionic strength changes, by altering the pH or adding salt
solution, the polarity changes or when a competitive ligand is used [77].
2.2.2.4 Hydrophobic Interaction Chromatography (HIC)
Hydrophobic Interaction Chromatography (HIC) separates biomolecules based on the
differences in their surface hydrophobicity using a reversible interaction between these
biomolecules and the hydrophobic surface of the HIC stationary phase [212]. This inter-
action is influenced by the presence of salts in the mobile phase, in which high salt con-
centration in the sample increases the interaction between the hydrophobic biomolecules
and the hydrophobic chromatographic medium, in contrast, the decrease of salt concen-
tration weakens the interaction. Separation principle of this technique is demonstrated
in Figure 2.11. Therefore, although this method can be used in all steps of the Capture,
intermediate purification and polishing (CIPP) purification strategy [73], it is widely used
as a complement to other chromatographic techniques, since the solution will already
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Figure 2.11: Separation principle of HIC. Hydrophobic binders are coupled to the matrix
through spacer arms. Hydrophobic molecules of the analyte are retained at the stationary
phase according to their level of hydrophobicity, and the presence of salts at the mobile
phase favors interaction.
be at higher levels of salt concentration, and can be applied directly to the HIC column,
without any or almost no additional preparation.
The elution principle uses the presence of salts in the running buffer to directly influ-
ence the hydrophobic interactions between the biomolecule and the stationary phase. At
the same time that the salt concentration decreases, the interactions become weaker, so by
reducing the ionic strength of the buffer the interaction is reversed and the biomolecule
with the lowest level of hydrophobicity is eluted first [72]. Elution thus occurs in the or-
der of hydrophobicity (from the less hydrophobic to the more hydrophobic biomolecule)
as the concentration of salts in the buffer is gradually decreased, performed by linear
gradient or step elution [170].
The stationary phase is formed by a immobilized ligand carrying alkyl or aryl groups,
an inert support or spherical particles, and spacer arms to combine them [72]. The
matrix material can be polystyrene/divinyl benzene, benzene, agarose, cellulose, dextran,
chitosan, silica, methacrylate, etc [73, 88, 170].
Water plays an important role in this type of chromatography. Since water is a
poor solvent for non-polar substances and their molecules are agglomerated (in liquid
phase) through hydrogen bonds between themselves forming a highly ordered struc-
ture, water is unable to form hydrogen bonds with the hydrophobic surfaces and forms a
highly organized shell around the hydrophobic ligand and the hydrophobic portion of the
biomolecule surface. As thermodynamically it is favourable that the entropy (disorder be-
tween molecules) increases, the hydrophobic substances are forced to merge to decrease
the extent of the water crown, leaving a greater number of water molecules dispersed
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in the liquid medium, consequently increasing the entropy [170]. So the hydrophobic
interaction depends more on the behaviour of the water molecules than on the direct
attraction between the hydrophobic molecules [88].
HIC is therefore based on the interplay between the hydrophobicity of the station-
ary phase, the distribution of hydrophobic regions present on the surface of the target
molecule (in the case of proteins, the hydrophobic residues are amino acids), the nature
and constitution of the analyte, and the salt concentration used in the buffers [72].
This technique has the advantage of having weaker interactions in relation to the other
techniques, which allows to preserve the biological activity of the biomolecule [247]. In
addition, hydrophobic interactions are highly selective [73].
HIC is widely used in protein purification protocols, including monoclonal antibod-
ies (antigen-antibody reactions), but also plays an important role in the purification of
other biomolecules, such as plasmid DNA (pDNA) for gene therapy or DNA vaccines [73].
Additionally, because of its greater selectivity than in other techniques, HIC is widely
performed for analytical purposes, for example, for monitoring and quality control, de-
termination of folded proteins, separation and quantification of different isoforms or
variants of proteins or pDNA, and evaluation of purity [65, 124, 153, 279].
2.2.2.5 Reversed Phase Chromatography (RPC)
Reversed Phase Chromatography (RPC) is a chromatographic technique that also uses
the hydrophobicity differences of the molecules as separation principle, although it is
a completely different technique from HIC. The surface of the RPC medium is more
hydrophobic than the HIC medium, resulting in stronger interactions, and needing the
use of non-polar elution, utilizing organic solvents (such as methanol, ethanol, propanol,
acetonitrile, etc) [206], whereas the HIC adsorbent is more polar and has a less denaturing
environment [88].
The nomenclature of this method comes from “normal phase chromatography” and
the difference is explained as follow:
• Normal phase chromatography: The stationary phase is polar (hydrophilic) in na-
ture and the mobile phase is non-polar (hydrophobic), consisting of organic solvents
(e.g. hexane, methylene chloride);
• Reversed phase chromatography: The stationary phase is hydrophobic while the
mobile phase is constituted by water/organic solvent.
In this procedure, the initial conditions are aqueous, which favors the formation of
the highly structured water crown surrounding the biomolecule. Therefore, in order to
obtain a "wetted"surface and avoid crown formation, a small portion of organic modifier
(3-5%) [88] is usually placed in the mobile phase. The more hydrophobic molecules will
bind more strongly to the chromatographic media.
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Figure 2.12: Separation principle of RPC. The interactions are also hydrophobic. How-
ever, in RPC the interactions are more hydrophobic than in HIC and, because of that, the
elution uses organic solvents. As the amount of organic solvent in the column increases,
biomolecules elution occurs in increasing order of hydrophobicity.
At elution, the percentage of organic solvent is increased, eluting the biomolecules in
increasing order of hydrophobicity [206], as evidenced in Figure 2.12. The elution can be
isocratic, but it is generally performed in gradient for reasons of reduced run time. For
molecules with large differences in hydrophobicity, step elution can still be conducted.
The RPC stationary phase may be composed by a hydrophilic matrix of silica beads
covered by hydrophobic carbon chains (n-alkyl or aromatic hydrocarbons) [206], or by a
naked hydrophobic polymer matrix. For operations at high flow rates, it is recommended
to use matrices with uniform particle size, and for high binding capacity highly porous
matrices are recommended because of their large internal surface area [88].
An important feature of RPC is that it achieves extremely high-resolution separations,
separating components that have a minimal difference in hydrophobicity. Because of this,
this method is well suited for separation and analysis of small proteins, oligonucleotides
and peptides, being required for peptide mapping or purity checking and for polishing
step of peptides and nucleic acids, but it has limited utilization for the separation and
characterization of large biomolecules [73]. Moreover, this technique is employed to
desalt and concentrate hydrophobic components of a sample, being utilized for sample
preparation and separations that require high selectivity [88].
2.2.3 Batch versus Continuous Chromatography
A chromatographic process can be operated in batch or continuous, being characterized
according to the number of columns employed; this terminology is somewhat confusing
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because some multicolumn processes can be discontinuous (that is, feed is not continu-
ously inject into the system and/or product is not continuously collected).
In Batch Chromatography (BC) the process is designated by the use of a single column,
and the injection of the feed mixture and the eluent is performed discontinuously on
the same column [47]. In this system, the components are collected at the same side
of the column, but at different periods of time due to the different speeds with which
each component propagates (Figure 2.7). Since the component fractions are collected
at the same end of the column, feed injection cannot be performed continuously. The
optimization of BC consists at the discrimination of the pulse duration and the frequency
with which it is injected into the column [100].
Meanwhile, in Continuous Chromatography (CC) the column is divided into a given
number of smaller columns operated in series over a large number of cycles [47], with the
feed being continuously or cyclically injected and the fractions of mixture are recycled
internally.
Besides the various advantages achieved by a continuous system over batch operation
already addressed in 2.1.4.4 (such as reduced equipment size, steady state operation, low
cycle times, high volumetric productivity, more homogeneous product quality, improved
controllability, and reduced economic costs), by allowing the simultaneous operation of
several columns in the process, each performing different steps (i.e. feed, wash, elution,
regeneration), the CC is more efficient in terms of resin and solvent usage [47]. This means
that, switching from batch to continuous implies a reduction in solvent consumption, as
well as an improvement in resin capacity utilization, achieved by continuously loading
(overloading, in fact) the column, thus requiring less resin volume and, consequently,
smaller columns, thereby saving cost and time.
The limitations faced by batch chromatography are explained by the existence of two
trade-offs:
i) Productivity vs Capacity Utilization: In a purification process, e.g. mAbs process-
ing, the capture is a loading or “saturation” adsorption process [248], with operating
conditions rendering yields approximately of 100%, i.e. there is no mAb break-
through [166]. For this case, the loading of bead-based stationary phase occurs under
mass transfer limitation because of the low diffusivity of the mAbs, and once the
flow rates increases, this becomes more evident, resulting in shallower breakthrough
curves (concentration vs load volume). Thus, in batch mode there is a trade-off to
be solved, since the high productivity originated from high loading flow rates face
earlier breakthrough and therefore has the consequence of the decrease of eluate
concentration and Capacity utilization (CU), which due to the high cost and limited
lifetime of Protein A resins, this is a relevant parameter. To improve this factor, the
loading flow rates can be reduced, which leads to a decrease in productivity. And so
the trade-off between productivity and capacity utilization is in place. In order to
solve it, it is expected to use countercurrent and internal recycling processes [267].
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ii) Purity vs Yield: Unlike capture phase, the polishing phase in bind-elute mode is
referred to as “elution separation” [266], in which different solutes must be resolved
by step or linear gradient over the length of the column. In the case of antibody
purification, the impurities elute before and after the target (mAbs), impurities being
weakly and strongly adsorbed, respectively, representing a case of separation of
three components. The point is that mAbs and impurities have a similar adsorptive
behavior, implying low resolution (incomplete separation of chromatographic peaks),
unless very low loadings and very flat gradients are chosen, which decreases the final
productivity and concentration of the product. Therefore, it suggests another trade-
off in batch processing, this time between purity and yield at a given productivity
value [267]. With this, or a small section of the chromatrogram is collected as a high
purity product, but low yield, or a large segment is extracted increasing yield but
abdicating purity. This problem is repeated whenever the separation is difficult (low
resolution) or if the column is not long enough.
Both trade-offs, in the capture and polishing steps, can be softened by continuous
countercurrent chromatography, where the unresolved portions of the elution stream are
recycled internally. For this, the first process that exploited these problems were the True
Moving Bed (TMB) [136, 266] and SMB [41] processes.
2.3 Continuous Multicolumn Countercurrent
Chromatographic Processes
2.3.1 True Moving Bed Process (TMB)
In batch chromatography it is impossible to feed the system continuously since product
fractions are collected at the same end of the column, as shown in Figure 2.13a (case
of binary separation). However, in countercurrent chromatography, Figure 2.13b, if the
adsorbent is moving within the column and traveling in the opposite direction of the
mobile phase, with an intermediate velocity between the migration velocities of the two
solutes, the less retained solute (A) is carried by the mobile phase and collected at the
liquid outlet, while the more retained component (B) is dragged with the adsorbent and
collected at the other end of the column. After the total development of the concentra-
tion profiles (i.e., when the system reaches steady state operation), solutes A and B are
collected purely at the extract and raffinate outlet, respectively.
Thus, since the components are collected at the extremes of the concentration profiles,
even if the resolution of the peaks is not total, high purities are obtained with the moving
bed, while in batch chromatography high purities are only achieved if the resolution is
also high (complete separation of the peaks). Moreover, in the moving bed the adsorbent
is more loaded with solute than in the fixed bed, this is because countercurrent operation
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Figure 2.13: Comparison between the principles of batch and countercurrent separations.
At 2.13a, the two products exit at the same end of the column, which makes it impossible
to continuously feed in the chromatographic column, while at 2.13b each component is
collected at one end of the column, thanks to the movement of the stationary phase in
countercurrent with the mobile phase movement, where the less retained bioproduct (A)
is arrested with the fluid and the more retained compound (B) accompanies the solid
phase.
maximizes the drive force for mass transfer, which increases the efficiency of use of the
adsorbent [177]. This greater use of the adsorbent increases the productivity significantly.
The TMB was the first projected method of continuous countercurrent chromatog-
raphy [230]. Its process is based on four chromatographic zones (groups of columns)
countercurrently-operated, sequentially linked and in closed-circuit, each zone perform-
ing a different function [177]. Its working principle is illustrated in Figure 2.14. For
a two-component separation, the mixture (A/B) is injected between sections II and III
where separation of A and B occurs. Because B is the most retained, it is drawn by the
chromatographic media to the outlet port of the extract stream, where it will be collected,
between sections I and II. The less retained solute A, however, moves along with the
mobile phase to the outlet port of the raffinate stream, being collected between sections
III and IV. The input of zone I is fed with pure solvent to regenerate the adsorbent before
it is recirculated to zone IV, whereas in zone IV the solvent is regenerated before being
recirculated to zone I.
However, the countercurrent movement of the solid bed is never implemented in
practice, as this causes some operational problems of friction and of particles mixing
(dispersing the concentration profiles and therefore losing efficiency).
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Figure 2.14: Functional principle of True Moving Bed process. The scheme is divided into
four columns (sections), with the stationary phase moving countercurrently with respect
to the mobile phase. Both phases (mobile and stationary) recirculate in the system, in
order that, the operation happens in closed-loop. Feed is injected between zones II and
III, extract is collected between zones I and II, raffinate is gathered between zones III and
IV and desorbent is inserted at the entrance of zone I to promote the regeneration of the
adsorbent. Adapted from [177].
2.3.2 Simulated Moving Bed Process (SMB)
To overcome the limitations of the TMB, rather the problems associated with the move-
ment of the bed particles, the Simulated Moving Bed was developed. The SMB is a
continuous process of multi-column chromatographic separation with countercurrent
adsorption.
Its emergence occurred in 1961 [41] (with Sorbex process as commercially name), for
first implementation in the petrochemical industry, for separation of hydrocarbons, and
soon after in the refining of sugar. It was only in the early 1990s that the opportunity
was seen to reduce the SMB scale for application in separations at the pharmaceutical
and fine chemistry areas [133], due mainly to the appearance of new stationary phases,
more economical and more stable [156, 190, 195]. Nowadays, the SMB process is widely
used in different chromatographic separations in distinct steps of the development cycle
of a new biopharmaceutical product, and one of the drivers for this is the variety of SMB
models that have already been developed based on the conventional process [149, 239],
approaching concepts such as asynchronous port switching (Varicol process) [8, 165, 262],
time-variable manipulation of the flow rates (PowerFeed process) [139, 149, 283, 287,
288], cyclic modulation of feed concentration [236, 237], solvent-gradient operation [2,
15, 127], and several others.
The trend is new schemes using only few columns, as it decreases the amount of
adsorbent, the units are more compact and more economical, in addition to being sim-
pler and faster to switch between separations of different mixtures [227]. Nevertheless,
this improvement in separation performance is achieved at the expense of increasing the
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complexity and the sensitivity to procedural uncertainties and operative variability. Be-
cause of this, requirements like highly versatile equipment [281], advanced optimization
tools [69, 137, 138, 261, 262] and robust automatic control procedures [3, 146, 147, 238]
are strongly requested for this added complexity.
The conventional SMB is also divided into four zones of constant flow rates by the
presence of four ports: two ports for addition of fresh feed and eluent, and two ports for
product collection (extract and raffinate) [227]. The difference of SMB operation when
compared to the TMB, as shown in Figure 2.15, is that the countercurrent movement be-
tween the fluid and the stationary phase is simulated/provided by switching the inlet and
outlet ports in the same direction as the fluid flows at each completed switching interval,
while the chromatographic media remains fixed in the column. SMB is, thus, a simula-
tion of the continuous operation of TMB, through replacement of each TMB section (or
column) by several identical chromatographic columns (or subsections) interconnected
circularly to form a closed-loop. In closed-loop operation, zone IV is a zone for raffinate
enrichment and solvent recirculation, so the outlet stream of zone IV is recirculated to
zone I. This solvent recycle configuration reduces solvent consumption; on the other
hand, it requires an extra pump to do the recycle.
Although traditional SMB has four zones, other schemes with fewer zones have been
developed in recent years. There is, for example, the three-zone SMB scheme [171, 230,
284] obtained by removing zone IV from a typical SMB. Since without zone IV there is no
solvent recirculation, the 3-zone configuration, as well as the open-loop operation, avoids
any possibility of contamination of the extract. This type of configuration with reduced
number of zones implies some advantages over the traditional configuration, such as
reduction of the number of pumps, reduction of the residence time of the components
that are collected in the raffinate stream (which can prevent aggregation and denaturation
at chromatographic process for protein purification [184], for example), reduction of
the total number of columns, reduction of the amount of adsorbent required (in some
chromatographic separations, the resin may represent the dominant cost), and finally, the
scheme is easier and simpler to control. As disadvantages, the three-zone configuration
shows raffinate dilution and increased solvent consumption [177, 281].
The two-zone SMB has also been implemented with variations in the operation mode
of each process, being able to have intermittent feed and partial withdrawal for binary
separation [160]; continuous feeding and withdrawal for ternary separation [13]; partial
feeding with implementation of a solvent collection tank, to reserve and subsequently
use applied for binary [128, 129] or ternary separations [121, 122], but in the former case
without use a storage tank; modulation of the port configurations and flow-rate during
the cycle used for binary [227] or ternary separation [223] (the former, performed through
the addition of a further withdrawal), among several others.
Finally, the limiting case of using only one column to reproduce the cyclic behaviour
of multicolumn SMB chromatography, through delay in the recycle, has been proposed [4–
7, 16, 17, 176, 209] and will be discussed further below since it fits into the main theme
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Figure 2.15: Schematic diagram of Simulated Moving Bed process. The conventional
scheme has four zones as well as the TMB. The continuous movement of the adsorbent is
simulated through the periodic switching of the inlet and outlet ports in the same direc-
tion as the fluid flow. In addition, each section is partitioned into several subsections (or
columns) to approximate the discrete movement of the SMB to the continuous movement
of the TMB, thereby increasing process efficiency. The system is composed by identical
columns and operated at a constant flow rate. Adapted from [222].
of this thesis plan.
In general, SMB enjoys numerous advantages over other preparative chromatographic
techniques, almost all have already been cited throughout the continuous (subsection
2.2.3) and countercurrent (subsection 2.3.1) chromatography approach. To summarize
the advantages:
• The process is continuous, which dispenses manual intervention and facilitates the
stabilization of product quality and controllability of the process, besides operating
at steady state after a few cycles;
• The consumption of solvent is considerably reduced due to automatic solvent recy-
cling;
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• Resin capacity utilization, purity and specific productivity (i.e., per mass unit of
stationary phase) are increased ;
• As a consequence of the last topic, less resin is necessary for the same product purity,
implying in reduced equipment size and reduction of total costs and operating time.
2.3.3 Multicolumn Countercurrent Solvent Gradient Purification Process
(MCSGP)
Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) [24, 26, 155, 181,
250, 252, 253] is a continuous chromatographic separation process that has been par-
ticularly highlighted as a suitable process for bioseparations, enabling ternary (three
fractions) separation and linear solvent gradient application, resolving the constraints
of the traditional SMB, which has the limitations of performing only two components
separations and elution by step [267], the SMB being then rarely used in the polishing
step. With this, MCSGP encompasses the benefits of SMB, and even goes beyond SMB.
This method has also received notoriety for mAb purification [178].
The process was first developed in 2006 [252] and there are already different versions
with two to six chromatographic columns [25, 26, 154, 182, 200, 250], allowing continu-
ous [24, 252] or cyclic [25, 154] feeding and elution, multiproduct separation [155], and
different cleaning-in-place steps [183]. MCSGP can be applied to any bind-elute chro-
matographic mode (CEX, AEX, HIC, RPC, etc.), although for mAbs the CEX is the most
commonly used [267].
Its method of operation is demonstrated in Figure 2.16 for the two-column version,
and consists of collecting the pure portions of the chromatogram, while the others frac-
tions (or unsolved portions) are recycled to a second column, allowing high purity and
yield. This is achieved thanks to alternation of the state of the columns between inter-
connected and batch. Each switching interval consists of four steps, two interconnected
and two in batch mode. After the end of each switch intervals, the column positions
are interchanged and the steps are repeated. These four steps are crucial for controlling
purity and yield more independently than possible in a traditional batch operation. For
this reason, the MCSGP responds well to the trade-offs of batch chromatography.
In the first interconnected phase (I1), column 2 elutes and recycles to column 1 prod-
uct (P) containing weakly adsorbing impurities (W). To bring the solutes into a binding
state, inline dilution is applied. The next step, the first batch step (B1), only begins when
the outlet product flow is sufficiently pure, and therefore product is collected from col-
umn 2, while column 1 is fed. Once strongly adsorbing impurities (S) contaminate the
product to a certain level, the columns are again interconnected for recycling including
inline dilution. After the entire product is eluted from column 2, the second batch phase
(B2) comes into action, where column 2 is regenerated (strip, CIP, equilibration) and the
gradient begins at column 1, eluting W.
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Figure 2.16: Schematic diagram of one switch interval of the two-column MCSGP process.
The switch is divided into four steps, two interconnected (I1 and I2) and two batch (B1
and B2) modes, interspersed with each other. Phases I1 to B2 are performed sequentially.
Source: [267].
MCSGP technology has low complexity and hardware demand, as well as high flexibil-
ity due to sequentially proceeded tasks [250]. In addition, the MCSGP has the advantage
of, from complex mixtures, isolate and enrich single species in preparative amounts with
a high resolution. This is attained by combining three factors: (i) use of high pressure,
resulting in high separation resolution; (ii) use of chromatographic matrices with very
low mesh size, which in preparative batch chromatography is not possible due to tech-
nical restrictions; (iii) and as a main factor, recycling of impurities containing product,
resulting in high yields [253].
When comparing the principle of MCSGP process with batch chromatography, long
process development times are generally solicited to achieve the required threshold prod-
uct quality, whereas in the MCSGP this time is considerably reduced, reaching a faster
higher product quality as can be seen in Figure 2.17. Furthermore, as the operating
costs can be reduced because of lower maintenance cost and lower solvent consumption,
while yield can be increased up to 50% for the same purity value, the Cost of goods
(COG), at manufacturing field, can be significantly reduced, thus having a direct effect
on profits [253]. COG is the expenses directly related to the production of a company’s
product.
In order to guide the decision of the most suitable chromatographic process to be used,
a decision tree of chromatographic process has been proposed (shown in Figure 2.18),
where it indicates that for problems of binary separation with great difficulty of separation
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Figure 2.17: MCSGP versus batch with respect to process development time. Batch process
generally requires a long process development time to reach the desired threshold quality,
whereas through the MCSGP it is possible to abundantly decrease this time, achieving
faster higher quality.
the SMB is the most suitable process, whereas for complicated ternary separations the
most indicated process is the MCSGP.
2.4 One-Column Processes Similar to SMB
Nowadays, biomanufacturers demand agility and flexibility, so modern installations are
expected to be increasingly efficient, capable of narrowing the ratio of produced volume
and production time, without losing the quality of the product (purity and activity),
through operating systems each simpler [199].
The way currently highlighted to achieve these benefits is through the transition from
batch to continuous [267]. For the change to happen, the development and implementa-
tion of alternative continuous unit operations in the different production steps is required,
as well as the robust connection between the steps and control of the different parts of the
process. This modernization in the biopharmaceutical production process is so important
that even the FDA has encouraged efforts in continuous bioprocessing and underscored
its shocking potential in solving problems of flexibility, agility and robustness [162].
Concomitantly, there has been a tendency to decrease the number of chromatographic
columns employed in a continuous process, thanks to advances in the development of
cyclical operation policies [22], allowing the improvement of the performance of SMB op-
erating units. By establishing units with a reduced number of chromatographic columns,
benefits are outstripped, such as less stationary phase used, more economical set-up and
reduction of overall pressure drop.
Therefore, working with the limit case of only one chromatographic column can be
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Figure 2.18: Chromatographic process decision tree. Scheme to aid in the selection of
the chromatographic process to be applied in a purification problem. For separations
where the product collection interval does not contain impurities, it is recommended to
use batch chromatography. Meanwhile, for difficult binary separations SMB is the most
recommended, and for more complicated ternary separations the MCSGP is indicated as
more appropriate. Adapted from: [253].
very advantageous in some cases, since only one column needs to be repackaged, switch-
ing from one mixture to another tends to be easier and takes less time than in a SMB
system [22], in addition to a simpler design bringing more flexibility [7]. One problem
faced by SMB is the differences in separation when the columns are switched, because
if the columns are not identically packaged, the purities are different, the pressure drop
and/or flow rates in each zone may vary when switching happens, so the use of a single
column is more stable to these fluctuations than the SMB [6].
Furthermore, when operating with only one chromatographic column, the total pres-
sure drop decreases, which implies the reduction of the resistance to mass transfer and
allows higher flow rates in the system. This may be a considerable benefit if smaller
particles than those suitable to the equivalent SMB are used. And so, with higher flow
rates, the specific productivity is also increased. An added consequence is that as the
Péclet number is increased (due to increased flow rate), the hydrodynamic contribution
to band broadening in the chromatographic column is reduced [176].
This limiting case of one-column process similar to SMB has been developed and stud-
ied by only two research groups in a recent past, one of which this thesis is embedded,
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Figure 2.19: Complete cycle of the Analog mimicking a four-zone SMB with one column
per zone. The system consists of one chromatographic column and mixed tanks in the
same amount of columns used in the equivalent SMB. In the example shown above, four
mixed tanks are used to reproduce the standard SMB. Its cycle is defined after studying
the same column of the SMB during a complete cycle and then replacing the remaining
columns with mixing tanks to procreate the recycle streams while maintaining constant
specific productivity. F, D, P1, P2, tsw, and Ti are feed, desorbent, raffinate, extract, switch
time and the mixed tanks, respectively. Source: [7].
with variations in process design as well as in application purpose, and tested in differ-
ent case studies. A brief literature review will be discussed below to explain the main
differences between these processes, since this topic fits the main subject of this thesis.
2.4.1 The Analog
Abunasser et. al. [7] in 2003 were the first to address the idea of one-column chromatog-
raphy with recycle to mimic the four-zone SMB, which they termed “the Analog.” Its
operating principle was based on one chromatographic column connected to a number of
mixed tanks equal to the number of steps of an SMB cycle. For example, eight tanks are re-
quired by an Analog to mimic a four-zone SMB with two columns per zone. The schematic
diagram of the Analog is presented in Figure 2.19. Case studies or proof-of-concepts were
considered for linear systems, namely the separation of dextran T6-fructose and dextran
T6-raffinose mixtures, as well as for nonlinear systems with the separation of binaphthol
enantiomers. These separations were reproduced using the Analogs of four-zone SMB
with one column per zone (under two different conditions: total-feed and partial-feed)
and with two columns per zone. These applications were created and compared to the
corresponding SMBs only at simulation level, using Aspen Chromatography.
A comparison of the different configurations showed there were no advantages of the
basic Analog with partial-feed compared to the total-feed due to the mixing in the tank.
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The Analog of the two-columns-per-zone SMB showed higher purities than the Analog of
the one-column-per-zone SMB, since the former uses a larger number of tanks.
As an overall result, for the same values of specific productivity and desorbent-to-feed
ratio (D/F), the Analog obtained less purity than the SMB due to mixing inside the tanks.
The increase of product purity was achieved by dividing the tanks into several smaller
tanks to approach plug flow. For the same specific productivity, equal values of purity
to that of the SMB were achieved by the Analog through a modest increase of D/F from
1.0 to 2.6 (for one column per zone) or for 2.3 (for two columns per zone), which is a
significantly smaller increase than that required for chromatography without recycle to
obtain purities equal to an SMB. Therefore, the proposed analog showed to be a flexible
(due to its simple design) and inexpensive alternative to elution chromatography and
to SMB, reaching relatively high purities. The authors concluded that for high purity
requirements, the SMB had advantages, but on the other hand, for frequent changes of
the adsorbent, the Analog was advantageous.
Another theoretical case study was performed [144], this time considering the sepa-
ration phenylalanine and tryptophan amino acids, in which a four-zone SMB with one
column per zone was compared to a single Analog with four mixed tanks. The purity
and yield results were very similar between the two systems, although the SMB obtained
slightly higher values because the concentration profiles were destroyed in the fluid phase
after mixing inside the collection tanks.
In 2004, Abunasser et. al. [6] provided further applications for the Analog, again in
the framework of simulation and for binary separations. This time, these authors tried to
solve the problems of purity existing in the basic design of the Analog due to the use of
well-mixed tanks in the same amount of columns. For this, the tanks were replaced by
an even larger number of smaller mixed tanks to approach a plug-flow behavior, using
4, 8, 16, 20 and even 28 tanks. Hence, the Analog obtained near-identical values of
purities using 28 tanks over a four-zone SMB with one column per zone for linear dextran
T6-fructose separation.
In addition, start-up and shutdown studies were performed using computational
simulation to find the optimal operating conditions. It was showed that correct start-up
conditions could reduce the time required to achieve steady state by 50%, while shutdown
strategies could reduce the time and amount of desorbent needed to clean up the system.
Still in the same study, the scheme of the Analog was applied for the linear dextran
T6-raffinose separation and compared to the three-zone SMB with partial-feed and selec-
tive withdrawal, and for the linear dextran T6-fructose separation and compared to the
VARICOL system. The two Analogs had very similar purities to the compared systems,
especially when additional tanks were used, concluding that the analogue concept was
versatile and could successfully replicate several different configurations of the SMB for
binary separations.
Detailed simulations were also used to investigate Analogs and SMBs with two-feeds
in two different conditions: total feed and partial feed [143]. Analyzes showed that
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Analogs obtained reasonable purities relative to SMBs, especially in the situation where
total feed was performed.
2.4.2 The Single-column Analog with Recycle Lead
Two new concepts, the chromatograph with advance in recycle [22] and the chromato-
graph with delay in recycle [176], were developed by the research group in which this
thesis was developed. In these concepts, the cyclic stationary state of the SMB, or of any
other multicolumn chromatographic process that simulates countercurrent contact, can
be reproduced by a one-column process with a recycle lag of (N − 1)τ time units (in the
case of chromatograph with delay in the recycle), N being the number of columns and
τ the switching interval of the SMB mimicked, or with and advancement of τ units of
time (in the case of the chromatograph with advance in the recycle); the recycle is the
fraction of the output stream from the column that is not collected as product (extract or
raffinate).
An SMB process can be pictured asN identical single-column processes operated with
a lag of τ time units; if only the concentration profiles of the input and output streams
of each column are analyzed, it is impossible to differentiate between these processes.
Therefore, the operation of one-column chromatographs is performed by analyzing an
arbitrary SMB column and following its operation over the complete cycle of operation, as
can be seen in Figure 2.20. Therefore, the delay of (N−1)τ time units is consequence of the
circular array of columns in the SMB and their periodic operation characteristics [177].
In practical terms, the chromatograph with advancement in the recycle, named “Single-
column SMB Analog with Recycle Lead,” is not physically feasible because it requires
access to future events; however it was shown to be an efficient computational method (us-
ing gPROMS software) for direct determination of the cyclic stationary state of the SMB or
any multicolumn chromatographic process that simulates countercurrent operation [18,
22].
2.4.3 The Single-column Analog with Recycle Lag
Differently from the chromatograph with advance in the recycle, the chromatogram with
delay in the recycle, named “Single-column Analog with Recycle Lag,” is physically
achievable and can solve deficits of the Analog project. Although the Analog has suc-
ceeded in proving that it is possible to mimic an SMB system using only one chromato-
graphic column and reduced number of two-way valves, the major drawback is that lower
purities were obtained for the same specific productivity and D/F of the SMB mimicked,
due to mixing in the tanks. This could be solved by increasing the amount of mixing
tanks or increasing the D/F ratio, where the former brings increased volume and capital
cost of the unit, while the latter brings increased separation cost.
Since it has been proven in previous studies with the Analog that by increasing the
number of mixed tanks (to simulate plug-flow) the purity values have been increased, a
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Figure 2.20: Schematic of a cycle of operation for (a) a classic SMB (4-zones, 1-column-per-
zone), (b) its single-column analogue with recycle lag, and (c) its single-column analogue
with recycle lead. The two monocolumn processes are obtained by selecting an arbitrary
column of the classical SMB process, column 1 for example, and following its operation
for a complete cycle. The recycle streams (i.e. the portion of the outlet stream of the
column that is not withdrawn as product) is reinjected into the system with a time delay
of (N − 1)τ or time advance of τ . Source: [22].
new design was created to improve its performance using a single plug-flow (unmixed)
reservoir connected to the chromatographic column [176], representing a promise due
to the reduced number of equipment used (e.g. tanks, valves and tees), becoming less
complex and expensive, while maintaining the flexibility of the Analog.
The scheme of the Single-column chromatographic process with recycle lag is illus-
trated in Figure 2.21. The project considered the use of a plug-flow device with an average
residence time equal to the lag time [176]. This device was designed to solve the problem
of the difference of flow rates between the column inlet and the column outlet fraction
that is not collected as a product, which are not equivalent in some steps of the mono-
column chromatograph cycle, because the lag duration is not a multiple of the overall
cycle duration (Nτ). Thus, the chromatographic column is connected to a plug-flow tube,
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Figure 2.21: Single-column with recycle lag analogous to a classical four-zone SMB. A
single plug-flow tube with a piston at one end is connected to the chromatographic col-
umn. The tube implements the recycle lag of (N − 1)τ time units. The difference of
flow rates at the inlet and outlet of the tube that occurs during some steps of the cycle is
compensated by the movement of the piston. F, E, R, X are the feed, eluent, raffinate and
extract streams, respectively. Source: [176].
which has a piston actuated with spring at one end, allowing the piston to be continu-
ously pressed against the fluid, moving to compensate the difference between the inlet
and outlet streams. At the design of the new scheme it was also assumed that there
are internal elements or filler at the internal structure of the tube, to produce a flow as
close as possible to plug-flow, which could be filling with high porosity and inert to the
adsorption of solutes, grid structure, polymeric or metallic foam, among others [177].
In theory, under Cyclic steady-state (CSS) conditions, this single-column process is
identical to the equivalent SMB, except for the discontinuous use of the input/output
ports [17].
The scheme was used for the separation of binaphthol enantiomers as case study, and
the efficiency of the process was compared with a four-zone SMB with one column per
zone and two columns per zone, by simulation in gPROMS [176]. For reference, the
comparison was also extended to the Analog [6, 7]. The system proposed, in addition to
having the advantages of a single column system already mentioned in this section, it
exceeds results found with the Analog system, since it could potentially achieve purities
identical to the equivalent SMB while keeping the specific productivity constant, while
reducing the costs and complexity of the system by using a single reservoir, fewer valves
and less tees.
In a second study, presented by Araújo et. al. [17], the enantiomeric separation case
study was used to demonstrate the applicability of the single-column process for asyn-
chronous operation. The analysis was performed for four different port configurations
of the SMB: one (1/1/1/1) and two (2/2/2/2) columns per zone, five columns (1/2/1/1)
and seven columns (2/2/2/1); and three different port configurations of Varicol: five
columns (1/1.5/1.5/1), six columns (1.5/1.5/1.5/1.5) and seven columns (1.5/2/1.5/2).
Considering the same specific productivity for all systems, the purity results indicated
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that, as the P e was increased, the purity values also increased. For very high values of P e
(i.e. almost no hydrodynamic dispersion inside the tube), the purities of single-column
processes approached to those of the analogous SMB and Varicol processes. Analogues to
Varicol presented superior results than those SMB analogues, due to the compensation
of the less-perfect operation of the recycle tube by the Varicol concept, improving the
performance of the Single-column analog system. This study demonstrated not only that
the single-column system is able to mimic different configurations of SMB, but mainly
the need for an efficient plug-flow device.
Even so, there is a lot that can be done on this system. The output flow rate of the
chromatographic column in this design, for example, is divided between product (X or R)
and recycle through the bifurcation of the liquid stream. This means that throughout the
τ that the output stream is flowing, some of the liquid is collected and another part goes
into the recycle tube at the same time, which can result in impurities in the product stream
as well as excess of pure component in the stream that goes to the recycle. Moreover, the
validation tests studied involved only binary separations and were only performed at
the theoretical level through simulations in gPROMS. As it was only approached the
conceptual implementation of the process, no filler was tested to ensure a plug-flow
behaviour inside the tube.
2.4.4 The Unmixed Analog
In order to develop a similar but simpler plug-flow device than Single-column Analog
with Recycle Lag, Abunasser et. al. [4] proposed a new design for a one-column chro-
matograph called the “unmixed Analog”. In this novel process, shown in Figure 2.22, a
fixed-size unmixed tank is used, i.e. it does not contain a piston therein, and is packaged
with inert packing (nonporous beads in this example). The unmixed tank is connected to
the chromatographic column in closed-loop. Since the size of the tank is not variable, its
volume is constant and the variation in flow rates entering and exiting the column are ac-
counted by dividing the inlet and outlet streams into two different streams (so F = F1 +F2,
D = D1 +D2, E = E1 + E2 and R = R1 + R2). For constant flow rates into and out of the
reservoir,
T1 +R2 = T4 +D2 = T3 +E2 = T2 +F2 (2.1)
where F, D, E, R are respectively, feed, desorbent, extract and raffinate flow rates. Sub-
script 1 indicates that the streams enters and leaves the chromatographic column; sub-
script 2 indicates that the stream enters and leaves the unmixed reservoir. Ti is the flow
rate exiting the corresponding tank in the Analog with mixed tanks.
Binary separation of 1,1’ bi-2-enantiomers was enforced to this analog for the classical
SMB using simulations, run at Aspen Chromatography [4], which obtained higher purities
than the Analog with mixed tank and values slightly lower than SMB due to dispersion
in the device (a result similar to that achieved with the design developed earlier by Mota
et. al [176]).
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Figure 2.22: Schematic of the Unmixed Analog. The plug-flow reservoir has constant
volume and is packaged with inert filler. To compensate for the variation of flow rates
entering and leaving the column, the inlet and outlet streams are each separated into
two distinct streams. F, D, R, E are respectively, feed, desorbent, raffinate and extract.
Subscript 1 indicates that the streams enters and leaves the chromatographic column;
subscript 2 indicates that the stream enters and leaves the unmixed reservoir. Ti is the
flow rate exiting the corresponding tank in the Analog with mixed tanks. Source: [4].
As shown in the previous subsection 2.4.3, Mota and Araujo [17, 176] studies showed
that decreasing the dispersion within the device (through the reduction of internal parti-
cles, for example) increases the purity values achieved by the system. Therefore, a second
case study was addressed. Scaling rules were applied to the unmixed Analog for the
separation of 1,1’ bi-2-enantiomers [4]. The scaling rules are essentially identical to those
used in SMB since Analog was designed to mimic a SMB [142]. For this, the Analog was
first scaled to increase purities and match the SMB values by reducing the flow rates,
and then the scaling rules were used a second time for each step operate at maximum
pressure drop allowable (15 bar) with the aim of increasing productivity. With this, it
was shown that if appropriate scaling is used, it can be matched to the standard SMB
with productivity values 11 to 15% higher than standard SMB.
Subsequently, the versatility of the basic analog and unmixed Analog was extended
for application at ternary separations, mimicking the following processes: a cascade of
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two four-zone SMBs with one column per zone and a five-zone SMB with one column in
each zone [5]. Simulations were performed at Aspen Chromatography for nucleosides
separations (considered an easy separation, with linear isotherm at low concentrations).
Analogs with mixed tanks showed lower purities than SMB due to mixing inside the tanks.
For example, while the five-zone SMB achieved a P I of 88.3, the basic Analog with five
mixed tanks had PI = 83.4 and the Analog with 10 smaller tanks (to consider the same
specific productivities) had the PI of 85.4, where PI is defined as
PI =
%-purity of less retained solute in raffinate + %-purity of more retained solute in extract
2
. (2.2)
However, the five-zone SMB is not robust for ternary separations, it can obtain pure
products only if the separation is easy.
On that account, the unmixed Analog system was compared to the cascade of two
four-zone SMBs with one column per zone, that is a more robust system for ternary
separations [5]. As the reservoir reduces the mixing, the separation was improved, where
the cascade of two four-zone SMB system had a PI of 86.7, the Analog with eight mixed
tank obtained PI of 82.9, and the unmixed Analog reached PI of 84.6. Therefore, it has
been shown that with the use of an unmixed reservoir it has still higher purities than the
analogue with mixed tanks, but lower than the corresponding SMB due to the dispersion
in the unmixed reservoir. The unmixed Analog could not be extended to the case of a
cascade four-zone SMB with two columns per zone, since it can only mimic simple SMB
configurations [5].
The design of the unmixed reservoir is limited to SMBs that have a small number of
columns, because when the number of columns increases, there are not enough variables
(input and output streams) to maintain equal the inlet and outlet flowrates of the unmixed
tank [4]. Therefore, SMB configurations such as (1,1,1,1) and (1,2,1,1) can be imitated.
Another point in question is that in practice, and in simulations, the reservoir is not
perfectly plug-flow (as well as the design developed by Mota et. al. [176]), which leads to
a deterioration of the purity values. One more situation commented by Abunasser [4] is
that the device needs to be repackaged as well as the chromatographic column when new
mixtures are used, although, when compared with SMB, this system is still simpler and
more flexible since in the SMB a larger number of columns must be packaged and must
have identical residence times. The authors further conclude [4, 5] that because extreme
changes in flow rates are commonly required when new campaigns are conducted, the use
of a plug-flow device with variable volume, like the proposed by Mota and Araujo [176],
would be a gain to a one-column system.
2.4.5 Alternative Version of the Single-column Analog with Recycle Lag
In every SMB process, uncertainties in pump stability and calibration, temperature stabil-
ity, dead volumes, isotherm parameters, band broadening, and reproducibility of packing,
are unavoidable. It is therefore recommended that new operating schemes be developed
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Figure 2.23: Schematic of the Alternative Version of the Single-column Analog with
Recycle Lag. It is composed by a chromatographic column, three HPLC pumps, an UV
detector to measure the outlet concentrations. Pumps and detector are coupled to a fully
automated data acquisition and control system. Source: [226].
and validated on a small scale to identify possible operational bottlenecks and robust
problems before executing them in large scale [225].
An alternative version to the system described in subsection 2.4.3 was designed and,
unlike previous one-column systems, an experimental unit was created (Figure 2.23). Its
purpose is not to separate components of mixtures, it is to quickly and economically
reproduce the periodic behavior (i.e., cyclic steady state) of the SMB to not require the
realization of experiments on the multicolumn unit. The same objective presented by
Single-column Analog with Recycle Lead [22]. As shown in Figure 2.23, in this design
there is no plug-flow tube with piston inside. The eﬄuent stream from the chromato-
graphic column has its composition monitored in-line and then this composition is arti-
ficially re-created by a multi-pump system and the stream resulting from that mixture
is injected with a delay of (N − 1)τ time units [225]. For this purpose, three variable
speed pumps are used, where the flow rates are continuously manipulated according to
the temporal profiles of the column output. For each pump a different solution: solute
1 concentrate, solute 2 concentrate and pure solvent; allowing the additive mixture to
replicate the column inlet concentration and flow rate, as it is desired to simulate the
concentration and flow rate collected at the outlet of the chromatographic column in
previous steps, creating conditions similar to those experienced by the column if it were
part of the SMB unit operating under stationary cyclic conditions.
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This apparatus was validated experimentally [225, 226] and proved to be a simple,
compact and fast method of experimentally reproducing the stationary cyclic state of
different configurations of the SMB with a minimum consumption of solute and solvent.
In addition, it may be useful in the early stages of development, optimization and valida-
tion of new multicolumn chromatographic separations. Several different configurations
were tested for this system, including the classic SMB [225], the Varicol process (asyn-
chronous port switching) [225, 226], the PowerFeed process (temporal modulation of
flow rate) [226], and a hybrid process that combines Varicol and PowerFeed in the same
unit [226].
A small disadvantage of this procedure is that it introduces solutions into the system
through two separate solutes, which may represent a problem for separations in which
pure components are expensive or difficult to obtain, such as enantiomeric separations.
However, since the experiment is very short (one or two cycles) the amount of solute
required is very low.
When analyzing all single-column processes already suggested in the literature, there
are gaps for a design and (mainly) an efficient single-column experimental prototype. A
single column system that combines all of the following benefits: able to mimic a wide
variety of existing multi-column continuous systems (with varying levels of complexity),
using only one volume-adaptable plug-flow reservoir, operating in closed-loop, and with
practical purpose of carrying out the complete process of separation of binary or even
ternary mixtures (which are considerably more complicated); was never designed, built
its experimental unit and validated. Closed circuit operation, i.e. no need to re-create
the output of the column through liquid pumps, and with as few equipment as possible
would bring a more real, dynamic, faster and with less experimental error system. Gaps
found in the literature will boost the current thesis to create an ingenious and efficient
monocolumn system.
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Single-column Analog with Recycle Lag
3.1 Introduction and Objective
Currently, liquid chromatography (LC) is the best and most used technique to purify
biopharmaceuticals, often used in downstream processing (DSP). The most common
type of chromatography used by the industry, chosen specifically because of its simplicity
of use and installation, is single-column batch chromatography. This process generates
three fractions: (1) a pure product fraction that elutes first, (2) an impure fraction and (3)
another highly pure product fraction that elutes last, like those shown in Figure 3.1. The
main disadvantage is the product loss in the impure fraction, since the purity must meet
the requirements established by government agencies or the company itself.
To solve this problem, some processes were developed, particularly the Simulated
Moving Bed (SMB) process and allied variants, that implement multicolumn continuous
chromatography. As demonstrated in Figure 3.2, the continuous process captures the im-
pure fractions by internal recycling and purifies them until the purity desired is achieved,
with new feed being continuously or cyclically injected. As easily seen, this gives higher
yields of purer product while being able to process much more feed and use significantly
less solvent, increasing the overall throughput relatively to batch chromatography [95,
132, 174, 254]. This process was first patented in the 1960s [41] as a practical approach
to the True Moving Bed concept, and simulates the countercurrent contact of the station-
ary phase with the mobile phase by moving the inlets (feed and desorbent) and outlets
(extract and raffinate) with the help of a system of valves, carefully placed among the
system [27, 230, 251].
A standard SMB unit is made up of identical chromatographic columns, organized
in-line, so that the output of one column is connected to the input of the next column. The
columns are arranged into four sections or zones, each performing a different function
55
CHAPTER 3. SINGLE-COLUMN ANALOG WITH RECYCLE LAG
First out
Less retained
Intermediate out
Mixed fraction
Last out
More retained
Figure 3.1: Outlet fractions of Single-column batch chromatography. The mixed frac-
tion(s) is(are) taken out of the system.
Out
Less retained
Stays in
Mixed fraction
Out
More retained
Feed
Figure 3.2: Output fluids of the Multicolumn continuous chromatography. The mixed
fractions remain in the system, which move to the next downstream column.
and having one of two input streams at its upstream end and one of two output streams
at its downstream end. Although the traditional process has four sections, there are other
processes studied and presented in the literature with a reduced number of sections: for
example, three sections [230, 281, 284], two sections [21, 128, 129, 161, 227, 228], or even
systems similar to the SMB with only one chromatographic column [6, 7, 17, 176].
The SMB technology was first applied in the petrochemical and sugar industries,
for large scale production [27]. However, as time passed, other areas started applying
this process in their production lines, such as the fine chemistry and pharmaceutical
industries, to separate and purify a wide variety of substances [133]. Especially in the
pharmaceutical industry, SMB systems are used in a wide variety of steps, performing all
kinds of separation in the production line in the development of a particular drug.
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For the biopharmaceutical field, the two most important problems in operating an
SMB process are: (1) assessing product quality and (2) mantaining a long-term, stable
and controlled operation. For product quality, there are several strict constraints imposed
by regulatory organizations, particularly the American FDA [74], which increased the
necessity of having much better ways to control product quality. These ways usually pass
through new configurations and operating schemes, much different from the conventional
process [226], in order to obtain pure drugs [234]. Highly versatile SMB equipment is
required for these new schemes [281], as well as advanced optimization tools [20, 68, 69,
132, 138, 261, 262] and robust control procedures [3, 146, 147, 150, 239]. With all of this
in mind, a smaller number of columns is preferable, since less solid phase is required, less
equipment is involved and the pressure drop is reduced. Therefore, although the SMB
technology is traditionally defined as a system that comprises more than one column, it
would be quite advantageous, practically and economically, to have a system analogous
to a SMB process that has only one column.
For this to be possible, single-column batch chromatography could achieve many of
the benefits of continuous chromatography through smart recycling of the mixed frac-
tions. Actually, some works have been published regarding this theory [4, 7, 22, 176,
226] (Appendix A.1), but without any experimental exploitation of the analogy with the
continuous multicolumn chromatography.
The explored concepts proved to be possible to mimic SMB processes with flexible
systems using just a single chromatographic column obtaining relatively high purities,
but many gaps exist on these concepts and there is still a lot to explore. Specifically,
single-column systems were validated only through simulations (with the exception of
one [225, 226]), i.e. without experimental proof-of-concept, and all reproduced binary
or simple ternary separations (nucleosides separation) [5]. In addition to these gaps, the
concepts that considered mixture between the impure fractions in the recycle tanks [6, 7,
143, 144] obtained processes with purity results still lower than the mimetized SMB and a
large amount of equipment was necessary; while the concepts that considered to maintain
the concentration profile of the fractions collected for recycle [4, 5, 17, 18, 22, 176, 225,
226] were only addressed through simulations, and/or limited to mimic only simple SMB
processes, i.e. with few chromatographic columns [4, 5], or even without the objective of
promoting separation of components from the mixture, but rather reproducing the cyclic
stationary state of the mimetized SMB [18, 22, 225, 226].
The most comprehensive concept, proved to be capable of mimicking a wide range of
SMB processes and that received greater relevance among the few single-column concepts
already created was developed in 2005 by our research group [176]. This novel concept
that comprises a novel single-column chromatography analogous to SMB demonstrated
that by collecting the column outlet to a plug-flow device that produces a recycle lag of
(N − 1)τ time units, where N and τ are the number of columns and switch interval of the
equivalent SMB process, the periodic state of the latter SMB can be reproduced. In theory,
there is only one difference in comparison with the traditional SMB process, which is the
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discontinuous use of the inlet/outlet ports. Although this has been approached in the
literature, this concept was little explored, having been validated and studied only in the
scope of simulation work.
3.1.1 Two-column Chromatography for Purification of Biopharmaceuticals
For a better understanding of the One-Column Analog system, it is convenient to work
through an example, and the simplest one can think of in terms of number of columns
is a two-column SMB. In chromatography, there are two modes of operation: positive
and negative mode. In the first one, the product is retained in the stationary phase and
the undesired impurities are eluted. One example of this operation is the mAb capture
step on Protein A. On the other hand, in negative mode, the product flows through the
stationary phase and impurities are retained on the resin. The intermediate flowthrough
purification and polishing of virus and other large biomolecules on Capto Core 700 resin
are examples of this operation mode.
These two operating modes can be applied to the basic cycle of a two-column SMB.
Because the process has two columns, a full cycle can be divided into two equal half-cycles
or switching intervals as they are known in the jargon. At the end of each half-cycle the
column positions are exchanged and the steps are repeated all over. Hence, the process
needs only to be explained by the first half-cycle, as shown in Figure 3.3. The plotted
axial concentration profiles are those in the interparticle liquid phase inside the columns
at the start of each step. The profiles have been normalized by the corresponding values
in the feed.
Feed mixture is injected into the upstream column, which has been loaded with feed
up to nearly breakthrough during the previous cycle. The outlet of the upstream column
is directed to the inlet of the downstream column. The latter provides pure P2 (raffinate).
At the end of step 1 the upstream column is fully loaded with mixture to a point where
part of the mixture has broken through to the downstream column. In step 2 of the cycle
buffer is injected to clean the interparticle fluid of the upstream column and displace it to
the other column. The downstream column provides the P2 fraction. During step 3 of the
cycle, P1 (extract) is started to be collected from the upstream column while at the same
time feed starts to be injected into the other column. Thus, the upstream column provides
pure P1, which can be purified mAb in the case of positive mode chromatography or viral
impurities in the case of negative mode operation; during this step the downstream
column still provides the P2 fraction. Finally, during steps 4 and 5 of the cycle the
upstream column is washed and re-equilibrated while at the same time feed continues to
be injected into the other column. The downstream column still provides the P2 fraction.
Steps 6 through 10 of the cycle make up the second half-cycle. They are the same as
steps 1 through 5 of the first half-cycle but the positions of the columns are exchanged.
At the end of these steps one full cycle is completed and the process is repeated.
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P2
P2
P2
P2
P1
P2
Figure 3.3: First half cycle of a two-column SMB process for capture or flowthrough mode.
In positive mode: P1 (extract) = mAb (product), P2 (raffinate) = undesired impurities; In
negative mode: P1 = undesired impurities, P2 = virus (product).
3.1.2 Objective
In this chapter we propose to implement the conceptual design of the chromatography
unit for the “Single-column Analog with Recycle Lag” concept, the assembly of the re-
spective laboratory prototype, and the study of the mathematical model of the proposed
system. The objective is to fulfill the purpose of the concept previously developed [176]
in order to develop a versatile setup for chromatographic processes using just one column,
capable of mimicking the broadest range of SMB and derived processes, and to perform
not only simple binary and ternary separations but also more complicated separations,
i.e. those with overlapping peaks in the chromatogram.
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3.2 Conceptual Design of the Purification Train
Our aim is to propose a significant change in the configuration of chromatographic pro-
cesses, with the replacement of single-column discontinuous chromatography and mul-
ticolumn chromatography in continuous or semi-continuous operation by one-column
chromatography in semi-continuous operation. To achieve this goal, the new purification
process should combine the advantages of recycle chromatography, simulated counter-
current operation of the solid and fluid phases, and additional flexibility provided by the
addition of solvent gradient.
The design for the new process was based on theoretical studies presented in the
literature [17, 176], which demonstrated that the periodic state of the SMB process is
reproduced by a single-column chromatographic process with a recycle lag of (N − 1)× τ
time units, where N is the number of columns of the equivalent SMB unit and τ is the
switching interval (time interval between consecutive switches of the inlet and outlet
ports).
The operation of this ideal one-column process is formulated by drawing the schematic
of the complete operating cycle of a multicolumn processes (say a process withN columns),
then selecting an arbitrary column of the SMB and following its operation over a complete
cycle. One important point to note is that, under cyclic steady state operation, the inlet
stream of any given column of the multicolumn process, at an arbitrary instant t, can
be reconstructed from its outlet stream at time t − (N − 1)τ . By cyclic steady state oper-
ation, we mean the periodic operation of the unit after the initial transient cycles have
died out and the process behaviour is replicated from cycle to cycle. Finally, the mixed
fractions exiting the single-column chromatography are saved and reused according to
the following scheme: they are recycled with a lag in time of (N − 1)τ .
Figure 3.4 shows the basis for the one-column analog via the example of how to
convert the process of the two-column SMB into the single-column process. The figure
shows a complete cycle, with the steps of the first half-cycle shown on the left hand
side and those of the second half-cycle shown on the right hand side. Firstly, one column
needs to be selected at random (in this case, the first column was chosen) and its operation
followed during a complete cycle. Then, it is required to track at each step of the cycle
where the outlet stream of the column is required to reconstruct the inlet stream. For
example, the outlet in step 1 of the cycle will be reinjected into the column in step 1
of the next half-cycle, and the same happens with the outlet of the column during the
second step of the cycle where this fraction will be reinjected into the column during the
second step of the next half-cycle. During the other steps of the cycle the outlet stream is
collected as product or discarded as waste; so it will not be used later on in the process.
Getting back to the beginning of the cycle, the fraction coming out of the column during
the first step of the cycle is collected by the newly developed device, just like the fraction
coming out of the column during the second step of the cycle, keeping in mind that there
is a previous fraction that must be kept ahead of the one currently collecting. Next, steps
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Figure 3.4: Recipe for the One-Column Analog. 1st task: A column is selected at random;
2nd task: The steps of the cycle where the outlet stream of the column is required to
reconstruct the inlet stream are selected. 3rd task: The fraction coming out of the columns
are collected in sequence and reinjected to the other columns at the same sequence.
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Figure 3.5: Conceptual sketch of the novel one-column analog system. The process has
one chromatografic column with UV detectors immediately before and after it, and a
recycle device to collect fractions from the column. The product and waste exit occurs
between the column and the piston. F, E, P and W are, respectively, feed, eluent, product
and waste streams.
3, 4, and 5 of the cycle are carried out, producing pure product and discarding the waste
fractions. After this, the second half-cycle starts and the first fraction collected at the
beginning of the previous half-cycle is reinjected into the column (in the figure this is the
fraction colored in orange). During the second step of the half-cycle, the second fraction
which was stored previously, is reinjected while the outlet of the column is discarded to
waste. Lastly, these steps keep repeating as many times as necessary.
To summarize the procedure, the one-column process operates by recycling mixed
fractions back to the inlet of the column with a lag in time. The conceptual sketch
of the new process is represented in Figure 3.5, which consists of a chromatographic
column and a new device to promote recycle, connected to each other by automatic valves,
which also allow the entrance of feed and eluent and the exit of products and waste. In
our experimental prototype the concentration profiles are obtained by measuring the
absorbance values, thanks to the presence of in-line UV detectors right before and after
the column.
The recycle lag is implemented, in practice, by means of a special type of plug-flow
tube that includes a moving piston to compensate for the difference between inlet and
outlet flow rates. The proper operation of the inlets and outlets of such device implements
an approximate “first in, first out” method for organizing and manipulating the fractions
of fluid collected from the chromatographic column, where the oldest (first) amount of
fluid, or ‘head’ of the fraction, is the first to exit the plug-flow tube. This is necessary
because the recycle lag is not a multiple of the overall cycle duration. This recycle device
should avoid, as much as possible, fluid mixing and deviations from plug-flow of the fluid
therein.
Several aspects regarding the new process should be highlighted before assembling it:
• The use of no more than one chromatographic column is a prerequisite to define the
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system as innovative, since the conceptual design craved the substantial reduction
of stationary phase volume for continuous systems, aiming at an economical set-
up and allowing a reduction in overall pressure drop. The use of smaller number
of chromatographic columns also makes easier and faster to clean the system and
switch from one mixture to another, since only one column needs to be repacked;
• More and more compact installations are developed by the competitive market, so
the new system should contain as few equipment as possible, having a compact
and simpler design without losing its versatility (i.e. capability to mimic, with
this design, different variations of the SMB and other countercurrent multicolumn
processes existing in the literature). Therefore, the overall dead volumes must be
reduced to the maximum and the amount of equipment (liquid pumps and valves)
must be optimized in order to have the most compact and versatile set-up possible;
• The process must operate in a stable, reproducible manner. Although the reduction
of the number of columns already helps in this respect, the process automation
is crucial to carry out the experimental procedures, in order to instantly (in-line)
measure the variables of the system;
• In order to successfully mimic different chromatographic processes, from simple
to more complicated separations, as center-cut separation cases, a wide variety of
operating steps is required and must be in perfect working order. Each step needs
to be taken into account in order to build the apparatus;
• In order to increase system flexibility and avoid operational errors, the liquid pumps
must be able to operate in continuous mode, doing recycle to the respective feed
tank when the corresponding solution is not being injected into the operating sys-
tem. In addition, the continuous operation of the eluent pump allows the operation
of the device (piston) without the need to implement an extra pump in the setup.;
• As the recycle device should avoid as much as possible axial dispersion and mixing
of the fluid inside it to ensure that the conceptual design is being applied, the
“first in, first out” method is crucial to this process and experiments are required to
ascertain the operation of this method.
3.3 Assembly of the Experimental Setup
3.3.1 Recycle Device
The device consists of a column with a fluid distribution system at the top, a closed end
at the bottom with three inlets/outlets, and a movable piston with a fluid collector at the
top surface. The fluid collector is connected to the closed end of the device by a flexible
tube. It is important to emphasize that it is not the chromatographic column but rather
the piston-type device that implements an approximate “first in, first out” method.
63
CHAPTER 3. SINGLE-COLUMN ANALOG WITH RECYCLE LAG
TOP
PISTON
BOTTOM
(a) Recycle device. (b) Top with fluid dis-
tributor.
(c) Movable piston.
Figure 3.6: Piston-type device utilized for the One-column analog to SMB. (a) Complete
recycle device. The device consists of a column with a fluid distribution system at the
top, a closed end at the bottom with 3 inlets/outlets, and a movable piston with a fluid
collector at the top surface. The fluid collector is connected to the closed end of the
device by a flexible tube. (b) Top of recycle device with the distribution system made
of polyethylene (porosity: 20µm). (c) Movable piston with polyethylene frit and a fluid
collector at the top, and an outlet for the flexible tube (1/16") at its bottom.
The prototype (Figure 3.6) was built from a modified SNAP column from Essential
Life Solutions Ltd (USA), made of borosillicate glass, with dimensions of 25 mm for
internal diameter (ID), internal height range of 0–125 mm, maximum pressure of 24 bar,
temperature range of 4–40◦C and tubing connections of 1/16". The upper and lower
cover, as well as the movable piston are in teflon, and the o-rings, which ensure the seal
between the two internal sections of the piston, are made of ethylene propylene diene
monomer (EPDM) material. The flexible tube that passes through this piston and connects
to a 2-position-6-port valve has 35 cm, so that the length of the part that lies inside the
piston is 12.5 cm. Two polyethylene frits, with external diameter (OD) of 25 mm and
porosity of 20 µm, produced by YMC Europe GmbH (Dinslaken, Germany), are coupled
at the top surface and up side of the movable piston, respectively, to ensure that there is
radial distribution of the fluid concentration and to avoid possible preferred paths, while
helping in decreasing the generation of pressure drop in the system.
The piston-type device has two main settings, as shown in Figure 3.7. In the left-hand
side schematic fluid injected into the top of the device is stored in section A by forcing
the piston to move downward and the excess fluid in section B is redirected to the tank
from where it was first pumped. The pump that injects fluid into section B is typically
an eluent pump that is used to inject the eluent into other parts of the process. Thus, no
extra pump is required. In the configuration in the right-hand side, the fluid injected
into section B by the pump forces the piston to move upward and the excess fluid in
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Figure 3.7: Main piston operating configurations. At left one, movable piston is moving
down while collecting fractions from column. In configuration on the right, the movable
piston is going up while the fluid is being reinjected to the column following the “first in,
first out” method.
section A is redirected via the collector and flexible tube to the inlet of the column. This
implements an approximate “first in, first out” method.
After the need to assemble and disassemble the piston several times, it was noted the
need to create a protocol of the best way to assemble the piston, thus avoiding errors and
difficulties. This protocol is described in Appendix A.2.
3.3.2 Purification Unit
After having mastered the process, the installation scheme was designed in several steps
until the most appropriate prototype design, shown in Figure 3.8, was obtained. In this
schematic F, E, P, W, R are the feed, eluent, product, waste, and recycle streams (it comes
out of the piston in direction to the column inlet), respectively; COL, RP, UVi, Vi refer,
in this order, to the column, recycle piston, UV detector and on-off valve apparatus; The
2-position-6-port valves are represented by the circles with their fluid passage position
inside, which can be A, B, IN (fluid injection to the column) or BY (fluid bypassing the
column); COMi is the communication port responsible for making each equipment to be
identified by the computer.
The current prototype for the one-column analog to SMB was built with a series of
instruments. It essentially contemplates three Knauer (Berlin, Germany) pumps: one
V5010 S100 Smartline pump, denominated Pump F, for injecting fresh feed into the chro-
matographic column and two HPLC K501 pumps, one for injecting fresh eluent or solvent
into the process, denominated Pump E, promoting elution of the separating mixture, and
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Figure 3.8: Schematic of the Single-column with Recycle Lag setup. The unit uses one
chromatographic column, the recycle device, three liquid pumps, two UV detectors, seven
one-way valves and three 2-pos/6-port valves, beyond an digital scale. The layouts were
created in the Adobe Illustrator image editor.
another to generate concentration gradients in the process, if necessary, denominated
Pump G; all with 10 mL pump heads, operating pressure range of 0–40 MPa (0–400 bar),
and controlled via RS232 communication protocol. If required, the pumps can run con-
tinuously, even when they are not injecting the stream into the chromatographic column.
This means that, when pumps are not pumping fluid into the system, they are promoting
fluid recycling to their own source tank.
The setup still has two multi-wavelength UV detectors (two UV cells from Icon Sci.,
United Kingdom, each one linked to USB2000 or USB4000 Spectrometer from Ocean
Optics, USA), located immediately before and after the chromatographic column, con-
nected with a DH-2000-S-DUV light source (Micropack, Ostfildern, Germany), which
has Deuterium and Halogen lamps, ensuring absorbance readings in a broad range of
wavelengths. The presence of UVs provides the inline reading, instantaneously to the
fluid passage, generating the chromatogram of the experiment, allowing to identify the
cycle zones, or the time intervals, in which the compounds are separated and therefore
to measure the purity of the flowing fluid.
The operation of the setup is manipulated via seven one-way (i.e., on/off) valves,
one manually-actuated 2-position 6-port valve (VICI Valvo, Schenkon, Switzerland) to
66
3.3. ASSEMBLY OF THE EXPERIMENTAL SETUP
manipulate the fluid path, by bypassing the chromatographic column or by passing
through the column depending on the experiments to be performed. There are still
two electrically-actuated, 2-position 6-port/3-channel-injection valves from Valco Inter-
national (Schenkon, Switzerland). The one-way valves are model SFVO, with pneumatic
actuation, and each valve is automated by means of a single computer-controlled three-
way solenoid: application of 50 psi opens the valve; venting the air allows the spring to
return the valve to the closed position [228].
Although the flow path configurations based on one-way valves are very flexible,
their assembly tends to be bulky because an on-off valve has only two positions: open,
which allows the fluid to flow through; and closed, which blocks the fluid flow. In this
way, although the 2-position-6-port valves also switch between only two positions, each
position is more flexible than those of the simpler one-way valve, allowing a combination
of injection valves and thus making the feed and eluent pumps to operate continuously
over the cycle. The simplest way to do this is to redirect the pumped fluid back to the feed
and eluent tanks, respectively, during the sub-steps in which these pumps are supposed
to be turned off.
Two OptoRLY88 relay boards (Robot Electronics, United Kingdom) are used to signal
the pneumatic actuators of the different on-off valves of the setup. Each relay board sup-
ports eight valves, so although two boards are installed (connected to a total of sixteen
on-off valves), only one is required to operate the seven pneumatic valves currently nec-
essary by the setup. This allows, if necessary, possible future changes to the prototype
scheme to be easily performed. The diagram explaining the relationship between relays
and pneumatic valves is provided in Appendix A.3.
Since a generic process is desired, applicable to the purification of different biomole-
cules, the chromatographic column type used varies according to the separation to be
processed with the setup. The recycling device has already been described in the previous
section.
All equipments are connected through ETFE tubing (Upchurch Scientific, Germany),
with 1/16"OD and 0.040"ID, through which mixtures and other solutions travel. ETFE
capillaries support operating temperatures up to 80 ºC and are suitable for pressures
up to 276 bar, being a highly resistant material for the application it was employed.
The capillaries have been connected with care to minimize system dead volume, so the
shortest possible tube lengths were used to assemble the prototype. The connectors used
to link capillaries and equipments were PEEK finger-tight fittings (ACE, Scotland), with
pressures rated to 350 bar.
Product and waste collection containers are positioned on a monolithic digital scale,
model TE3102S (Sartorius AG, Germany), which allows to calibrate the pumps prior to
the experiments, as well as to verify the real pump flow rates during the experiments,
making the setup operating conditions more accurate, measuring the amount of raffinate
and extract yielded during the separation process.
It is worth mentioning the use of 8-port RS-232 PCI board (Moxa, China) installed on
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Figure 3.9: One-column with Recycle Lag prototype. Its installation was carried out in the
Laboratory of Adsorption Technology and Process Engineering (Chemistry Department,
FCT-UNL, Portugal).
the computer to allow communication with the RS232 connectors present on pumps and
2-position valves. The rest of the instruments, the OptoRLY88 relay boards and USB2000
and USB4000 Spectrometers, are linked with the computer via USB 2.0 B connectors.
The final result of the laboratory prototype is shown in Figure 3.9. The constituent
components of the prototype, their respective technical specifications and drawings, the
possible suppliers and the suggested prices are given in Appendix A.4. The estimated
overall cost of the setup is around 33930.00 €, disregarding the chromatographic column
and resin used, since these two items vary according to the separative process to be
mimicked. Although not accounted for the budget, the column and resin data used for
the next chapter are also present in the Appendix A.4.
3.3.3 Automation of Prototype Operation
Economic transformations require companies to adapt quickly to the market to keep their
businesses competitive, and thus have to adapt to broad digital transformation policies,
changing work tools and internal strategies [42]. For this reason, one of the most followed
path is process automation, so when it comes to the development of new machinery, it is
essential that its operation be as autonomous as possible, that is, that human intervention
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during operation cycles be minimized to the extremely essential.
The creation of a computational interface of operation, that is, of process automation,
brings several benefits, among them:
1. It allows you to streamline the process, saving time, so that there are no operating
intervals between steps and therefore increases productivity;
2. It avoids human operational errors, as it is more accurate;
3. It reduces operating costs, as employees become more productive by taking advan-
tage of process automation;
4. It integrates data, as all experimental information is concentrated in one place,
allowing easy access to data;
5. It integrates systems, allowing easy transfer to other software, such as software for
analyzing these data;
6. It also makes process reproducibility more reliable, as it substantially reduces the
error rate.
Taking this in consideration, all the Single-column Analog setup is fully automated
and driven by an in-house developed automation system using Julia software, initially
written for version 0.7.0 and recently upgraded to version 1.2.0. Julia is a very powerful
and versatile programmimg language for technical computing and is open-source. Be-
cause of that, special modules with different functions were created by J. Antunes and
J.P.B Mota [16], later joined by T. Santos, specifically to work in the Laboratory of Adsorp-
tion Technology & Process Engineering (LATPE, FCT-UNL Lisbon, Portugal) with the new
chromatographic system, aiming to facilitate the interaction between each instrument
and for realization of experiments in an automatic way, selecting only the sequence of
cycle operation, and for analysis of several experimental data. Thus, the prototype has
In-Line & Real-Time bioprocess monitoring, with the following key features:
1. Real-time display of Chromatograms (Absorbance (AU) x Time (s)), Intensity Spec-
trum (Light intensity (pixels) x Wavelength (nm)) and Absorbance Spectrum ( Ab-
sorbance (AU) x Wavelength (nm));
2. Easy calibration of pumps’ flowrates, due to the presence of functions that take
equipments information, in this case the weight information on the scale. The
pumps calibration protocol is expressed in Appendix A.5;
3. Simplicity in setting instrument operating parameters, such as pump flowrate;
4. System protection against too high pressure drop. The computational program
stops the operation of the pumps as soon as they reach unwanted pressure, previ-
ously indicated by the operator of the set-up, which ensures that the installation
will not suffer damage;
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5. Ease of operation through pre-implemented cycle steps, operating through easy-to-
understand macros;
6. Easy data handling: acquisition/recording of experimental reference data for later
data analysis in external software.
The command line interface (CLI) created and used to run the experiments is called
ChromatographyStudio.jl (see Figure 3.10), a versatile program that allows process automa-
tion and data acquisition. This main module calls all the others programs required for
this project (the explanation of each one can be found in [16]), assisting with the coordi-
nation between devices and different functions. Annex I shows a briefly diagram of the
programs created to work with this interface.
The most commonly used macros, i.e. codes placed on the interface that serve as
commands for system operation, as well as a brief exposition of their corresponding
function, are present in Table 3.1, as a usage protocol format for potential users. The
commands were designed (by the present author and interface’s authors) to be clear,
simple to understand, for any operator who needs to use them.
Table 3.1: Protocol of mostly used macros in ChromatographyStudio.jl. The action of each
command is explained in this protocol, serving as a help to the program user. (E = Eluent;
F = Feed; G = Gradient; R = Recycle Piston).
Command Action
julia7 Starts Julia software, version 0.7.0.
using ChromatographyStudio Starts the program created for the sys-
tem’s operation.
cal=calibrate_pump
(pump_Z,bal,[FLOW1, FLOW2, ...])
Pumps the selected pump, collecting 5
measurements for each chosen flow. Z
= E, F or G; FLOWi = pump flowrate
(mL/min).
cal.fit[4].p) Gets the four coefficients of the calibra-
tion equation (a fourth-degree polyno-
mial function).
cal.fit_inv[4].p Gets the four coefficients of the inverted
calibration equation.
(Table 3.1 – continued on next page)
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Command Action
@step Y=>COL=>Y’ Sets the pathway of the system’s
fluid by turning valves ON/OFF
and/or changing valves position A/B.
Y = E, F, G, R or E+F; Y’ = P, W or R.
@pump Z = VALUE Sets the value of the flow for the selected
pump. VALUE = flow rate (mL/min).
@pump Z PMAX = VALUE Sets the maximum pressure for the se-
lected pump. VALUE = max. pressure
(bar)
get_pump(pump_Z; :P) Gets the current pressure for the selected
pump (bar).
@valve +Vi Turns ON the selected valves. i = 1, 2, up
to 7.
@valve +all ; Turns ON all the valves.
@valve -Vi Turns OFF the selected valves.
@valve -all Turns OFF all the valves.
uv1.uv.po.integration_time
_micros(VALUE)
Sets the integration time. VALUE = inte-
gration time (µs).
@uvc A set=dark Sets the value of the UV when the Deu-
terium and Halogen lamps are closed. All
@uvc A commands also work with the
other UV cell, @uvc B .
@uvc A set=ref Sets the reference value of the UV ab-
sorbance when the Deuterium lamp is
open and passing the reference solution.
@uvc A plot=[I] Plots the Intensity Spectrum (Light Inten-
sity (-) x Wavelength (nm)).
saveintensityspectrum(uv1,
"Experimental Data\\FileName.tsv")
Saves the Intensity Spectrum.
(Table 3.1 – continued on next page)
71
CHAPTER 3. SINGLE-COLUMN ANALOG WITH RECYCLE LAG
Command Action
@uvc A wavelengths=[VALUE1,
VALUE2, ...]
Sets the selected wavelengths whose ab-
sorbances will be measured and plotted.
VALUEi = wavelengths (nm)
@uvc A plot=[A] Plots the Absorbance Spectrum (Ab-
sorbance (AU) x Wavelength (nm)).
save_absorbances(uv1,
"Experimental Data\\FileName.tsv")
Saves the absorbance spectrum.
@uvc A monitor=all Measures and saves the absorbances val-
ues (AU) of all wavelengths vs time (s).
monitorAbsorbance(uv1,"") Plots the Chromatogram with the selected
wavelength(s) (Absorbance (AU) x Time
(s)).
@uvc A plot=all Plots three graphs: Intensity Spec-
trum; Absorbance Spectrum and Chro-
matogram .
monitor_balance(bal,TIME) Measures, saves and plots the weight val-
ues (g) of the scale vs time(s), and plots
the corresponding flow rate(mL/min) vs
time(s). TIME = time interval (s) for each
measurement.
@monitor file =
"Experimental Data\\FileName.mon"
Monitors the complete experiment
(@pump, @step, @valve, @uvc com-
mands, Chromatogram values, Scale
values), saving the acquired data in a
created FileName.mon file.
include
("Experimental Routines\\
FileName.jl")
Runs a personalized script, executing ev-
ery command with the desired time.
@monitor stop Stops the monitorization of every com-
mand and data acquisition, finalizing the
created FileName.mon file.
(Table 3.1 – continued on next page)
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Command Action
@mon_to_tsv
"Experimental Data\\FileName.mon"
Changes the file extension of File-
Name.mon from .mon to .tsv, allowing
the data analysis of all the data.
exit() Shuts-down the Julia software, automati-
cally setting all pump values to zero and
closing all ON/OFF valves.
3.3.4 Implemented Steps
The setup implements a broad range of system configurations, demonstrated in Fig-
ure 3.11, that give rise to a lot of different steps: fresh feed, fresh solvent, and fresh
gradient can be injected while storing the outlet fractions of the chromatographic column
into the recycle device; fresh feed, solvent or gradient can be injected while producing
one or more product fractions or waste fractions; steps can be done by admixing feed,
solvent, or gradient with one or more fractions from the recycle device in open-loop or
closed-loop operation; or the setup can even operate in completely closed-loop, i.e. with
no solution added or fluid withdrawal, just recirculating system streams.
In conjunction with the definition of the steps to be implemented in the system,
the positions of on-off and switching valves were rigorously studied in order to set up
as few valves as possible for the system. The positions of the valves are described in
Appendix A.6.
All steps have been implemented in Julia’s software so that it is not necessary to select
which valves should be open or closed, i.e. when selecting the desired step, the path
that fluid must travel is already determined. This noticeably facilitates the operation of
process cycles, as well as avoiding human and experimental errors and saving time when
performing experiments. The default settings do not limit prototype versatility as it is
easily possible to implement new operating steps directly from the command prompt on
the computer.
The implemented commands generate the following prototype responses, and the
schematics for all these implemented configurations are presented in Appendix A.7,
demonstrating the path that fluid should take in each step:
• F+R => COL => R : Feed (F) is pumped by pump F to the chromatographic column
(COL). At the same time, the column is also receiving mixing fractions from the
recycle device (R). The fluid at the column outlet is directed to the recycling device.
As there is constantly flow entering the system and no fluid is being collected, the
piston is forced down. This is only achieved because the section B outlet is open
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Figure 3.10: ChromatographyStudio.jl command line interface. Print-screen taken from
the program as it starts, which shows the secondary modules that the main program calls,
the devices controlled by this central module and their respective input ports, as well as
the system’s initial state.
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Figure 3.11: All implemented steps of the novel Single-column chromatographic process.
The configurations were implemented on Julia’s software, allowing system automation.
allowing the eluent of this section to be redirected to the solvent tank. This is a case
of closed-loop recycling with feed injection (Figure A.5);
• R => COL => R : The mixing fractions of the recycle device (R) are redirected to
the chromatographic column (COL), and the column outlet fluid is again directed
to the recycle device, providing a case of closed-loop operation, thanks to pump E
operation. In this case, the piston is static (Figure A.6);
• E => COL => R : Eluent (E) is pumped by pump E into the chromatographic col-
umn (COL) until the recycling device (R), where fluid is stored, forcing the piston to
go down as it receives the fluid fractions. For this to happen, while fluid is being re-
ceived from section A of the device, the existing eluent from section B is redirected
back to the eluent tank at the same flow rate (Figure A.7);
• E => COL => P or E => COL => W : Eluent (E) is pumped by pump E into the
chromatographic column (COL) and the fluid is collected as product (P) or waste
(W), with the collector located on top of the weight scale (Figure A.8);
• F => COL =>P or F => COL =>W : Feed (F) is pumped by pump F into the chro-
matographic column (COL) and the fluid is collected as product (P) or waste (W),
with the collector located on top of the weight scale (Figure A.9);
• F => COL => R : Feed (F) is pumped by pump F into the chromatographic column
(COL) until the recycling device (R), where fluid is stored, forcing the piston to go
down as it receives the fluid fractions. Thus, the section B outlet is open to direct
the eluent therein to its respective tank (Figure A.10);
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• F+R => COL => P or F+R => COL=> W : Feed (F) is pumped by pump F to the
chromatographic column (COL). At the same time, eluent is pumped by pump E to
section B of the recycle device (R), while the inlet at the top of the device is closed,
forcing the piston to rise and thus forcing fluid to flow from section A through the
flexible tube to the chromatographic column . The fluid exiting the column is then
collected as product (P) or waste (W) (Figure A.11);
• R => COL => P or R => COL => W : Eluent is pumped by pump E to section B
of the recycle device (R), while the inlet at the top of the device is closed, forcing
the piston to rise and thus forcing fluid to flow from section A through the flexible
tube to the chromatographic column (COL). In this step product (P) or waste (W) is
collected, with the collector on the digital scale (Figure A.12).
3.4 Revisiting the theory
LetΩj be the operator that advances over a switching interval the state of the chromatog-
raphy column in position j relative to the locations of the inlet/outlet ports of the SMB
unit. Consider, for example, what happens over the kth switching interval from instant
(k − 1)τ to kτ , where τ is the duration of each switching interval. For this purpose let τk
stand for t = kτ , i.e., the end of the switching interval, and Tk the interval (k−1)τ < t ≤ kτ ,
i.e., its duration; the start of the switching interval is simply τk−1.
Using this notation the operator Ωj can be symbolically represented as
(Cstartj ,C
out
j−1)|k
Ωj−→ (Cendj ,Coutj )|k . (3.1)
That is, given initial conditions Cstartj |k for column Cj at τk−1 and outlet conditions Coutj−1|k
for the upstream column connected to Cj during Tk , which together with other external
inputs specific of Ωj define the inlet conditions for Cj during Tk , Ωj advances the state
of Cj from C
start
j |k to Cendj |k and computes the outlet conditions Coutj |k for C during Tk .
Using Ωj the operation of the SMB unit can be defined as follows:
Cstartj |k = Cendj+1 |k−1, (Cstartj ,Coutj−1)|k
Ωj−→ (Cendj ,Coutj )|k . (3.2)
This operation is represented in the schematic of Fig. 3.12.
Under cyclic steady-state (CSS) conditions Cj is τ-periodic, ie, its state is repeated
every τ time units:
Cj |k = Cj |k′ ∀k,k′ ∈ CSS. (3.3)
Hence, under CSS conditions Cendj+1 |k−1 in the previous equation can be replaced by Cendj+1 |k
to yield the following equation:
Cstartj |k = Cendj+1 |k , (Cstartj ,Coutj−1)|k
Ωj−→ (Cendj ,Coutj )|k ∀k ∈ CSS. (3.4)
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Figure 3.12: Schematic representation of SMB operation.
But given that under CSS conditions the dynamics of the switching intervals are all
identical (they are τ-periodic), we can even drop the k subscript in the previous equation
to get
Cstartj = C
end
j+1 , C
start
j ,C
out
j−1
Ωj−→ Cendj ,Coutj (CSS), (3.5)
or, enumerating for the N positions,
Cstart1 = C
end
2 , C
start
1 ,C
out
N
Ω1−→ Cend1 ,Cout1 (CSS), (3.6)
. . . (3.7)
Cstartj = C
end
j+1 , C
start
j ,C
out
j−1
Ωj−→ Cendj ,Coutj (CSS), (3.8)
. . . (3.9)
CstartN = C
end
1 , C
start
N ,C
out
N−1
ΩN−→ CendN ,CoutN (CSS). (3.10)
This set of equations is perhaps the best to define the CSS behavior of an SMB unit.
If a particular column, say the one that happens to be in position N at the start of
a cycle—a sequence of N consecutive switching intervals—is followed over a complete
cycle, it will got through positions j = N at switching interval k, j = N − 1 at k + 1, . . . ,
j = 1 at k +N − 1. Its operation can be defined as follows:
Cstart|k = Cend|k−1 , (Cstart,CoutN−1)|k
ΩN−→ (Cend,Cout)|k , (3.11)
Cstart|k+1 = Cend|k , (Cstart,CoutN−2)|k+1
ΩN−1−→ (Cend,Cout)|k+1, (3.12)
. . .
Cstart|k+N−2 = Cend|k+N−3, (Cstart, Cout1 )|k+N−2
Ω2−→ (Cend,Cout)|k+N−2, (3.13)
Cstart|k+N−1 = Cend|k+N−2, (Cstart, CoutN )|k+N−1
Ω1−→ (Cend,Cout)|k+N−1. (3.14)
To derive a one-column process analogous to the N -column process it is necessary to
replace the references to CoutN , . . . , C
out
1 in the equations above by references to C
out that
are equivalent to the former under CSS conditions. For example, given that under CSS
conditions
Cj |k = Cj−1|k+1 ∀k ∈ CSS, (3.15)
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the equations above could be rewritten for the CSS as follows:
Cstart|k = Cend|k−1 , Cstart|k ,Cout|k+1 ΩN−→ (Cend,Cout)|k , (3.16)
Cstart|k+1 = Cend|k , Cstart|k+1 ,Cout|k+2 ΩN−1−→ (Cend,Cout)|k+1, (3.17)
. . .
Cstart|k+N−2 = Cend|k+N−3, Cstart|k+N−2,Cout|k+N−1 Ω2−→ (Cend,Cout)|k+N−2, (3.18)
Cstart|k+N−1 = Cend|k+N−2, Cstart|k+N−1,Cout|k+N Ω1−→ (Cend,Cout)|k+N−1. (3.19)
Unfortunately, these equations as they stand describe a process that is physically
impossible to realize because Cout in each of them is specified for one switching interval
ahead in time (into the future) of that for C. But under CSS conditions any given column
goes through the same state every Nτ time units (it is Nτ-periodic), that is
Cj |k = Cj |k−N hence Cout|k = Cout|k−N , (3.20)
and this allows us to rewrite the equations for the one-column analog as follows:
Cstart|k = Cend|k−1 , Cstart|k ,Cout|k+1−N ΩN−→ (Cend,Cout)|k , (3.21)
Cstart|k+1 = Cend|k , Cstart|k+1 ,Cout|k+2−N ΩN−1−→ (Cend,Cout)|k+1, (3.22)
. . .
Cstart|k+N−2 = Cend|k+N−3, Cstart|k+N−2,Cout|k−1 Ω2−→ (Cend,Cout)|k+N−2, (3.23)
Cstart|k+N−1 = Cend|k+N−2, Cstart|k+N−1,Cout|k Ω1−→ (Cend,Cout)|k+N−1. (3.24)
These equations show that Ωj uses Cout|k−N+1 to define the inlet conditions for C at
switching interval k, ie, the outlet fractions of C that are neither collected as product nor
discarded are recycled back to its inlet with a lag in time of (N − 1)τ time units.
It is important to notice that although the governing equations for the one-column
analog were derived from eq. 3.25 rewritten here as
(Cstartj ,C
out
j−p)|k
Ωj−→ (Cendj ,Coutj )|k , p = 1, (3.25)
they are still valid for other integer values of p ≥ 1 as long as p is independent of j and
does not change over the course of the switching interval. This will always be the case for
two-column processes.
If N ≥ 3, there will be nonstandard SMB processes for p > 1 that cannot be mimicked
by the one-column analog either because p = p(j) or/and p changes over the course of the
switching interval. But a little reasoning shows that even in cases when p = p(j) changes
over the course of the switching interval, the one-column analog will still work if there
at most two different column connections per switching interval.
For example, consider GE Health Care’s three-column periodic counter-current (PCC)
chromatography (3C-PCC) setup for the mAb capture step using protein A resin. Fig. 3.13
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Figure 3.13: The principle of 3C-PCC chromatography (adapted from GE Healthcare’s
open literature). Step 1: columns 1 and 2 are loaded with clarified cell culture supernatant
(red). Step 2: column 1 has reached the determined level of breakthrough and column 2
becomes the first column in the loading zone. In step 2, column 3 becomes the second
column in the loading zone, while column 1 is subjected to wash, elution, strip, CIP, and
re-equilibration (yellow). Step 3: column 2 has been loaded to the determined level of
breakthrough and is disconnected from the loading zone and column 3 becomes the first
column in the loading zone. In step 3, column 1 is now ready for the next cycle and
becomes the second column in the loading zone. This procedure is repeated in a cyclic
manner to achieve a continuous operation. ∗The elution phase in this figure includes
wash, elution, strip, CIP, and re-equilibration.
shows a schematic of the basic process. In a PCC setup, columns are switched between the
loading step and non-loading steps comprising column wash, elution, cleaning in place
(CIP), and equilibration. At a predefined level of breakthrough, the primary column in
the loading zone is disconnected from the loading zone and the load is redirected to the
next column. In parallel, the disconnected, saturated column will be washed, eluted, and
regenerated. To fully utilize the potential of this setup, the non-loading steps should be
shorter or equal to the time for loading of a column. One cycle equals three loadings, one
on each column.
As shown in Fig. 3.13, the basic 3C-PCC process is a three-column SMB process with
p = 1 (standard) and hence can be mimicked by the one-column analog with recycle lag.
This process, however, has yield losses associated with the wash step (with product either
in void or loosely bound to the chromatography medium), which can be minimized by
the wash strategy described in Fig. 3.14. The content of column 1 (saturated column) is
79
CHAPTER 3. SINGLE-COLUMN ANALOG WITH RECYCLE LAG
Figure 3.14: Wash strategy in 3C-PCC (adapted from GE Healthcare’s open literature).
This strategy is used to avoid yield losses associated with the post-load wash step: col-
umn 1 (saturated column) is washed into column 3 (regenerated column) before column 3
is added into the loading zone. ∗Includes wash, elution, strip, CIP, re-equilibration.
washed and bound in column 3 (regenerated column) before column 3 is placed as second
in the loading zone.
When this enhanced variant of the 3C-PCC process is drawn over a full cycle (three
switching intervals), as in Fig. 3.15a, it is seen that p = 1 for connection A whereas p = 2 for
connection B. But given that this process has only two different column interconnections,
A and B, per switching interval, it is possible to devise a one-column with recycle lag
that mimics its operation. Fig. 3.15c shows the one-column process derived from the
operation of column 3 over a complete cycle (Fig. 3.15b). The first two cycles correspond
to the start-up of the process whereas from the third cycle onwards the process is fully
periodic. Note that, and this is extremely important, in the second cycle fraction B is
replaced by washing buffer to stagger the ABAB sequence from cycle three onwards.
Consider now the hypothetical three-column process depicted in the schematic of
Fig. 3.16. This process was obtained by adding an extra step to the one in Fig. 3.15a.
The one-column analog derived by following the operation of column 3 over a full cycle
(Fig. 3.16b) is shown in Fig. 3.16c. It is seen that for the new process p = 1 for connections
A and C whereas p = 2 for connection B. We now have p = p(j) and more than two different
column interconnections per switching interval. The resulting one-column analog is
not physically realizable because the sequences of inlet and outlet fraction histories are
incompatible as shown in Fig. 3.16d.
As another example, consider Novasep’s Sequential Multicolumn Chromatography
(SMCC) commercialized as BioSC. Fig. 3.17 shows a schematic of a full SMCC switching
interval with five steps applied to a four-column BioSC. At the start of cycle the highly
loaded layers are contained in the first column (1), which is isolated from the process, and
the latter steps of the chromatographic method are applied independently. A washing
step, of appropriate volume for this first column, pushes unbound target product con-
tained in the liquid phase of the first column to the second (2) column, thus preventing
product loss and maximum buffer usage. The first column is now eluted while loading
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Figure 3.15: (a) Full cycle of 3C-PCC with wash strategy (FT stands for flowthrough;
∗includes wash, elution, strip, CIP, re-equilibration). (b) Isolation of the operation of
column 3 over a full cycle. (c) Corresponding one-column analog with recycle lag (©→
stands for injection of wash buffer).
restarts in linear sequence through partially loaded columns (3). The second column will
reach a highly loaded state as the first column described before and the process repeats
for each column completing a full SMCC cycle. At the end of one cycle, each column is
exposed to the same quantity of product and buffers.
This process is an SMB with constant p = 1 and can thus be mimicked by a one-column
analog with recycle lag. Figure 3.18a shows a schematic of a full SMCC cycle with any
given column, say column 4, targeted for emulation. To generate the one-column analog,
the operation of the targeted column is followed over a complete cycle, as illustrated
in Fig.3.18. The fractions exiting the one-column analog that are neither recovered as
product nor discarded—fractions A–H in this case—are recycled back to the inlet of the
one-column analog with a lag of 3τ time units (Fig. 3.18c). Figure 3.18d shows a sim-
plified schematic of the full cycle of the one-column after merging identical, sequential
steps.
Figure 3.18 illustrates another important feature of the single-column analog with
recycle lag. It is that any multicolumn process with steps involving sequences such as
→2→2→2→ or ←→2→2→
(the latter for the case of a two-column unit) gives rise to a one-column analog with steps
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Figure 3.16: One-column analog of an hypothetical variant of the 3C-PCC process. (a)
Schematic of a full cycle with column 3 targeted for emulation. (b) following-up of
column 3 over of a full cycle. (c) Full cycle of the one-column analog. (d) Expected inlet
sequence of fractions for the chromatographic column and outlet sequence of fractions
obtained from the recycle device.
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Figure 3.17: Example of a full SMCC switching interval with five steps applied to a
four-column BioSC (adapted from Novasep’s open litterature).
such as the second one in Fig. 3.18d in which the one-column chromatograph operates in
closed-loop recycle, ie, the outlet of the chromatography column is directed to the recycle
device while at the same time the outlet of the recycle device is directed to the inlet of
the chromatography column.
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Figure 3.18: One-column analog of a four-column SMCC BioSC with five steps per switch-
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cycle with column 4 target for emulation. (b) following-up of column 4 over of a full
cycle. (c) Full cycle of the one-column analog. (d) Full cycle of the one-column analog
after merging identical, sequential steps.
3.5 Mathematical Modelling of the Proposed System
In a dynamic system, the values of the variables change with time. In this section, it will
be considered the dynamic modelling for the setup, detailing the role that each equipment
prints to the model. The mathematical model were divided in four steps.
3.5.1 Recycle Piston
Solute transport through the recycle piston lies between two limiting cases: the best case
scenario—that of plug flow—and the worst case scenario—that of a perfectly mixed tank.
A detailed analysis of the flow pattern inside the piston would require solution of the
dispersed-flow equation for an inert scalar coupled to the Navier Stokes equation for
laminar flow of an incompressible Newtonian fluid, subject to inlet and outlet conditions
defined by the geometries of the distributor and fluid collector, a task that is beyond the
scope of this work. Instead, we consider the simpler intermediate case of axially-dispersed
plug flow [23, 257, 258] inside the piston:
∂ci
∂t
=DL
∂2ci
∂z2
− v0∂ci∂z , ∀t > 0, 0 < z < L(t), (3.26)
where ci(z, t) is the concentration of solute i in the fluid inside the piston, t the time
coordinate, z the axial coordinate along the piston, v0 the inlet fluid velocity, and DL the
axial dispersion coefficient. The inlet is at a fixed spatial position, z0 = 0, whereas the
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Figure 3.19: Schematic of the recycle piston with dead volumes. V0 and VL are the dead
volumes at the piston inlet and outlet, respectively.
axial position of the outlet, zL = L, can vary depending on whether the piston is steady
or moving (Figure 3.19). If DL→∞, the model describes the worst case scenario (perfect
mixing); if DL→ 0, the model describes the best case scenario (pure plug flow).
If vL is the outlet fluid velocity then the difference vL − v0 gives the velocity at which
the piston is displaced, that is,
dL
dt
= v0 − vL. (3.27)
For example, if the piston is being filled, v0 > 0 and vL = 0, and the piston moves with
velocity v0. If the piston is being emptied, v0 = 0 and vL > 0, and the piston moves with
velocity −vL.
Eq. (3.26) is subjected to the following (Danckwerts) boundary conditions:
v0ci −DL∂ci∂z = v0c
in
i for z = 0
∂ci
∂z
= 0 for z = L(t)
, (3.28)
where cini is the inlet solute concentration; henceforth we shall also use the shorthand
notation couti ≡ ci(L,t) to denote the outlet solute concentration.
Eqs. (3.26) and (3.28) are easier to solve numerically if the moving boundary condition
is replaced by a fixed one. To achieve this we introduce a change of variable that maps
the spatial domain z ∈ [0,L(t)] onto a dimensionless domain x ∈ [0,1], of fixed length,
through the transformation
x(z, t) =
z
L(t)
or z(x, t) = xL(t). (3.29)
where, the partial derivative of z(x, t) is
∂z(x, t)
∂t
= x
dL(t)
dt
= x(v0 − vL). (3.30)
84
3.5. MATHEMATICAL MODELLING OF THE PROPOSED SYSTEM
𝑐
𝑧 𝑡
𝑡𝑥
𝜕𝑐
𝜕𝑧
𝜕𝑐
𝜕𝑡
𝜕𝑧
𝜕𝑥
𝜕𝑧
𝜕𝑡
Figure 3.20: Chain Rule.
Moreover,
∂ci
∂z
=
∂ci
∂x
∂x
∂z
=
1
L
∂ci
∂x
and
∂2ci
∂z2
=
1
L2
∂2ci
∂x2
. (3.31)
Using the chain rule (Figure 3.20) we obtain:
∂ci(x, t)
∂t
=
∂ci(z, t)
∂t
+
∂ci(z, t)
∂z
∂z(x, t)
∂t
. (3.32)
Replacing z by x, using eqs. 3.28, 3.30 and 3.31, gives the following transformed equation:
∂ci
∂t
=
DL
L2
∂2ci
∂x2
− v0
L
∂ci
∂x
+
1
L
∂ci
∂x
x(v0 − vL), (3.33)
or, simplifying
∂ci
∂t
=
DL
L2
(
∂2ci
∂x2
)
− v0 − (v0 − vL)x
L
(
∂ci
∂x
)
, ∀t > 0, 0 < x < 1, (3.34)
subject to the boundary conditions
v0ci − DLL
∂ci
∂x
= v0c
in
i for x = 0
∂ci
∂x
= 0 for x = 1
. (3.35)
At any time the volume of fluid in the piston is VP(t) = APL(t), where AP is the cross-
sectional area of the piston. Moreover, the flow rate at the piston’s inlet is Q0 = APv0
and the flow rate at the piston’s outlet is QL = APvL. Rearranging these equations gives
AP =
VP(t)
L(t) and v0 =
Q0
AP
= Q0VP(t)
L(t)
.
Thus, the above equations can also be written as a function of the inlet and outlet flow
rates:
∂ci
∂t
=
DL
L2
(
∂2ci
∂x2
)
−
Q0
VP
L
−
(
Q0
VP
L
− QLVP
L
)
x
L
(
∂ci
∂x
)
, or
∂ci
∂t
=
DL
L2
(
∂2ci
∂x2
)
−
Q0−(Q0−QL)x
VP
L
L
(
∂ci
∂x
)
, or
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VP
∂ci
∂t
=
VPDL
L2
(
∂2ci
∂x2
)
−
[
Q0 − (Q0 −QL)x
](
∂ci
∂x
)
, ∀t > 0, 0 < x < 1, (3.36)
Q0
VP
L
ci − DLL
∂ci
∂x
= Q0VP
L
cini for x = 0, or
Q0ci − VPDLL2
∂ci
∂x
= Q0c
in
i for x = 0
∂ci
∂x
= 0 for x = 1
. (3.37)
It is also more convenient to quantify the effect of the axial dispersion by means
of a Péclet number than via DL directly. If dispersion in the piston is assumed to be
proportional to the fluid velocity then
DL ≈Dm (1 +γPed) =Dm +γDPv0 =Dm +γDPQ0AP . (3.38)
where Dm is the molecular diffusivity, γ should be regarded as an empirical constant
whose value is much smaller than 1/192, and Ped = v0DP/Dm is the Péclet number based
on the diameter, DP, of the piston. If the dispersion within the piston was assumed to be
approximated by Taylor dispersion, then γ ≈ 1/192, but this consideration is only valid
for fully developed laminar flow in an infinitely long tube, which is certainly not the case.
Thus, the reciprocal of the Péclet number based on the piston length is
1
Pe0
=
DL
v0L
=
Dm
v0L
+
γDP
L
=
1
Pem
+
1
Peh
. (3.39)
where Pem = v0L/Dm is the molecular Péclet number and Peh = L/γDP is the hydraulic
Péclet number.
Hence, multiplying the eq. 3.38 by A
2
P
VP
, results:
A2P
VP
DL =
A2P
VP
Dm +
A2P
VP
γ
DPQ0
AP
, or
V 2P
L2
1
VP
DL =
A2PDm +APγDPQ0
VP
, or
VPDL
L2
=
γm +γhQ0
VP
, γm = A
2
PDm, γh = γAPDP, (3.40)
We can finally write our model as follows.
dVP
dt
=Q0 −QL, (3.41)
V 2P
∂ci
∂t
= (γm +γhQ0)
(
∂2ci
∂x2
)
−VP
[
Q0 − (Q0 −QL)x
](
∂ci
∂x
)
, (3.42)
VPQ0ci − (γm +γhQ0)
(
∂ci
∂x
)
= VPQ0c
in
i for x = 0(
∂ci
∂x
)
= 0 for x = 1
, (3.43)
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γm = A
2
PDm, γh = γAPDP. (3.44)
The last consideration is the time scaling. If we decide to replace t by θ = t/τ , a
reduced time coordinate scaled by a reference time τ , the corresponding model equations
are as follows.
dVP
dθ
= τ(Q0 −QL), (3.45)
V 2P
∂ci
∂θ
= τ(γm +γhQ0)
(
∂2ci
∂x2
)
− τVP
[
Q0 − (Q0 −QL)x
](
∂ci
∂x
)
, (3.46)
VPQ0ci − (γm +γhQ0)∂ci∂x = VPQ0c
in
i for x = 0
∂ci
∂x
= 0 for x = 1
. (3.47)
Finally, if the flow rates are replaced by volumes of fluid, W = τQ, the equations are
expressed as follows.
(Dynamic volumetric balance)
dVP
dθ
=W0 −WL, (3.48)
(Dynamic component balance)
V 2P
∂ci
∂θ
= (γmτ +γhW0)
(
∂2ci
∂x2
)
−VP
[
W0 − (W0 −WL)x
](
∂ci
∂x
)
, (3.49)
(Boundary conditions)
VPW0ci − (γmτ +γhW0)∂ci∂x = VPW0c
in
i for x = 0
∂ci
∂x
= 0 for x = 1
. (3.50)
It is interesting to analyze the previous equations and compare them against the usual
ones for dispersed-plug flow in an inert porous medium or empty tube:
∂ci
∂θ
=
τQ
VP
(
1
Pe i
∂2ci
∂x2
− ∂ci
∂x
)
, (3.51)
ci − 1Pe i
∂ci
∂x
= cini . (3.52)
The equations are identical, the equivalence rules being
Q =Q0 − (Q0 −QL)x, 1Pe =
γm +γhQ0
VPQ
(3.53)
Notice that
Q =Q0 − (Q0 −QL)x = (1− x)Q0 + xQL, (3.54)
is a weighted average of Q0 and QL and, moreover, Q ≥ 0 for all Q0,QL ≥ 0.
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3.5.2 Perfectly Mixed Chamber
It is of interest to consider the model of the worst case scenario, that of perfect mixing
in the piston chamber. The ideal Continuous Stirred Tank (CST) model [244], or Perfect
Mixed Tank model, is very simple:
(Dynamic volumetric balance)
dVP
dt
=Q0 −QL, (3.55)
(Dynamic component balance)
In−Out = Accumulation−Generation,
cini Q0 − couti Q0 = VP
dcouti
dt
− 0, or
VP
dcouti
dt
=Q0(c
in
i − couti ), (3.56)
where VP is the piston volume, Q0 and QL are respectively the volumetric flow rates at
inlet and outlet of the piston, and cini and c
out
i are respectively the piston inlet and outlet
concentrations of component i.
The time-scaled model is very simple:
dVP
dθ
= τ(Q0 −QL) =W0 −WL, (3.57)
VP
dcouti
dθ
= τQ0(c
in
i − couti ) =W0(cini − couti ). (3.58)
Notice that during the emptying of the recycle piston, Q0 = 0 and QL > 0, and thus
dcouti /dt = 0→ couti = const, as it should be.
To avoid numerical errors when VP ≈ 0 it is probably safer to replace eq. (3.58) by
(δ+ |VP|)
dcouti
dθ
= τQ0(c
in
i − couti ) =W0(cini − couti ), (3.59)
where δ is a small positive real, say 10−4. This does not change the results and avoids the
singularity
0× dc
out
i
dθ
= 0 (3.60)
when VP ≈ 0 and Q0 = 0.
3.5.3 Dead Volumes
It is of interest to consider the implications of the existence of non-negligible dead vol-
umes in the recycle piston. For the purpose of the present discussion we considered the
schematic shown in Figure 3.19. Two dead volumes are considered for this set-up. V0 and
VL are the dead volumes at the piston inlet and outlet, respectively.
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The equation for the dead volumes was taken from the usual axially-dispersed plug
flow model (eq. 3.26), where, when applying the chain rule (eq. 3.32) to put ci as a
function of (x, t), the term ∂z(x,t)∂t is null, since the dead volume has a fixed position, with
no change of z over time. Hence:
∂ci
∂t
=
DL
L2
∂2ci
∂x2
− v
L
∂ci
∂x
, or (3.61)
∂ci
∂t
=
v
L
(
DL
vL
∂2ci
∂x2
− ∂ci
∂x
)
, (3.62)
Remembering that Q = vA, V = LA and Pei =
Lv
DL
:
∂ci
∂t
=
Q
V
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, (3.63)
where x = z/L is the dimensionless axial position along the column (L is the column
length), and Pei is a Péclet number for axial dispersion in the column. Here, V can be V0
or VL depending on which dead volume is being referenced.
Thus, the time-scaled model is:
(Inlet dead volume)
∂c0i
∂θ
=
W0
V0
 1Pe0 ∂
2c0i
∂x2
− ∂c
0
i
∂x
 , W0 = τQ0, (c0i )out(θ) ≡ c0i (x = 1,θ), (3.64)
c0i −
1
Pe0
∂c0i
∂x
= (c0i )
in for x = 0,
∂c0i
∂x
= 0 for x = 1.
(3.65)
(Outlet dead volume)
∂cLi
∂θ
=
WL
VL
 1PeL ∂
2cLi
∂x2
− ∂c
L
i
∂x
 , WL = τQL, (cLi )out(θ) ≡ cLi (x = 1,θ), (3.66)
cLi −
1
PeL
∂cLi
∂x
= (cLi )
in for x = 0,
∂cLi
∂x
= 0 for x = 1.
(3.67)
(Piston outlet)
couti = c
L
i |x=1. (3.68)
3.5.4 Chromatographic Column
The differential material balances in preparative chromatography are based on several
important considerations. It is assumed that: (1) the column is radially homogeneous;
(2) the mobile phase is incompressible (then the velocity of the mobile phase can be
considered constant along the column); (3) the axial dispersion coefficient is constant (it
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is not dependent on the solute concentration); (4) the partial molar volumes of sample
components are the same in both phases; (5) the solvent is not adsorbed; and (6) there are
no thermal effects and there is no influence of the heat of adsorption [100].
It is well known that a chromatographic column with isothermal operation is satisfac-
torily defined by a dispersed-plug-flow model, with Linear-driving-force (LDF) approx-
imation for mass transfer under the form of a lumped solid-diffusion model. These are
sufficiently general to provide a realistic representation of preparative chromatography
and SMB modeling [61, 101].
Furthermore, the LDF model can be fairly well approximated by an equilibrium-
dispersed model with dispersion coefficients dependent on the local slopes of the adsorp-
tion isotherms [61].
For a linear adsorption system the material balance of the ith solute can be written
by an equilibrium dispersed plug-flow model. To arrive at this model, we start from the
transport equation for a solute dissolved in a liquid with dispersed plug-flow through a
fixed bed of adsorbent:
∂ci
∂t
=DL
∂2ci
∂z2
− v∂ci∂z −
(1− )

∂qi
∂t
, ∀t > 0, 0 < z < L(t), (3.69)
where  is the interparticle void fraction (i.e. interparticle porosity of the fixed bed), q
the amount of solute adsorbed at any given time (i.e. concentration of adsorbed solute),
DL = vL/Pei the axial dispersion coefficient (v = Q/A is the interstitial velocity of the
liquid [30], i.e. liquid velocity between the particles and between the particles pores) and
Pei the Péclet number for axial dispersion at adsorbent fixed bed. In this equation the
concentration of solute adsorbed is expressed per unit of apparent volume of solid: Vc
is the column volume occupied by interparticular fluid, (1− )Vc is the column volume
occupied by the solid and intraparticular liquid.
Introducing the chnage of variable x = z/L gives
∂ci
∂t
=
DL
L2
∂2ci
∂x2
− v
L
∂ci
∂x
− (1− )

∂qi
∂t
, ∀t > 0, 0 < x < 1. (3.70)
It is important to note that this equation presupposes local equilibrium between liq-
uid and adsorbed phase (mass transfer between interparticular fluid and the adsorbent
interior is infinitely rapid).
Given that local thermodynamic equilibrium is assumed:
∂qi
∂t
=
∂q∗i
∂t
, (3.71)
where q∗ is the solute concentration at solid phase in equilibrium with the solute concen-
tration at liquid phase.
For linear adsorption isotherms [100]
qi =Hici (3.72)
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where Hi is the slope of the isotherm (Henry’s constant of adsorption). It’s worth noting
that this is an apparent constant (Hi =H
app
i ), which covers the intraparticle porosity (p)
and the real Henry’s constant (H ri ). Hence, Hi = p +H
r
i [242]. Thus,
∂q∗i
∂t
=
∂q∗i
∂ci
∂ci
∂t
=
∂(Hici)
∂ci
∂ci
∂t
=Hi
∂ci
∂t
, (3.73)
where q∗ is the concentration of solute adsorbed in equilibrium with the concentration of
solute in mobile phase, c.
Substituting eq. 3.73 and DL at eq. 3.70, the transport equation takes the following
form:
∂ci
∂t
=
vL
PeiL2
∂2ci
∂x2
− v
L
∂ci
∂x
− (1− )

Hi
∂ci
∂t
, or (3.74)(
1 +
(1− )

Hi
)
∂ci
∂t
=
v
L
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, multiplying by
(A
A
)
(3.75)(
+ (1− )Hi

)
∂ci
∂t
=
Q
Vc
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, (3.76)
Finally, the equilibrium dispersed plug-flow model is
∂ci
∂t
=
Q
[+ (1− )Hi]Vc
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, or (3.77)
∂ci
∂t
=
Q
Vi
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, Vi ≡ [+ (1− )Hi]Vc. (3.78)
The time-scaled version of this model is
∂ci
∂θ
=
W
Vi
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, Vi ≡ [+ (1− )Hi]Vc, W = τQ, (3.79)
where Vc is the column volume and Vi is the apparent volume for solute i.
Some authors prefer to use the dimensionless plate height, h, instead of Pe; the rela-
tionship between them is simple: h = 2/Pe. Replacing Pe by h in the previous equation
gives
∂ci
∂θ
=
W
Vi
(
h
2
∂2ci
∂x2
− ∂ci
∂x
)
. (3.80)
Returning to equation 3.79, Pei can be expressed as the sum of two components:
1
Pei
= αi + βiQ, αi =
1
(Peh)i
, βi =
Vi − Vc
kiV
2
i
, (3.81)
where (Peh)i is the hydraulic Péclet number and ki is the LDF mass transfer coefficient.
This equation shows that the ki is represented (masked) by the axial dispersion coefficient
(DL), or more properly, by Pe, which symbolizes the lumped solid-diffusion model.
Thus, the differential material balance can be expressed as
∂ci
∂θ
=
W
Vi
[(
αi +
βiW
τ
)∂2ci
∂x2
− ∂ci
∂x
]
, (3.82)
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subject to the usual Danckwerts boundary conditions
W
[
ci −
(
αi +
βiW
τ
)∂ci
∂x
]
= (Wci)in for x = 0,
∂ci
∂x
= 0 for x = 1.
(3.83)
We shall also employ the following shorthand notation: couti (θ) ≡ ci(x = 1,θ).
Although there are several boundary conditions, the conditions of Danckwerts are
more realistic, since they consider the continuity of the system, contrary to what occurs
with changes in pulse [78].
3.6 Final Outlook
Based on the analysis that single-column batch chromatography can potentially achieve
many of the benefits of continuous chromatography through smart recycling of the mixed
fractions, the purpose of this chapter was to describe the most efficient way of mimicking
the behaviour and performance of continuous multicolumn chromatography with a single-
column apparatus for the purification of biopharmaceuticals. Hopefully, this single-
column process can achieve the same specific productivity (feed processed per unit time
per resin volume or feed processed per unit time per column) as the multicolumn process
mimicked.
To fulfill the purposes of the work, as first step, the basis for single-column analog and
a brief explanation of how to replace multicolumn continuous chromatographic systems
was given. The conceptual prototype design of the biomolecule purification train, using
only one chromatographic column, was developed to work in a broad range of configu-
rations (including a fully continuous way). To define the best project, results obtained
in previous studies [17, 176] carried out by the research group from which the thesis
project is inserted was taken as reference. In order to show that the outlined design is
feasible, the operation of the recycle piston was depicted and the experimental proto-
type was described and assembled with attention to minimize dead volumes, quantity of
equipment required and size of the installation in general, as well as to operate with the
least possible human intervention. A full automated system, controlled by Julia, was ob-
tained. The automation of the entire structure avoids operating errors during the capture
or purification process of a biomolecule. The mathematical model of the new system was
described and discussed, being divided in four sections: recycle device, perfectly mixed
tank, dead volumes and chromatographic column.
This out-of-the-box process has the potential to entirely revolutionize the field of
continuous chromatography, once the newly developed platform shares the benefits of
SMB chromatography in that it not only gives significantly higher yields of purer product,
but also enables processing more feed and thereby increasing the overall throughput
comparing to batch chromatography. However, the novel single-column analog to SMB
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process uses just a single chromatographic column, which implies a great added value:
a smaller number of columns is preferable, less solid phase is required, less equipment
is involved and the pressure drop is reduced. The only thing that can compromise the
product purity and productivity of this process comparing to the analogous SMB is the
efficiency of the plug-flow device.
The built prototype was used to validate the new method, the Single-column Analog
with Recycle Lag, in the following chapters of the thesis.
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Experimental Validation of the Adsorption
Unit: Nucleosides Separation by
Reversed-phase
4.1 Introduction and Objective
4.1.1 Validation of Chromatographic Methods
Analytical chromatography is a method commonly used for quantitative and qualitative
analysis of drugs substances and compounds in biological fluids. Preparative chromatog-
raphy is used for the separation and/or purification of these compounds under undiluted
conditions. When it comes to a new chromatographic method, validating this process is a
key requirement [232]. Method validation is defined as the process by which the method
is tested by the developer for accuracy, reliability and reproducibility of its intended
purpose, as well as to ensure process robustness and product quality.
In addition, testing a new method should ensure that it is reproducible when used
by other users on other equivalent equipment, on other day or location. The validation
process should also be a work in progress, open to method changes, with the possibility of
re-validation if required. Therefore, design and validation is the starting point for using
a new method before generating important results.
The Analytical Methods Technical Committee of the Chemistry Manufacturing Con-
trols Coordinating Committee (CMCCC), at FDA, published a Technical Reviewer Guid-
ance for the validation of new chromatographic methods, presenting the issues to consider
when evaluating chromatographic methods from a regulatory perspective, discussing the
weaknesses of chromatography that must be taken into account to ensure good perfor-
mance of the method [45]. Although not all parameters of validation are applicable for
all types of tests, the typical validation characteristics are [46]:
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• Accuracy: Measure of how close the experimental value is to the true value;
• Detection Limit: The lowest analyte concentration in a sample capable to be de-
tected, although not inevitably quantified, under the established experimental con-
ditions;
• Quantitation limit: The lowest analyte concentration in a sample capable to be
quantitated with precision under the established experimental conditions;
• Linearity: The working sample concentration and samples tested for accuracy should
be in the linear range (UV response x concentration at a linear relationship). The
linear range of detectability is dependent on the detector and compound utilized;
• Precision (Repeatability or reproducibility): Measure of how close the data val-
ues are to each other for a number of measurements under the same analytical
conditions;
• Range: Interval between the low and high concentrations of analyte studied;
• Recovery: Amount of the compound of interest at the product as percentage of the
theoretical amount present in the analyte;
• Robustness: Measure of the method’s capability to persist unaltered by little varia-
tions in method parameters, e.g. column type, column temperature, age of columns,
reagents, pH of buffer in mobile phase;
• Specificity/selectivity: The analyte must not have interference from other foreign
components. Therefore, a representative chromatogram should be generated show-
ing that the extraneous peaks are well resolved from the main analyte.
• System suitability specifications and tests: Parameters that provide assistance in
achieving a well-behaved chromatographic system. The parameters can be capacity
factor, precision/injection repeatability, relative retention, resolution, tailing factor,
theoretical plate number, among others.
4.1.2 Two-column SMB for Binary Separation
In 2010 our research group developed and validated experimentally a streamlined, two-
column SMB process for two-fraction separation [228]. As the name suggests, this system
uses two identical chromatography columns and the fluid is injected and circulated into
the system through two liquid pumps. The feasibility and effectiveness of the reported
two-column process were verified experimentally using the linear separation of uridine
and guanosine by reversed phase chromatography, operating in an open-loop configura-
tion, as case study. The schematic of one full operating cycle is shown in Figure 4.1. This
semi-continuous, two-column process implements pulsed feed injection and selective
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Figure 4.1: Schematic of one full operating cycle for the two-column, semi-continuous,
open-loop process. E = eluent inlet, F = feed inlet, and P = product outlet, which can be
either the less or more retained compound depending on the separation [228].
product withdrawal, representing a compromise between continuous, multi-column SMB
and traditional batch chromatography.
Because the process has two columns, a full cycle can be divided into two equal
half-cycles, or switching intervals as they are known in the jargon. At the end of each
half-cycle the column positions are exchanged or, alternatively, the columns are fixed in
space and instead the inlet and outlet ports [192] are moved, and the steps are repeated
all over. Therefore, the process can be explained by the first half cycle only. The up-
stream column outlet is continuously eluted, feed is periodically injected into the fluid
stream between the two columns, and the two components are selectively collected in the
downstream end.
Experimental results were compared to simulated data generated from a dynamic
model implemented in gPROMS and a very satisfactory agreement between was obtained.
Steady-state operation was reached after six operating cycles, while the minimum puri-
ties of extract and raffinate were set at 99% each. The performance of the two-column,
semi-continuous, open-loop scheme was compared to single-column batch chromatog-
raphy and its enhanced version with ideal steady-state recycling (SSR) technique, but
also with the closed- and open-loop versions of a classical, four-column SMB, taking into
consideration that the total amount of stationary phase was the same on all processes.
As result, the two-column process obtained the best performance, with lower eluent con-
sumption (Eluent-to-Feed flow rate ratio) for the same feed flow rate in comparison with
the batch systems, and very similar compared with the two four-column SMBs; however
the developed process has less equipment and half the number of columns than the two
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Figure 4.2: Schematic of one full operating cycle for the two-column, semi-continuous,
open-loop process with discontinuous elution. E = eluent inlet, F = feed inlet and P =
product outlet, which can be either the less or more retained compound.
SMB systems [224].
Actually, there is also a variant of the same process that was not explored in that paper.
In this second process the elution is stopped at the upstream column during the step in
which fresh feed is injected into the downstream column. The schematic of this variant is
shown in Fig. 4.2. The two processes have about the same performance.
This two-column system presents itself as a promising alternative to single-column
batch chromatography due to its increased performance, simplicity of operation and im-
plementation, and ease of scaling-up. Therefore, the two-column SMB proved to be a
combination of simplicity and flexibility of the batch process and the increased productiv-
ity of multi-column chromatography. Because of these qualities, this system was chosen
as reference for the experimental validation of the Single-column Analog to SMB.
4.1.3 Objective
The purpose of this chapter is to validate the single-column process developed in this the-
sis, proving the effectiveness of its operation. For this, a two-column SMB process already
developed in the past for linear binary nucleoside separation is used as reference for the
Single-column Analog to SMB and, moreover, the general techno-economic challenges
are evaluated and discussed, specifically data of purity, recovery, solvent consumption,
complexity, cost, maintenance, dimensions and reproducibility. Some secondary objec-
tives arise to achieve the main objective; they are: preliminary tests of piston operation
evaluation and the characterization of the system; experiments previously necessary to
be able to proceed to the separation of biomolecules.
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Table 4.1: Reagents used in the execution of the activities of Chapter 4.
Reagent Molecular formula Manufacturer
Blue Dextran (from dextran w/ MW 2x106) C6H10O5 Sigma-Aldrich
Ethanol absolute CH3CH2OH Panreac
Uridine (99%) C9H12N2O6 Sigma-Aldrich
Guanosine (98%) C10H13N5O5 Sigma-Aldrich
4.2 Materials and Methods
4.2.1 Materials
The reagents are listed and described in Table 4.1.
4.2.2 Preliminary Tests: Piston Proof-of-Concept
Preliminary experiments (Figure 4.3) to test the operation of the recycle device were
carried out. The first two experiments were ran even before coupling the device to the
setup structure with the rest of the setup equipments. An isocratic pump K501 (Knauer,
Germany) was connected to the inlet capillary of section A of the device, while another
similar liquid pump was connected to the inlet of section B of the recycle equipment.
First, isocratic injection of blue dextran solution, at 0.08 g/L, was done into the recycle
bin at a flow rate of 5 mL/min until 10 cm of heigh in section A, while the section B
outlet was open. Soon after, the pump connected to the section B inlet was started with
deionized water at the same flow rate of 5 mL/min up to full piston closure, while the
section A inlet was closed and the section A outlet was open, fluid coming out of the
equipment through the flexible tube that connect section A outlet to the bottom of the
recycle device.
The second piston function test consisted of gradient injection using blue dextran
solution, at c = 0.24 g/L, and performing the experiment in the same two configurations
as the previous one: solution injection in section A and later deionized water injection
in section B. A third pump was used with deionized water to promote the gradient. A
connector was placed in the piston inlet capillary to receive fluid from the two pumps and
promote mixing before it enters in section A. The gradient was performed from highest
to lowest concentration. To achieve the flow rate of 5 mL/min, the flow rate of each pump
changes over time, starting with the pump responsible for the dye solution at maximum
flow rate down to 0 mL/min, while the other pump starts at flow rate 0 mL/min up to
5 mL/min. Approximately 6 mL fluid fractions were collected in small glass vials whereas
the piston was returning to original position (closed).
In a third experiment, it was tested if there was mixture between sections A and B of
the piston. This time, the piston was already connected to the system, with possibility of
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Figure 4.3: Four preliminary tests for piston proof-of-concept. The first consist of iso-
cratic injection, in the second gradient injection was performed, while in the third fluid
mixture between section A and B were tested, and finally, in the fourth experiment, the
hydrodynamic behaviour inside the piston was tested for different heights.
UV reading. The test consisted of injecting uridine solution to the piston, in order to put
the movable part down, and then remove this solution from the piston, so that the mobile
piston touches the top of the piston. This test was conducted with 0.05 g/L uridine in
5%-v/v ethanol solution. The solvent used as reference for the UV reader was 5%-v/v
ethanol in deionized water. The flow rate of each the pump was 2 mL/min. The UV
absorbance was read at the entrance of the piston during the injection and at the output
of the same during the closing, with sampling intervals of 0.5 s, with absorbance reading
at 260 nm, using the USB2000 spectrometer, only Deuterium lamp turned on, integration
time of 15000 µs.
To characterize the piston, in order to determine the hydrodynamic behaviour within
the piston, the fourth preliminary experiment was conducted. Uridine injections, up
to UV signal saturation, were performed for different heights of the movable piston, 0,
5, 10, and 25 mm, which remained static throughout the experiment. For each height,
the experiments were performed in triplicate. Furthermore, for these experiments, the
absorbance detector was placed after the piston. All other operating conditions were
similar to the previous experiment. The Julia’s command script, used for this experiment,
is listed in Appendix B.1.
4.2.3 System Characterization
The characterization of the system consists in determining the parameters of the chro-
matographic column, piston and capillaries of the setup.
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4.2.3.1 Column Packaging and Interparticle Porosity ()
The chromatographic column used for the nucleosides separation was a Superformance
26 mm i.d. thermojacketed glass column (Götec Labortechnik, Germany). The resin
utilized was Source30 RPC (GE Healthcare Amersham Biosciences, Uppsala, Sweden).
The stationary phase was slurry packed into the column, as described elsewhere [228], to
a bed height L = 6.0 cm, using mobile phase at 25 mL/min, back-pressure of 30 bar and
30 min packing time.
The interparticle porosity of the resin packed into the column (interparticle void
fraction, ) was determined from the difference of retention volumes of step injections
of blue dextran (c = 0.24 g/L) in an aqueous solution of 5%-v/v ethanol eluting through
the column (tinjection ≈ 1000 s) and bypassing the column (tinjection = 60 s). The flow
rates were set at 1 mL/min for each pump. The wavelength of 620 nm was used to
measure the absorbances at bypass and column. The choice for wavelength is discussed
in Appendix B.2. The UV sampling time was 1.0 s. The experiments were performed in
triplicate.
The retention volume (θR) is defined by
θR = tRQ, (4.1)
where Q is the volumetric flow rate and tR the retention time, ie, the time that the solute
takes to travel the entire column and elute. The retention volumes for bypass (θbpR ) and
column (θcolR ) were calculated using the Equal-Area Method (EAM) (see Figure 4.4), that
is, the point in the graph giving the retention volume is found when the area between the
reference and the point is equal to the area between the same curve point and the plateau
(UV signal for saturation absorbance, or saturation concentration).
Hence, the interparticle porosity is
 =
θcolR −θbpR
Vc
, (4.2)
where Vc is the empty column volume. Figure 4.5 illustrates the calculation method for
the porosity of a packed chromatography column.
For each set of experiments done in triplicate the results were averaged and the error
was calculated. An error of up to 5% was deemed acceptable to take the average as the
final result. All experiments in triplicate or duplicate hereinafter were treated as such.
For the error determination, first the standard deviation was calculated:
σ =
√∑N
i=1(xi −µ)2
N
, (4.3)
where σ is the standard deviation, xi is the ith experimental value, N is the number of
experimental data, and µ is the arithmetic mean of the values.
Thus, the error is
error or σrelative(%) = 100× σµ . (4.4)
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Figure 4.4: Scheme for Equal Area Method. The point is determined when the areas
below the curve and above the curve are equal. tFeed = 0 is the time when blue dextran
solution (feed) begins to be injected.
4.2.3.2 Henry’s Constant (H)
If the concentration ci of a solute i in a fluid phase in thermodynamic equilibrium with
an adsorbent is sufficiently diluted, the solute concentration in the adsorbed phase, qi ,
will be directly proportional to ci , ie,
lim
ci→0
qi =Hici , (4.5)
where Hi is known as the Henry constant. The solute concentration ci is commonly
expressed as a molar or mass concentration (amount of solute per volume of fluid, but
sometimes per column volume) and seldomly as molar, mass or volumetric fraction in
the solvent. For example, if ci is expressed as amount of solute per unit volume of mo-
bile phase, which is the convention adopted in this work, the amount of solute in the
interparticle fluid per unit volume of packed column will be simply given by ci .
The solute concentration in the adsorbed phase is usually expressed as amount of
solute (moles or mass) per unit amount of solid, which can be mass, number of moles,
volume of solid, or even column volume. If qi is expressed as amount of solute per unit
volume of solid, which is the convention adopted in this work, the amount of adsorbed
solute per unit volume of packed column will be simply given by (1− )qi .
Experimentally the Henry constants were determined from the difference of reten-
tion volumes of diluted pulses (40 s) of each component of the mixture (guanosine and
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Figure 4.5: Calculation method for the interparticle porosity of the chromatographic bed.
θ
bp
R is the retention volume of fluid bypassing the chromatographic column and θ
col
R is
the retention volume of blue dextran passing through the column.
uridine), at ci = 0.05 g/L, passing through (θ
col
R,i ) and bypassing (θ
bp
R,i) the column, where
θR,i = QtR and Q is the volumetric flow rate. It was known beforehand that the two nu-
cleosides exhibit linear adsorption behavior for concentrations well above 0.05 g/L. The
Henry constant is related to θcolR,i and θ
bp
R,i as follows:
θcolR,i −θbpR,i = [+ (1− )Hi]Vc or Hi =
θcolR,i −θbpR,i
(1− )Vc −

1−  . (4.6)
Here, the retention volumes for bypass (θbpR ) and column (θ
col
R ) are the intervals measured
between half of the peak of their respective detections and half of injected pulse peak
(see Figure 4.6).
Five flow rates were utilized, with the experiment performed in triplicate for each
flow rate: 1, 2, 3, 4 and 5 mL/min. The experimental chromatograms were monitored
using a USB2000 spectrometer at a wavelength of 260 nm, integration time of 37000 µs
and 1 s sampling rate.
Figure 4.7 illustrates the calculation method for the Henry constant of each com-
ponent. Appendix B.3 contains the sequence used in Julia. Appendix B.4 shows the
absorbance spectrum of uridine and guanosine, previously analyzed to decide the ideal
wavelength to work with the components.
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Figure 4.6: Scheme for the test of solute pulse injection at dispersion plug flow.
4.2.3.3 Adsorption Isotherms
Adsorption isotherms were determined by step injection (1080 s, or 18 min) at five dif-
ferent concentrations for each solute. The experiment was performed in duplicate. The
stock solution had ci = 0.2 g/L, and the operating flow rate was set at 5 mL/min. The
concentrations were obtained through the effect of solution gradient, thanks to the use
of two pumps, promoted by the operation script presented in Appendix B.5, so that the
total flow rate always remained constant. USB2000 spectrometer was used, IT = 37000
µs, with a UV measurement range of 1 s, and λuri = 287.25 nm and λgua = 293.20 nm.
For the concentrations to be used in the case studies of this thesis, linear isotherm is
expected, therefore:
q∗ =Hc, (4.7)
where q∗ is the concentration of solute adsorbed in equilibrium with the liquid phase
and c is the concentration of solute in the mobile phase.
Therefore, with this procedure, the adsorption isotherm is verified and the Henry
constant for each compound is also obtained by the curve slope, which can be compared
to that determined in the previous section.
4.2.3.4 Column Dynamic Behaviour: Péclet Number (Pe)
The Péclet number, Pe, is a measure of band broadening (ie, smearing or smoothing of a
concentration font in the fluid phase) or axial dispersion as a solute percolates through
a packed column by the action of a mobile phase. The phenomena lumped into Pe can
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Figure 4.7: Calculation method for the Henry constant for each component. θ(Fi) = 0
is the eluted volume when compound solution (feed) begins to be injected, θbpR is the
retention volume of fluid bypassing the chromatographic column and θcolR is the retention
volume of the same compound passing through the column.
range from the simplest case of the combined effect of molecular diffusion and hydrody-
namic dispersion to cases which also account for external film mass transfer, intraparticle
(molecular and surface) diffusion and, in some rare cases, even adsorption kinetics. A
related measure of band broadening is the plate height, hL, defined as
h =
2
Pe
, (4.8)
where h is the dimensionless plate height and L the column length; the number of theo-
retical plates is 1/h.
In the present study of nucleosides Pe is taken as a measure of the lumped contribu-
tions of molecular diffusion and hydrodynamic dispersion of the solid in the interparticle
fluid and intraparticle solute mass transfer. For the range of flow rates commonly used
in preparative chromatography the dependence of h (or 1/Pe) on the flow rate is usually
well approximated by a straight line with negative slope.
The Péclet number was determined from the same chromatograms used to determine
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the Henry constant, fitting the experimental dependence of the plate height on flow rate
for diluted pulses of the solutes. For this purpose the experimental absorbance data as
a function of time (ie, the chromatogram) obtained at the various flow rates (1, 2, 3, 4,
5 mL/min) were fitted in gPROMS software to a dispersed plug-flow model to estimate
Pe for uridine and guanosine.
4.2.3.5 Characterization of the Recycle Device: Dead Volumes (V0 and VL)
The dead volumes at piston inlet (V0) and outlet (VL) due to the presence of frits at the
ends of piston were determined by step injection of blue dextran solution (c = 0.24 g/L in
5%-v/v ethanol) until saturation in UV detector at Q = 1 mL/min, as was proceeded in
the column porosity experiment. The reference solution was ethanol 5% (v/v) in water,
at c = 0.05 g/L. The absorbances were measured at λ = 620 nm and the UV sampling
interval was 1.0 s.
The difference here is the UV detector position, which is located, in this experiment,
at the capillary immediately after the piston. The piston is kept closed and the fluid flow
is always bypassing the column. The total dead volume is divided by two to obtain values
of V0 and VL, given that the two frits are identical.
Two different setup settings are required for piston dead volumes determination:
1. Feed stream flows through the closed piston, obtaining θRPR . Feed injection time,
tinjection = 350 s;
2. Feed stream bypasses the piston, with a capillary of L = 35 cm replacing the piston,
obtaining θ
RPbp
R . The 35 cm represents the flexible capillary that is contained within
the piston and must be accounted for when calculating the eluted volume. Feed
injection time, tinjection = 200 s.
Therefore, the frits dead volumes are:
V0 = VL =
θRPR −θ
RPbp
R
2
, (4.9)
The calculation of the eluted volume is done exactly as explained in section 4.2.3.1,
through EAM calculation.
4.2.4 Experimental Validation
4.2.4.1 Cycle Determination
The experimental proof of concept of the single-column process with recycle lag, that uses
a simplified version of the plug-flow device, uses the linear separation of two nucleosides,
uridine and guanosine, by reversed phase Source30 RPC, as case study to demonstrate the
effectiveness of the proposed chromatography apparatus to mimic the behaviour of two-
column continuous chromatography. An optimized two-column chromatographic process
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for nucleosides separation has been previously addressed by our research group [228].
For this reason, this process was selected to be mimicked by the new apparatus presented
in this thesis.
To convert the multicolumn process into a one-column process with recycle lag, it
is necessary to select a column at random from the two-column process, say column 2,
and follow its operation over a full cycle. The fractions of its eﬄuent that are directed to
the other column are, instead, diverted to the recycle piston to be reinjected later in the
cycle. This procedure was applied to the two-column process whose cycle is depicted in
Figure 4.2.
4.2.4.2 Steps Duration
Using the column parameters determined experimentally (Section 4.2.3) and the resulting
single-column process (Section 4.2.4.1), the cycle parameters were determined using
model-based optimization in AMPL, achieving the ideal times for each step of the cycle.
This procedure is explained in detail later on.
4.2.4.3 Experimental Procedure
The linear separation of two nucleosides, uridine (Figure 4.8a) and guanosine (Figure 4.8b),
by reversed phase Source 30 RPC, was performed isotermically at 30ºC. To give adequate
retention and separation factors, 5% (v/v) ethanol in water was fixed as mobile phase [3].
The organic solvent is added to lower the polarity of the aqueous mobile phase, and
thereby improve the eluting strength in reversed phase chromatography. In addition, the
organic solvent (modifier) should not have high viscosity (such as isopropanol), in order
to avoid low column efficiencies and high back-pressures [10].
Uridine (99%) and guanosine (98%) were purchased from Sigma-Aldrich (Steinheim,
Germany), and HPLC-grade ethanol from Panreac (Spain). The solvents were mixed in
the appropriate volumetric proportions. Feed solution was prepared with ci = 0.05 g/L
(i = 1 for uridine and i = 2 for guanosine) in ethanol 5% (v/v), and subsequently sub-
jected to an ultrasound bath, to remove possible dissolved air. These concentrations
were selected to ensure linear calibration curves. Therefore, the deconvolution of the UV
measurements taken at several, suitably chosen, wavelengths results in the individual nu-
cleoside concentration. Only one UV detector is used in this experiment placed right after
the chromatographic column. As monitoring scheme, the sampling rate of the UV was
fixed at 0.5 s, monitoring the outlet eﬄuent composition of the chromatography column.
Absorbance measurements were made using the USB2000 spectrometer, integration time
15000 µs, and λ in the range 260–300 nm. The pumps of the system were calibrated using
Julia’s software, and both pumps, for feed and eluent, were operated at constant flow rate.
The flow rates were set at QE = QF = 4 mL/min. The experimental script performed in
Julia for this procedure, “ColExps.jl”, is described in Appendix B.6.
107
CHAPTER 4. EXPERIMENTAL VALIDATION OF THE ADSORPTION UNIT
(a) Uridine molecule. (b) Guanosine molecule.
Figure 4.8: Biomolecules utilized at experimental procedure. Guanosine is a purine nucle-
oside in which guanine is attached to a ribose (ribofuranose) ring via a β-N(9)-glycosidic
bond, and is essential for metabolism [53, 67]. Uridine is a ribonucleoside consisting of a
molecule of uracil attached to a ribofuranose moiety via a β-N(1)-glycosidic bond, and as
guanosine, it also has a function as a human metabolite [54]. Images source: [209].
The mode of operation performed for the experimental validation is the open-loop
configuration. For this, the cycle design for this configuration was established before each
experiment is performed.
The process takes a few cycles to attain what is called the cyclic steady state when the
concentration profiles are identical from cycle to cycle. Therefore, for this experiment it
was decided to produce thirteen cycles.
The choice of the mixture to be used for this experimental validation, as well as
the concentrations of the mobile phase and the desorbent were based on previous stud-
ies [228] carried out by the group in which the present thesis is inserted, where the
validation of another chromatographic system, a two-column SMB process, was carried
out for binary separation.
The experiments were evaluated in terms of purity, recovery, and solvent consumption.
The calculations of purity (Pur) and recovery (Rec) of the extract and the raffinate are
based on the following equations:
PurR =
∫ tn+τ
tn
cout1 QRdt∫ tn+τ
tn
(cout1 + c
out
2 )QRdt
, PurX =
∫ tn+τ
tn
cout2 QX dt∫ tn+τ
tn
(cout1 + c
out
2 )QX dt
, (4.10)
RecR =
∫ tn+τ
tn
cout1 QRdt
cF1
∫ tn+τ
tn
QF dt
, RecX =
∫ tn+τ
tn
cout2 QX dt
cF2
∫ tn+τ
tn
QF dt
, (4.11)
where indices 1 and 2 denote the less (uridine) and more (guanosine) retained solute,
respectively, τ =
∑
k τk is cycle duration (τk is the duration of the kth step of the cycle),
and t ∈ (tn, tn + τ) the time interval during which the nth cycle takes place.
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Figure 4.9: gPROMS logo. Source: [218].
The productivity (mL/min), specific productivity (min−1), and solvent consumption
(–) are defined as
Productivity =QF , QF =
QFτF
τ
, (4.12)
Specific productivity =
QF
Vc
, (4.13)
Solvent consumption =
QE
QF
, QE =
QEτE
τ
, (4.14)
where Qj is the volumetric flow rate, j = R, X, F or E, being the raffinate, extract, feed
and eluent, respectively. τF is the step duration of the cycle during which feed is injected
into the process, τE the step duration of the cycle during which fresh eluent is injected
into the process, and τ the overall cycle duration.
4.2.5 Data Simulation
Two distinct simulations were developed for the separation of uridine and guanosine us-
ing the single-column apparatus. Both used the same experimental cycle (section 4.2.4.1)
and system and cycle parameters (sections4.2.3 and 4.2.4.2, respectively) experimentally
obtained; however one simulation considered the piston as a dispersed plug-flow device
and another one considered it as a perfectly stirred tank.
The simulations were implemented in the process modelling platform, gPROMS
Model Builder, version 4.0.0 (Figure 4.9). The simulation was performed to ensure con-
sistency of the new process and to evaluate which fluid behaviour corresponded within
the recycling device when the experimental data is compared with these two distinct
simulation conditions: the best scenario, dispersive piston flow behaviour, or the worst
scenario, tank with perfect agitation.
4.3 Results and Discussions
4.3.1 Piston Proof-of-Concept
The initial experiments performed on the recycle device allowed analysing not only if
the design of the equipment was well established through the operation of the movable
piston, but also the pressure reached when the piston is operating and also the behaviour
of the fluid inside it. Thanks to the dark blue colour of the blue dextran solution, serving
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Down Up
(a) Isocratic injection. (b) Gradient injection.
Figure 4.10: Proof-of-concept of the piston-type device. Fig. 4.10a proved that the design
of the recycle device really works, making the movement of the mobile plunger, while in
Fig. 4.10b the gradient was done from the more concentrated solution of blue dextran to
the less concentrated, successfully collected in fractions.
as a dye, the analysis of this proof of concept could be performed with the naked eye for
the proper purpose. The operating configurations chosen promoted piston movement.
Injection of solution in section A with the open section B outlet promoted lowering of the
piston, and subsequent injection of deionized water in section B with the output of the
device opened, forced the piston to rise. The chosen height of 10 cm is long enough to
cover almost the full length of the recycle column, which allowed to analyse the pressure
drop differences for different piston heights.
When the newly designed piston was tested for isocratic injection, results showed that
its mechanical operation is very good and the design was successful (see Figure 4.10a).
The maximum pressure reached on the piston was 6 bar, which gives a satisfactory low
pressure, considering that the piston would still be inserted in the setup and, when in
operation with other equipments (valves, UV detectors, capillaries and chromatographic
column), the total system pressure would increase. The main responsible for the maxi-
mum pressure values achieved are the o-rings (two, in total) of the piston, which provide
resistance when moving due to friction with the column glass. Thus, when operating only
the piston, the resistance offered by the piston o-rings cannot be too high, given that the
maximum pressure recommended by the manufacturers is 24 bar for recycle device and
60 bar for the chromatographic column used in this chapter, so the total system pressure
must not exceed 20 bar to work with a safety margin.
In the second experiment, the gradient promoted on the piston was well identified, as
shown in Figure 4.10b, where over the length of section A (from inlet to outlet), whereas
the piston was descending, the gradient was clearly maintained. Since fluid collection
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Figure 4.11: Graph of the mixing evaluation between the sections, A and B, of the piston.
Uridine injection, 0.5 g/L v/v in ethanol 5%, was made by triggering the piston filler (UV
at the piston inlet), and shortly after the piston closure (UV at the piston output. The
graph shows the good sealing of the o-rings, that is, there is no fluid passing between the
sections.
occurs as the piston is placed to rise, the collected fractions showed that the hydrodynamic
behaviour of the piston matched the design presented in the previous chapter, keeping
the concentration profile inside, not only in the descent as in the ascent of the mobile
plunger, which gave, at first instance, the validity of the “first in, first out” method.
The third experiment proved that there was no mixture between the upper and lower
part of the piston’s movable plunger, indicating that the o-rings are fulfilling the function
well. The result can be seen through the graph in Figure 4.11. After conducting these
base experiments, the piston is ready to operate in processes of biomolecules separation.
The piston fluid characterization experiments were performed with the piston closed
and with heights of 5, 15 and 25 mm inside the piston. Before the injection of uridine,
the piston was only eluted; after saturation, the eluent was again injected until the piston
was completely cleaned. It is important to mention that the injection times were different
for each height, since they needed different times to reach saturation. From graph of Fig-
ure 4.12, it is envisaged that the hydrodynamic behaviour within the piston approached
a dispersed plug flow, being acceptable and valid for the continued experiments. More
detailed experiments on the fluid performance inside the recycle device were carried out
in subsequent units of this chapter.
After conducting these base experiments, the piston is ready to operate in processes
of biomolecules separation.
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Figure 4.12: Hydrodynamic behaviour inside static piston, with uridine 0.05 g/L injection
until saturation and subsequent cleaning with ethanol 5% v/v for piston heights of 0
mm (black), 5mm (blue), 10 mm (gray) and 25 mm (red). The piston presented similar
behaviour to a dispersed plug flow for all different conditions.
4.3.2 System Characterization
4.3.2.1 Packaging and Interparticle Porosity () of the Chromatographic Column
The chosen matrix, Source 30RPC, is a naked hydrophobic matrix, composed by mono-
sized and spherical polystyrene/divinyl benzene particles, properly used for reversed-
phase chromatography. With this resin, the components of the feed mixture bind to
the stationary phase by order of hydrophobicity. The most hydrophobic compounds
are adhered more strongly, while the less hydrophobic compounds are the first to leave
the column when the elution is performed. The matrix and column used were exactly
the same utilized in the two-column process already validated [228] for nucleosides
separation. In this way, the imitation of the multicolumn process is subjected to more
realistic conditions, that is, less experimental errors, considering that one of the major
problems addressed by multicolumn processes is the fact that it is very difficult to obtain
exactly the same fixed bed columns, even when they are subject to the same conditions of
packaging. The column colume is Vc = 31.86 cm3, since the column has L = 6.0 cm and
i.d. = 2.6 cm.
To calculate the column’s interparticle porosity (), a blue dextran solution was used.
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Blue dextran is commonly utilized for void volume calculations in chromatographic
columns, since it does not adsorb nor penetrates in resin particles [98]. The experimental
data for the proper calculation are shown in Figure 4.13. The moment when the step
of 60 s begins to be injected is the starting point of the data (θFeed = 0). The retention
volume for bypass was θbpR = 0.180 cm
3, while for column it was θcolR = 10.302 cm
3. The
difference between the retention volumes of the Blue Dextran solution passing through
the chromatographic column and bypass the column allowed to calculate the interparti-
cle porosity of the fixed bed, resulting  = 0.318. Since the column is the same used by
the chromatographic process mimicked in this chapter, when comparing with the result,
 = 0.318, obtained in the literature [228], the values present total concordance. Thus,
the interparticle porosity calculated by the present doctoral student was used hereafter.
It is important to note that the column bypass retention volume also represents the
dead volume of the setup up to the first UV, printed by the existing capillaries between
the connector that joins the input streams of the system (Feed and Eluent) and the UV2
detector.
4.3.2.2 Henry’s Constant (H)
The graphs used to calculate Henry’s constants are shown in Figures 4.14 to uridine com-
ponent, and Figure 4.15 to guanosine component. The difference between the retention
volumes of the component passing through the column and bypassing (θcolR,i −θbpR,i), and
consequently the Henry’s constant (Hi) were calculated for each flow rate. This differ-
ence must remain constant with the flow variation, as it is equal to the apparent column
volume (Vi). The θ value considered for each graph was the average triplicate value.
The results obtained are expressed in Table 4.2. H1 = 1.264 andH2 = 1.896 are Henry’s
final values for uridine and guanosine, respectively, calculated by averaging Hi between
the flow rates. As Henry does not change with the flow rate, it was expected that the
Hi values for the different flow rates would be very similar. The low relative standard
deviations obtained for H presented in the table prove the theory’s agreement with the
experimental results.
Moreover, it is noteworthy that the calculated values are very similar when compared
with the values present in the literature [228], where was obtained H1 = 1.275 (uridine)
and H2 = 1.9 (guanosine). Therefore, the parameters calculated in this section were used
hereinafter.
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(a) Step injection (60 s) of blue dextran bypassing the column. The retention volume was θbpR =
0.180 cm3.
-0.05
 0
 0.05
 0.1
 0.15
 0.2
 0.25
 8  9  10  11  12  13  14  15  16  17
Ab
so
rb
an
ce
 a
t 6
20
nm
 (A
U)
Time (min)
Col 1
Col 2
EAT
(b) Step injection (≈ 1000 s) of blue dextran passing through the column. The retention volume
was θcolR = 10.302 cm
3.
Figure 4.13: Blue dextran step injection curves for interparticle porosity calculation of
the chromatographic column. The differences between the retention volumes of the
Blue Dextran solution, bypassing (θbpR ) and passing through the column (θ
col
R ), allow to
calculate the void volume between the fixed bed particles. Since the experiments were
performed at a flow rate of 1 mL/min, the time (min) shown in the graph also represents
θ (cm3). The experiments were performed in triplicate for the bypass and duplicate for
the column. 114
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Figure 4.14: Pulse injection (40 s) of Uridine (c = 0.05 g/L) at five different flow rates: 1,
2, 3, 4, 5 mL/min; and two paths: bypassing the column and passing through the column.
The θR calculated from these curves are used to find Henry’s constant and Peclet number.
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Figure 4.15: Pulse injection (40 s) of Guanosine (c = 0.05 g/L) at five different flow rates:
1, 2, 3, 4, 5 mL/min; and two paths: bypassing the column and passing through the
column. The θR calculated from these curves are used to find Henry’s constant and Peclet
number.
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Table 4.2: Experimentally calculated Henry’s constants. The retention volumes expressed
here are the mean values taken from triplicate experiments. The final Hi is the mean
value from experiments at five different flow rates, as Henry constant must not change
with variations in flow rate. The equation used for Henry’s constant determination was
Hi = (θ
col
R,i −θbpR,i)/[(1− )Vc]− /(1− ).
Uridine Guanosine
Q (mL/min) θbpR,1 (cm
3) θcolR,1 (cm
3) H1 θ
bp
R,2 (cm
3) θcolR,2 (cm
3) H2
1 0.564 37.75 1.245 0.512 52.23 1.914
2 0.860 37.99 1.243 0.838 52.92 1.931
3 1.190 39.08 1.278 1.153 53.44 1.940
4 1.550 39.37 1.275 1.520 52.38 1.874
5 1.862 39.81 1.281 1.172 51.51 1.821
H1 1.264 H2 1.896
σrelative,1 (%) 1.469 σrelative,2 2.589
4.3.2.3 Adsorption Isotherms
The adsorption isotherm, which is dependent on the compound and the chromatographic
column used, determines the relationship between the concentration of adsorbed solute
in the stationary phase in equilibrium with the mobile phase and the concentration of
the same solute in the mobile fluid. The nucleosides separation, uridine and guanosine,
can be described by linear adsorption isotherms (eq. 4.7) for low solute concentration
range [228]. The linear isotherm is widely used in validation process of new chromato-
graphic systems [19].
Therefore, to prove the linearity of the isotherm curves, the experiment was per-
formed with a very low concentration range, so that the 0.05 g/L concentration would
be covered by the curve, since it is the concentration used for the nucleosides separation
case study. The cimax = 0.2 g/L was chosen based on the solubility of each compound in
water, 0.75 g/L (25 °C) for guanosine [52] and 50 g/L for uridine [241]. Since the uri-
dine and guanosine solutions used in the separative process are prepared with 5% (v/v)
ethanol, these solubilities should subtly reduce; or temperature variations may occur,
contributing to slightly changes in solubility; and furthermore, it is noteworthy that it is
not recommended to use concentrations above 80% solubility, to not subject the system
to the no risk of precipitation within the column. Taking this into account, the maximum
concentration of 0.2 g/L is a safe margin of concentration for the ongoing experiment.
Since the experiment was performed on five different steps, equally sparse between
concentration values, the steps corresponded to the concentrations is shown in Table 4.3.
The chromatograms of Figure 4.16 were obtained at the outlet of the chromatographic
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Table 4.3: Solute concentrations used at adsorption isotherms experiments. Diluted
solution (cimax = 0.2 g/L) was used as bulk solution, a considerably low concentration
compared to the solubility of each compound, i.
Stair, j ci (g/L)
1 0.04
2 0.08
3 0.12
4 0.16
5 0.2
column. It can be seen that the injection time, tinj = 1080 s, was sufficient to achieve
equilibrium saturation in the chromatographic column for both components.
Since the duplicate curves are almost the same, henceforth the graphs will be plotted
for Exp 2 only, although calculations were made for both curves of each compound. With
the five concentration values already set, and together with the obtained absorbances, the
calibration curves were determined, for uridine and guanosine. The trend line drawn on
the experimental points that best represented the relationship between the axes was a
cubic type curve.
To facilitate the analysis, the eluted volume (θ =Qt) was used instead of experimental
time (t). Then the concentration versus eluted volume graph was plotted (see Figure 4.17).
The adsorbed volume on the chromatographic column (θads), for each component i
and for each concentration (or step injection, j), was calculated:
θadsi,j = θEAMi,j −θ0i,j , (4.15)
where θEAMi,j is the retention volume of compound i (uridine or guanosine) passing
through the chromatographic column, at step j, added to the eluted volume of the previ-
ous steps. This term is taken from the graph x-axis, through EAM calculation. While θ0i,j
is:
θ0i,j = θ
col
R + (j − 1)θinj , (4.16)
where θ0i,j is the eluted volume when accounting for: the bypass to the column plus
the internal column volume occupied by the mobile phase, the θcolR (this value was already
determined by the blue dextran passing through the column, θcolR = 10.302 cm
3); and the
θinj = 90 cm3 is the injection volume of one step.
The adsorbed mass (madsi,j ) could then be determined:
madsi,j = ci,jθadsi,j +
j−1∑
j=1
madsi,j . (4.17)
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Figure 4.16: Step injections of the nucleosides, at different concentrations, to determine
the adsorption isotherm. The highest concentration solution was 0.2 g/L, a value substan-
tially far from each component solubility. The UV reading was performed at the exit of
the chromatographic column. The experiments are shown in duplicate.
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Figure 4.17: Relationship between concentration and corresponding eluted volume for
each component i (uridine and guanosine). The eluted volumes were taken from this
graph to calculate q∗.
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Figure 4.18: Adsorption Isotherm for each component i (uridine and guanosine). The
graphs proved the linear behaviour of isotherms for dilute solutions of each component.
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Table 4.4: Henry’s constant calculated by the slope of adsorption isotherm curve. The
values obtained are very close to the obtained with the pulse experiments, previously pre-
sented in this chapter. Exp1 and Exp2 are the duplicate experiments, µ is the arithmetic
mean of H values for each component, and σrealive is the relative standard deviation.
Henry’s constant (H)
Uridine Guanosine
Exp 1 1.375 1.974
Exp 2 1.297 1.985
µ 1.336 1.979
σrealive (%) 0.116 0.002
Knowing the adsorbed solute mass (mads) and the stationary phase volume (Vmatrix =
(1 − )Vc = 21.726 cm3), the equilibrium concentration in the adsorbed phase (q∗) is
calculated by the formula:
q∗i,j =
madsi,j
Vmatrix
. (4.18)
Hence, the adsorption isotherm plot was finally generated, shown in Figure 4.18.
The experimentally determined isotherm showed linear behaviour (q∗ =Hc) for both
nucleosides at concentrations up to, at least, 0.2 g/L. This indicates that ci = 0.05 g/L, the
concentration used for prototype validation, is in a safe region of linearity. As a positive
consequence, the prototype validation experiments can be performed with the isolated
solutes, in order to equate the separation of a mixing solution from the two solutes by
analysing their respective graphs.
In addition, Henry’s values obtained through the linear isotherm, whereHi is the slope
of the linear relation between q∗i and ci , are showed in Table 4.4. Since the values differed
very little from those previously calculated, earlier Henry constants were considered for
subsequent work.
4.3.2.4 Péclet Number (Pe)
The gPROMS software has advanced parameter estimation capabilities and can even
estimate multiple parameters from multiple steady-state and dynamic experiments [211].
The following equilibrium dispersed plug-flow model (already discussed in previous
chapter) was implemented in gPROMS:
x = 0 : ci − 1Pei
∂ci
∂x
= cini , (4.19)
0 < x < 1
∂ci
∂t
=
Q
Vi
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, (4.20)
x = 1 :
∂ci
∂x
= 0, (4.21)
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Table 4.5: Estimated column Peclet number (Pe) for the nucleosides on five different flow
rates. P e1, uridine; P e2, guanosine. The values assumed for the following tasks are those
found for Q = 4 mL/min.
Q
(mL/min)
P e1 P e2
1 994 941
2 1040 910
3 1153 771
4 1151 765
5 1185 584
where Vi = [+ (1− )Hi]Vc, x is a dimensional axial coordinate along the column length,
Vc the column volume,  the interparticle porosity,Hi the Henry constant,Q the flow rate,
and cini the inlet conditions for the solute concentration, which for a rectangular pulse
injection are
cini =
cFi for t ≤ tinj0 for t > tinj . (4.22)
Here, cFi is the solute concentration in the injected fluid and tinj the injection duration;
these conditions assume that the flow rate of the injection is the same as that of the elution
(Q is constant throughout the experiment). If instead of time t as independent variable
we opt for eluted volume, θ =Qt, the dispersed plug-flow model becomes
x = 0 : ci − 1Pei
∂ci
∂x
= cini , (4.23)
0 < x < 1
∂ci
∂θ
=
1
Vi
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, (4.24)
x = 1 :
∂ci
∂x
= 0, (4.25)
cini =
cFi for θ ≤ Vinj0 for θ < Vinj , (4.26)
where Vinj is the volume of the injection. where ci is the solute concentration at mobile
phase, Q is the volumetric flow rate, Hi is the Henry’s constant,  is the interparticle
porosity and Vc the column volume.
This model was implemented in gPROMS and fitted to the experimental data of dilute
solute pulses showed in section 4.3.2.2 for the five different flow rates using the Péclet
number as a fitting parameter to characterize the hydrodynamic behaviour at the column.
The estimated Péclet numbers (Pe) are given in Table 4.5.
The relationship between 1/P e and the flow rate (Q) is shown in Figure 4.19. The
dependence of 1/P e on the flow rate was expected to be given by a straight line with
a negative slope, ie, decreasing 1/P e as the flow rate increases. Experimental points
for uridine followed this behaviour; however, experimental data for guanosine did not
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Figure 4.19: Relationship between 1/P e and corresponding real flow rate for each com-
ponent i (uridine and guanosine). The values assumed for the following tasks are those
found for Q = 4 mL/min.
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Table 4.6: Column and piston characterization for the linear separation of uridine and
guanosine on Source 30 RPC (reversed phase) and 5% (v/v) ethanol in water at 30ºC, with
the setup of the Single-column Analog with Recycle Lag.  is the packing interparticle
porosity, H is the Henry constant, Pe is the Péclet number, V0 is the inlet piston dead
volume, VL is the outlet piston dead volume, D
RP
L is the axial dispersion coefficient of
piston, and DFritL is the axial dispersion coefficient of each frit. D
RP
L and D
Frit
L were
determined through parameter estimation in gPROMS, using the experiment of different
heights in the static piston, presented in the section 4.3.1.
 = 0.318
V0 = VL = 0.273 cm3 H Pe D
RP
L D
Frit
L
Uridine (i = 1) 1.264 1151 1/25.0 1/80.0
Guanosine (i = 2) 1.896 765 1/25.0 1/80.0
demonstrate this relationship. Although there is no clear explanation for this behavior,
the triplicate curves showed the reproducibility of the experiment, as well as the success
of Henry’s calculation. Therefore, as the nucleosides separation were performed at the
constant flow rate Q = 4 mL/min, the Pe values the next tasks were fixed at the values
obtained for this flow rate: P e1 = 1151 (uridine) and P e2 = 765 (guanosine).
4.3.2.5 Recycle Piston Dead Volumes (V0 and VL)
The reflux container has two fluid distributors (frits) inside, both with 20 µm porosity, one
located on the upper fixed part of the device and the other on the upper part of the mobile
plunger. The fluid distributors are intended to radially disperse the fluid that is injected
by the capillary into the piston, the latter being located in the radial center of the device
(in the case of the upper frit) and ensure that the fluid received by the capillary outlet, in
a very short time interval (∆t), is homogeneous to be re-injected into the chromatographic
column (in the case of the lower frit). Distributors are essential to ensure that there is
equal radial distribution of the fluid concentration and to avoid possible preferred paths,
since radial dispersion is disregarded in the mathematical model.
The frits, as it is expected, print dead volumes for the piston, the V0 for the distributor
from the top and VL to the distributor at the bottom (can be seen in the Figure 3.19).
For the dead volume to be minimal, the base of the mobile plunger and the top of the
equipment that receive the frits are flat, i.e. there is no cone shape.
Experimental results for calculating piston dead volumes are presented in Figure 4.20.
The estimated values of the dead volumes were V0 = VL = 0.273 cm3, which are very small
when compared to the chromatographic column volume, representing only 0.86 % of the
chromatographic column volume. In any case, these volumes were taken into account in
the process simulation.
Table 4.6 lists the experimentally calculated values of the set-up parameters.
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(a) Step injection (200 s) of blue dextran bypassing the recycle piston. The retention volume was
θ
RPbp
R = 0.884 cm
3.
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(b) Step injection (350 s) of blue dextran passing through the recycle device. The retention volume
was θRPR = 1.430 cm
3.
Figure 4.20: Blue dextran step injection curves for dead volumes calculation of the recycle
device. The differences between the retention volumes of the Blue Dextran solution,
bypassing (θ
RPbp
R ) and passing through the reflux container (θ
RP
R ), allow to calculate the
frits void volume. Since the experiments were performed at a flow rate of 1 mL/min, the
time (min) shown in the graph also represents θ (cm3). The experiments were performed
in triplicate for each experiment.
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Figure 4.21: Schematic of converting the process depicted in Figure 4.2 into its one-
column analog. Each step in which the flow goes to the next column must be replaced by
the flow being redirected, in the new single column process, to the reflux piston.
4.3.3 Nucleosides Separation by RPC
4.3.3.1 Cycle Determination: From two-column to one-column process
After isolating only the downstream column from the two-column chromatographic pro-
cess for nucleosides separation [228], and following its operation for a complete cycle
in order to replace each step at which the fluid stream went to the upstream column
by redirecting that fluid to the recycling device, the schematic shown in Fig. 4.21 was
obtained.
Note that in the penultimate step the column stays idle, that is, there is no flow
through it. Hence, this step can be eliminated. If this is done, the last two steps of the
cycle are identical ( E ⇒ COL ⇒ R ) and can be merged into a single one. So the original
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Figure 4.22: Schematic of the one-column analog’s cycle. At (a) is the final cycle after
executing the recipe for converting the two-column process for nucleosides separation
into the equivalent single-column system. Since the column at the beginning of the
process is completely clear, the process can start at any of the steps since the sequence is
not changed, so in (b) is the cycle that it was decided to work in this chapter.
cycle that had six steps, now, with the new process, boils down to just four steps. This
already adds an advantage since step changes can lead to experimental errors or pressure
drop changes.
The resulting cycle for the one-column analog is depicted in Fig. 4.22a. The cycle can
start with any of the steps as long as the sequence is not changed. For example, it was
decided to start the cycle with step E ⇒ COL ⇒ R ; this is depicted in Fig. 4.22b.
The full sequence for this cycle is:
1. E ⇒ COL ⇒ R : τ1
2. R ⇒ COL ⇒ P or W : τ2
3. F ⇒ COL ⇒ P or W : τ3
4. R ⇒ COL ⇒ P or W : τ4
Here, P stands for the fractions where the purified guanosine is collected and W for the
fractions where the purified uridine is collected; τk is the duration of the kth step. Then,
necessarily, τ1 = τ2 + τ4, because the piston must return to it’s original position after each
cycle.
136
4.3. RESULTS AND DISCUSSIONS
At process startup the column is initially clean. Thus, if step 1 is executed, ( E ⇒ COL ⇒ R ),
it is essentially filling the recycle piston with pure eluent. The next step is R ⇒ COL ⇒ P .
However, since the column is still clean and the recycle piston filled with eluent, this step
does basically nothing. In the last step of the first cycle, the column is basically being
eluted, because the remaining liquid in the recycle piston is pure eluent. Thus, to speed
up the inicial cycle, it is possible to start it with step 3, F ⇒ COL ⇒ P , and replace
step 4 by E ⇒ COL ⇒ P .
Then, the full sequence is:
(Initial cycle)
3. F ⇒ COL ⇒ P : τ3
4. E ⇒ COL ⇒ P or W : τ4
(Cycles 1 to 17)
1. E ⇒ COL ⇒ R : τ1
2. R ⇒ COL ⇒ P or W : τ2
3. F ⇒ COL ⇒ P or W : τ3
4. R ⇒ COL ⇒ P or W : τ4
Where:
• E ⇒ COL ⇒ P : fresh solvent is pumped from the solvent container, passes in-
side of the chromatographic column and pushes the outlet of the column into the
product recipient, present on top of the weight scale;
• F ⇒ COL ⇒ P : fresh feed is pumped from the feed container, passing inside of
the chromatographic column, pushing the outlet of the column into the product
recipient, without the usage of the recycle piston;
• E ⇒ COL ⇒ R : fresh solvent is pumped, passing inside of the chromatographic
column, pushing the outlet of the column into section A of the recycle device, low-
ering the piston and transferring the solvent from section B to the solvent recipient;
• R ⇒ COL ⇒ P : fresh solvent is pumped into section B of the recycle device, rising
the piston and transferring the mixture inside section A into the chromatographic
column, pushing the outlet of the chromatographic column into the product recipi-
ent.
The obtained cycle features a semi-continuous process with pulsed feed injection and
product collection at selected cycle intervals.
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4.3.3.2 Cycle Steps Injection Time
As shown in the previous section, for the Single-column analog process that mimics the
two-column SMB process for nucleosides separation, each cycle is composed by four steps.
The cycle length is determined by the sum of the time durations of the four steps, then:
Cycle duration (τ) =
4∑
k=1
τk . (4.27)
At each cycle, the process is fed during step 3. As QF is the flow rate of the feed pump,
the feed volume injected per cycle (V cycleF ) is:
V
cycle
F =QFτ3. (4.28)
Therefore, the average feed flow rate per cycle (QF) is:
QF =
V
cycle
F
τ
=
QFτ3
τ
=
QFτ3
τ1 + τ2 + τ3 + τ4
, (4.29)
and in order to calculate the specific productivity (min−1):
Specific productivity (min−1) = QF
Vc
. (4.30)
Taking this into account, the process optimization in the case of nucleosides separation
consisted of maximizing the specific productivity, or more specifically, QF , subject to the
following restrictions for products purity, feed flow rate, and eluent flow rate:
PurX ≥ 0.95,
PurR ≥ 0.95,
QF = 4 mL/min
QE = 4 mL/min
(4.31)
where PurX is the extract purity and PurR the raffinate purity. After applying these
restrictions together with the already mimicked process cycle (Figure 4.22b) and the
previously determined column and piston parameters (Table 4.6), the duration of each
step was obtained.
Here, we briefly outline how the step durations were determined. Let t0 = 0 and
tk = tk−1 +τk , k = 1 . . . ,4, where τk is the duration of the kth step and tk the instant at which
it finishes. The duration of a full cycle is simply τ =
∑
k τk . Let θk = (t − tk−1)/τk ∈ (0,1) be
the dimensionless time for step k. Moreover, let ci(x,θk) denote the axial concentration
profile of solute i in the liquid phase in the chromatography column at dimensionless
time θk where x = z/Lc is the dimensionless axial position along the length Lc of the
column.
The workings of the recycle piston have been detailed in the previous chapter; here,
we recover its governing equations without further details. For this purpose, let c˜i(x,θk)
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denote the axial concentration profile of solute i in the liquid in the recycle piston at
dimensionless time θk , where x = z/LP(θk) is the dimensionless axial position along the
(time-variable) length LP of the moving piston, VP its (time-variable) volume, Q0 its inlet
flow rate and QL its outlet flow rate.
Given this notation the mathematical model governing the time-periodic dynamics of
the one-column analog process is given by the following set of equations.
(Column breakthrough model, 0 < θk ≤ 1)
x = 0 : ci − 1Pei
∂ci
∂x
= cini , (4.32)
0 < x < 1
∂ci
∂θk
=
τkQ
Vi
(
1
Pei
∂2ci
∂x2
− ∂ci
∂x
)
, (4.33)
x = 1 :
∂ci
∂x
= 0. (4.34)
(Recycle piston, 0 < θk ≤ 1)
dVP
dθk
= τk(Q0 −QL), (4.35)
V 2P
∂c˜i
∂θk
= τk(γm +γhQ0)
(
∂2c˜i
∂x2
)
− τkVP
[
Q0 − (Q0 −QL)x
](
∂c˜i
∂x
)
for 0 < x < 1, (4.36)
VPQ0c˜i − (γm +γhQ0)∂c˜i∂x = VPQ0c˜
in
i for x = 0,
∂c˜i
∂x
= 0 for x = 1.
(4.37)
(Cyclic operating conditions, 0 < θk ≤ 1)
k = 1 : Q0 =Q =QE , QL = 0, c
in
i = c
E
i , c˜
in
i = c
out
i , (4.38)
k = 2 : QL =Q =QR, Q0 = 0, c
in
i = c˜
out
i , (∂c˜i/∂x)x=0 = 0, (4.39)
k = 3 : Q0 =QL = 0, Q =QF , c
in
i = c
F
i , (∂c˜i/∂x)x=0 = 0, (4.40)
k = 4 : QL =Q =QR, Q0 = 0, c
in
i = c˜
out
i , (∂c˜i/∂x)x=0 = 0, (4.41)
where QE , QF and QR are the eluent, feed, and recycle flow rates, respectively, c
E
i = 0 is
the solute concentration in the fresh eluent, cFi the concentration in the feed, and c˜
out
i the
outlet concentration of the recycle piston at dimensionless instant θk .
(Time-periodic boundary conditions)
ci(x, t = 0) = ci(x, t = τ) for 0 < x < 1, (4.42)
VP(t = 0) = 0, (4.43)
c˜i(x, t = 0) = c˜i(x, t = τ) for 0 < x < 1. (4.44)
As stated above, in the present work we fixed QE =QF =QR = 4 mL/min and solved
the following optimization problem that aims at maximizing the average feed flow rate
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Table 4.7: Parameters values of the cycle, determined by model-based optimization, for
the separation of nucleosides using the one-column analog. Each step has a specific time
of operation expressed in minutes.
Step, k τk (min)
1 10.15
2 6.15
3 3.94
4 4.01
per cycle (which is directly proportional to the productivity):
max
τk
QF (4.45)
s.t. τk ≥ 0, (4.46)
τ2 + τ4 = τ1, (4.47)
PurR ≥ 0.95, (4.48)
PurX ≥ 0.95. (4.49)
This nonlinear mathematical programming problem has been implemented in AMPL
by J. P. Mota via a full discretization approach and solved using the nonlinear interior
point solver Ipopt v. 3.11 coupled to the parallel linear solver WSMP v. 16.0. These
optimal step durations are given in Table 4.7.
4.3.3.3 Experimental Results
A clever implementation of single-column chromatography with recycle to mimic the
operation and performance of a two-column, semi-continuous, open-loop configuration,
for a efficient binary separation was proceeded experimentally.
For this, the separation of two nucleosides, uridine and guanosine, was employed.
This mixture was chosen because of the ease of separation at low concentrations, as
these low concentration compounds have linear isotherm, and no experiments with the
mixture need to be performed, i.e. experiments can be performed with the compounds
alone to reproduce the separation behaviour proceeded with mixed bulk. This facilitates
the handling of the experiment.
Guanosine has important neuroprotective and neuromodulator functions in the cen-
tral nervous system [114]. This molecule is associated with diseases such as colorectal
cancer [169], Crohn’s disease, ulceratite colitis [37], and purine nucleoside phosphorylase
deficiency [50]. As well as guanosine, uridine is also one of the five standard nucleosides
which make up nucleic acids, and is located in most biofluids, including urine, breast
milk, cerebrospinal fluid (CSF), and blood. In humans, uridine is involved in several
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metabolic disorders, as MNGIE (mitochondrial neurogastrointestinal encephalopathy),
beta-ureidopropionase deficiency, and dhydropyrimidinase deficiency [115].
At this operation, the eluent pump and the feed pump were operated with constant
flow rates, so that when one of these solutions was not being injected into the column, it
was being recirculated to its own containers, avoiding the need for constant change in the
flow of the pumps of the system.
The cycles were reproduced experimentally in the prototype apparatus, having been
carried out from an initial cycle until thirteen complete cycles. The system takes some
time to reach steady state operation.
For data processing, the time data was scaled to a dimensionless coordinate (α), each
unit of α representing a cycle, i.e. with dimensionless time one to two corresponding to
the first cycle, two to three corresponding to the second cycle, successively until the four-
teen cycles (initial + 13 complete cycles) are represented in the graphs. The calculation
for α is following:
α = n+
t − ti,n
τ
, (4.50)
being n the cycle number and ti,n the initial time of each cycle The curves are also nor-
malized to the chromatogram’s y-axis, showing values for c/cmax.
The dimensionless concentration profiles for all fourteen cycles (initial + 13 complete
cycles), experimentally obtained at outlet of the column, are expressed in Figure 4.23.
The extract (guanosine) and raffinate (uridine) were recovered at the downstream end
of the column. The first component to be collected, in this experiment, is the more
retained, that is guanosine, because the less retained one goes directed to the piston
device at initial cycle. The cyclic steady state was achieved, at nucleosides separation,
after approximately six cycles. From cycle 1, each colored region of the graph represents
one step of the operating cycle, so that the white region represents step 1, the gray block
covers step 2, and the light red region indicates steps 3 + 4. This makes it easy to identify
the steps in which products are recovered.
For a better understanding of the results, a graph was generated with fewer cycles,
comprising the operating region already under cyclic steady state. Therefore, cycles
ten through thirteen are shown in Figure 4.24. Each step operation period is indicated,
clearly showing the collection intervals of guanosine at step 2 and uridine at steps 3 and
4, proving that the two components were successfully collected separately in each cycle
and that the process developed in this chapter has the potential to separate nucleosides
and strongly mimic this kind of two-column process.
The calculations performed for each component of the mixture showed that the prod-
ucts, guanosine and uridine, reached medium purity values of 99.57 % and 97.03 %,
respectively. The purity values per cycle, for each component, are shown in Figure 4.25.
In addition, Figure 4.26 exhibit calculated values for recovery in each cycle. The system
achieved mean recovery values, after cyclic steady state was reached, of 97.8% for guano-
sine and nearly 100.0% for uridine. Note that the recoveries increase from cycle to cycle
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Figure 4.23: Experimental concentration profiles for nucleosides separation. The points
represent: black, guanosine; red, uridine. From cycle 1, the injection intervals of each
step (tK ) are represented in different area colors: step 1, white area of the graph; step 2,
gray area; step 3 and 4, light red area. Guanosine is clearly recovered in step 2, while
uridine is recovered in steps 3 and 4.
because the fluids containing the pure compounds are stored in the piston and reinjected
into the system with a lag in time. These high purity and recovery results highlight the
separation capacity of the Single-column Analog with Recycle Lag process, validating the
chromatographic process through the case study chosen.
Besides purities and recoveries, since the injected feed volume per cycle (V cycleF ) was
15.8 mL and the average feed flow rate (QF) was 0.65 mL/min, the separation process
achieved productivity of 0.66 mL/min, specific productivity (QF/Vc) of 0.020 min−1 and
eluent consumption (QE/QF) of 2.54. These productivity and specific productivity values
are just for informational purposes, as they are not considerably important in this chapter,
since the main focus is on the effectiveness of the separation process in terms of purity
and recovery.
In order to promote further analysis, Figure 4.27 shows the axial concentration pro-
files of the steady periodic solution in liquid phase and placement of the outlet lines for
a unique full cycle, the 12nd cycle. In a more detailed approach to a complete cycle of
operation, it is noted that much of the output fluid in step 3 is pure eluent, represented
in the graph by the gray area. The blue block expresses the collection interval needed for
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Figure 4.24: Experimental chromatogram for steady state cycles at nucleosides separation.
The points represent: black, guanosine; red, uridine. The injection intervals of each step
(tK ) are represented in different area colors: step 1, white area of the graph; step 2, gray
area; step 3 and 4, light red area. Guanosine withdrawal occurs at 2nd step of the cycle.
Meanwhile, withdrawal of uridine happens at 3rd and 4th steps.
Figure 4.25: Guanosine (black) and uridine (red) purities per cycle for the separation of
nucleosides using One-column Analog to SMB. Guanosine: P urgua = 99.57%; Uridine:
P ururi = 97.03%.
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Figure 4.26: Guanosine (black) and uridine (red) recoveries per cycle for the separation
of nucleosides using One-column Analog to SMB. Guanosine: Recgua = 97.76%; Uridine:
Recuri = 100.00%.
the guanosine, and green area is the uridine picking interval. After calculations using
the experimental data, it was concluded that at least 10.5 mL of solvent can be saved
per cycle, which would result in a 25.87% decrease in solvent consumption at each cycle.
The most effective solution is to redirect the fluid within that time interval of pure eluent
through an internal recycle for the solvent tank and reuse it. An advantage when com-
pared to the two-column is the number of pumps that the installation needs to operate
with solvent recirculation, since the operation of the one-column with recycle lag occurs
with only two pumps, confronting with the three pumps necessary for the two-column,
semi-continuous configuration, if solvent recirculation is needed (closed-loop operation
case) [228].
In view of the good results, an important aspect to be evaluated is how much the
single-column system allows to reduce the cost in contrast to the benchmark process. In
this exercise several other factors should be accounted for in this budget, for example,
the reduction in the length of capillaries required for installation, or number of valves
(ten ON/OFF valves in the two-column system versus seven ON/OFF valves and one
2-pos-6-port valve in the single-column system). Although the number of pumps is
equal in both systems when considering open-loop configuration, i.e. two pumps, if
internal recirculation is required, two-column (closed-loop configuration in this case)
needs one pump for each outlet and more two recirculating pumps, totaling four pumps,
while single-column setup only requires still two pumps. It is clear, therefore, that the
equipment employed in single-column is much simpler than two-column.
In addition to the added simplicity, there are other adjacent benefits, the setup is
smaller, less complex, and then less expensive than the technology covered by the two
column system. It is worth noting that complexity usually increases costs. In terms of ef-
ficiency, the new process presented in this chapter seems competitive with the previously
developed 2-column technology.
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Figure 4.27: Guanosine (black) and uridine (red) concentration profiles for cycle 12 of
the One-column Analog to SMB. The gray region of the graph represents the range at
which the pure solvent can be recovered, representing a decrease of 25.87 % in solvent
consumption. Blue area, guanosine recovery; green area, uridine collection.
4.3.3.4 Comparison with Simulated Data
gPROMS simulation for contrast with experimental data is an essential tool in the analysis
of hydrodynamic behaviour within the recycle piston. Because of its ability to generate
predictive information with high accuracy, it serves as decision support for product and
process innovations, design and operation [211].
Taking into account the dynamic simulation variations for the recycling device: disper-
sive plug-flow and perfectly agitated tank, were built as demonstrated in Appendix B.7.
A parametric adjustment was performed to characterize the process in the simulation,
adjusting the simulated curves to the experimental curves. Thus, the parameters used in
the simulation are presented in Table 4.8.
The simulated solute composition profiles were compared, for each component, to
the experimental ones, as can be seen in the Figure 4.28. The top graph shows the
chromatograms for uridine, while the bottom graph shows the results for guanosine. The
experimental points are expressed in red, while the results of the simulations are shown
by blue lines for piston considered as dispersed plug-flow, and black lines for the data
regarding the piston condition as perfectly stirred tank.
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Table 4.8: Parametric adjustment to characterize the entire process. Parametric adjust-
ment is required to fit simulated curves to experimental curves.  is the packing interpar-
ticle porosity, H is the Henry constant, Pe is the Péclet number, V0 is the inlet piston dead
volume, VL is the outlet piston dead volume.
 = 0.295
V0 = VL = 0.35 cm3 H Pe
Uridine (i = 1) 1.34 1100
Guanosine (i = 2) 2.20 1100
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Figure 4.28: Comparison between experimental and simulated data for solute concen-
tration profiles at the column outlet of the One-column analog to SMB defined in Fig-
ure 4.22(b). The top graphic shows the result for uridine, while the bottom one for
guanosine. Points denotes experimental data, whereas lines represent the solutions of
the dynamic process models (blue, piston as dispersed plug-flow; black, piston as perfect
mixed tank.)
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Figure 4.29: Comparison between experimental and simulated data, considering only
steady state cycles at nucleosides separation, for solute concentration profiles at the col-
umn outlet of the One-column analog to SMB defined in Figure 4.22(b). The top graphic
shows the result for uridine, while the bottom one for guanosine. Points denotes experi-
mental data, whereas lines represent the solutions of the dynamic process models (blue,
piston as dispersed plug-flow; black, piston as perfect mixed tank.)
Due to the number of cycles performed, a simpler graph was again generated, consid-
ering only steady state cycles (cycles 10 to 13), in order to facilitate the analysis, which
is shown in Figure 4.29. When analysing the graphs, it was noticed that, for uridine (top
graph), the concentration front rises were better captured by the simulation of piston
as dispersed plug-flow, while the concentration front descents were better represented
by the simulation in which the piston has behaviour of perfectly mixed tank, while for
guanosine (bottom graph), the opposite happens, where the concentration front rises
approached better to the simulation of piston as perfectly stirred tank, while the concen-
tration front descents were better constituted by the simulation in which the piston is as
a dispersed plug-flow.
Nevertheless, although the results are not exactly alike, a certain qualitative and quan-
titative agreement between the experimental and simulated results is easily noticeable,
so it was concluded that the behaviour of the piston is somewhat intermediate between
dispersed plug-flow and perfectly mixed tank. However, as shown in the previous section
( 4.3.3.3) through results of purities, recoveries and solvent consumption, this undefined
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Figure 4.30: Shape of the dimensionless Langmuir adsorption isotherm as a function of γ .
hydrodynamic piston behaviour does not affect the good response of the chromatographic
process when performing the separation of uridine and guanosine molecules, which does
not invalidate the prototype’s effectiveness.
Before concluding it is important to note that the prototype system was tested with a
linear separation which, although counter-intuitively, can be considered more challenging
than many nonlinear separations. This is because a linear isotherm is the boundary be-
tween favorable and unfavorable isotherms: the moving concentration front for a linear
adsorption isotherm is not compressed during adsorption nor broadened during des-
orption. The resins for most overloaded (bio)separations are chosen to yield favorable
adsorption isotherms under overloaded conditions so that the concentration fronts get
compressed during the adsorption or capture steps. And in many cases the mobile phase
is changed for the elution or washing steps to produce faster desorption, so the problem
of band broadening is not even an issue there. Hence, the effect of fluid mixing in the
recycle device has less adverse effects with a favorable adsorption isotherm than with a
linear one.
To further elaborate on this point consider the problem of comparing breakthrough
curves obtained under linear and nonlinear conditions when the chromatographic column
is connected to an unmixed recycle device and to a perfectly mixed one. The reference
isotherm is the linear one:
q =Hc, (4.51)
where H is the Henry constant. The aim here is to compare the breakthrough curve for
this isotherm and those for a family of Langmuir isotherms:
q =
q∞αc
1 +αc
, (4.52)
where q∞ = limc→∞ q is the saturation capacity and q∞α = limc→0 q/c the Henry constant.
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In order to obtain a meaningful comparison between the two types of isotherms, the
Langmuir one should yield the same adsorption capacity as the linear one at the feed
concentration cF, that is,
q∞αcF
1 +αcF
=HcF. (4.53)
This allows us to express the Langmuir isotherm as
q =
H(1 +αcF)c
1 +αcFc
. (4.54)
Moreover, by introducing the changes of variable y = c/cF and w = q/(HcF) the Langmuir
isotherm can be rewritten as
w =
(1 +γ)y
1 +γy
, γ ≡ αcF. (4.55)
Notice that the linear adsorption isotherm, w = y, is recovered by setting γ = 0, whereas
increasing its value makes the shape of the adsorption isotherm progressively more con-
cave. This is illustrated in Fig. 4.30.
The equilibrium, dispersed plug-flow model governing the dynamics of the adsorp-
tion column can be written as
x = 0 : y − 1
Pe
∂y
∂x
= yin, (4.56)
0 < x < 1 :
∂y
∂θ
=
τ Q/(V )
1 + β(dq/dc)
(
1
Pe
∂2y
∂x2
− ∂y
∂x
)
(4.57)
x = 1 :
∂y
∂x
= 0, (4.58)
where  is the bed porosity, β ≡ (1− )/ the phase ratio, x = z/L the dimensionless axial
coordinate along the column of length L and volume V , Q the volumetric flowrate, and
Pe the Péclet number.
Expanding dq/dc gives
dq
dc
=H
1 +γ
(1 +γy)2
(4.59)
and if the chosen time scale is τ = (1 + βH)V /Q, the governing equation for the interior
of the domain simplifies to1
0 < x < 1 :
∂y
∂θ
=
(1 + βH)(1 +γy)2
βH(1 +γ) + (1 +γy)2
(
1
Pe
∂2y
∂x2
− ∂y
∂x
)
. (4.60)
Let us now consider the two limiting cases of operation of the recycle device. Suppose
that when the column is connected to the unmixed recycle device the former is subject
to an inlet concentration profile consisting of a linear gradient from 0 to cF followed by
saturation of the column at cF. This is an idealization of, say, moving the mass-transfer
zone stored in the recycle device into the column. In the second case, when the column is
connected to a perfectly mixed tank, the mass transfer zone is completely mixed in the
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Figure 4.31: Inlet concentration profile of the column when it is connected to an unmixed
device (dashed, purple line) and a mixed tank (solid, red line).
recycle piston, so the column is initially fed with a step concentration at cF/2 followed by
saturation of the column at cF. Fig. 4.31 illustrates these two inlet concentration profiles.
Fig. 4.32 shows that for γ = 0 (linear adsorption isotherm) the outlet concentration
profile when the column is fed from the mixed tank is clearly different from when the
column is fed from the unmixed device. However, as the value of γ is increased the outlet
concentration profile for the column connected to the mixed tank gets progressively closer
to that when the column is fed from an unmixed recycle device. Hence, for very favorable
adsorption systems the degree of mixing in the recycle device is not very important as
long as the mixed fractions are reinjected into the column ahead of the fresh feed fraction
(for a favorable isotherm lower concentrations travel slower than higher ones).
4.4 Conclusions
Seeking to validate the experimental prototype created in the laboratory and show its
effectiveness, the first experimental validation was proceeded. For this, a linear binary
separation of nucleosides, considered a simple and easy separation, was performed for
open-loop operating configuration. Before executing the experiment for this configura-
tion, preliminary experiments were performed to test the recycle device operation.
The recycle device has been validated for the successful operation of its movable pis-
ton. The hydrodynamic behaviour of the piston is somehow aligned with the plan of the
previous chapter, in which, at first analysis, the fluid concentration profile is maintained,
i.e. the “first in, first out” method is being obeyed by the recycling device. The maximum
pressure reached with the piston in operation, 6 bar, is much lower than the maximum
1When γ = 0 this time scale yields ∂y/∂θ = (∂2y/∂x2)/Pe− (∂y/∂x), which explains our choice.
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Figure 4.32: Outlet concentration profile of the column when it is connected to (a) an
unmixed device and (b) a mixed tank, as a function of parameter γ ; βH = 3.0, Pe = 300.0.
pressure supported by the equipment, which is very positive since operation with the
complete setup would give to the system a higher pressure drop, and is crucial for the
installation to operate at safe pressure margins.
As the first analysis was done only with the naked eye, further detailed study of the
fluid behaviour within the piston was performed, this time with UV reading and for
different piston heights, resulting in graphs with behaviour very close to the dispersed
piston flow.
Furthermore, characterization regarding the chromatographic column and recycle
device was proceeded.
The experimentally calculated interparticle porosity of the bed,  = 0.318, is identical
to the porosity presented in the literature [228] for the same chromatographic column.
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The same occurred with the constants of Henry experimentally calculated from pulse
injections of each component. Therefore, the most recent results, calculated in this chap-
ter, were used for the following chapter works. Peclet number of each compound were
calculated for five flowrates, although only P ei values at Q = 4 mL/min were considered
for the following steps.
The calculated piston dead volumes, V0 = VL = 0.273 cm3, are very low volumes,
which was intended for the system. Despite being very small values, they were not
neglected in the mathematical model applied in the process simulation in gPROMS.
Overall, the general cycle depicted in this chapter for the Single-column Analog to
SMB can be viewed as a streamlined version of a previously optimized two-column, open-
loop SMB [228] with pulsed feed and selective product withdrawal, which characterizes
as a quasi-continuous chromatographic operation. As another important point, the cycle
determination has been able to reduce the number of cycle steps when comparing with
the mimicked multicolumn process, from six to four steps, which is an advantage since
step changes can come along with experimental errors and pressure changes.
Optimization in AMPL, maximizing the average feed flow rate, coupled with the
purities and feed flow rate constraints, has provided optimum cycle times for each step
of the cycle.
The experimental data was approached, for comparison purposes, with simulated
data in gPROMS. The simulation against the experimental data serves to aid in process
validation to evaluate the hydrodynamic behaviour of the fluid within the piston. The
piston used in One-column SMB Analog system has been designed and engineered to
maintain a dispersed plug-flow operation inside. However, the experimental curves of
the 13 complete cycles compared to the simulated ones showed that the piston has an
intermediate behaviour between dispersed plug-flow and perfect mixed tank, however,
this does not cast doubt on the prototype effectiveness once the challenges of purity,
recovery and solvent consumption have been met. The very high values of purities (99.57
% for guanosine and 97.03 % for uridine) and recoveries (97.76 % for guanosine and
100 % for uridine), and the reduced desorbent consumption showed that, despite the
still undefined behaviour of the fluid inside the piston, the prototype presented excellent
results in the nucleosides, uridine and guanosine, separation process, proving the efficacy
of the new system.
In addition, the single column is very easy to perform, thanks to its simplicity of
equipments, consequently bringing a process with reduced dimensions, smaller compo-
nents number, reduced complexity, reduced costs, greater ease of maintenance, and even
reduced time needed to perform one cycle in comparison to the conventional technology,
the two-column mimicked system, while maintaining the efficiency.
Through the results, it was examined whether it would be necessary to improve the
plug-flow operation inside the recycle container. Therefore, this topic will be covered in
the following chapter.
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Improvements of Plug-flow Operation in
the Recycle Device
5.1 Introduction and Objective
Three-dimensional (3D) printing, also called Additive Manufacturing (AM), Rapid Pro-
totyping (RP), or Solid-FreeForm Technology (SFF), designates parts fabrication with
the principle of material layer by layer exposure [91]. This technology emerged in the
early 1980s, developed by Charles Hull [97], after which countless patents have emerged
in these thirty years. 3D printing allows focusing on innovative product development,
realizing creative ideas for the industrial market [82].
A large number of printer models already allow the user to focus on 3D model de-
sign, putting the printing software responsible for the difficult tasks, offering options to
automatically orient, support, and present the 3D model.
There is a large diversity of 3D printing methods. The most common technologies are
presented in Table 5.1.
Accompanying the variety of technologies, various materials for high-resolution rapid
prototyping are already explored, destined for a wide range of purposes. With different
materials, it is possible to produce pieces of plastic, metal, ceramics, among others.
The 3D printing market has grown quickly, with the emergence of an increasing num-
ber in high-precision machines, as well as a wide variety of modelling materials to cater
to various industries’ needs. The latest 3D production systems are capable, not only of
producing 3D models for mechanical testing, but also of successfully manufacturing func-
tional prototypes as an industrial production unit [56]. The 3D printing technology has
achieved applications in the automotive and aerospace industries, through the production
of car and airplane parts, in architecture, building structural models, in the consumer
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Table 5.1: Overview of the most common 3D printing processes. Source: [9, 58, 97, 264]
3D Printing
Technology
Methods Principle Materials
Vat
Polymerization
Stereolithography
(SLA), Direct Light
Processing (DLP).
Curing of photoresin
layers by the inci-
dence of UV light.
Photopolymer resin
(Standard, Castable,
Transparent, High
Temperature). Epoxy
or acrylate based
resins with photoini-
tiators.
Material
Extrusion
Fused Deposition
Modeling (FDM).
Extrusion of molten
thermoplastics.
Filament of PLA, ABS,
PET, TPU, PEEK, ny-
lon.
Binder Jetting Binder Jetting (BJ) Powder-liquid bind-
ing.
Sand or metal powder:
stainless / bronze.
Material
Jetting
Material Jetting (MJ),
Drop on Demand
(DOD).
Hybrid between SLA
and BJ. Photopoly-
mers are cured when
exposed to light.
Photopolymer resin
(Standard, Castable,
Transparent, High
Temperature).
Power Bed
Fusion
Selective Laser Sin-
tering (SLS).
Powder particle
heating provided by
laser incidence.
Thermoplastic pow-
der (ABS, PVC, nylon,
resin), ceramic pow-
ders.
Power Bed
Fusion
(Metals)
Direct Metal Laser
Sintering (DMLS);
Selective Laser
Melting (SLM); Elec-
tron Beam Melting
(EBM).
A thermal source
induces fusion be-
tween metal powder
particles.
Metal powder: alu-
minum, stainless Steel,
titanium.
Sheet
Lamination
Laminated object
manufacturing
(LOM).
Cutting (with laser
or razor) of heated
coated sheet mate-
rial.
Adhesive-coated poly-
mer, cellulose, paper,
metal sheets.
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goods industry [245], in the food industry [93], in fashion, with the production of tex-
tiles [202], in the medical sector, with dental prostheses production and implants [163],
and even in the field of government defence through weaponry production for the mili-
tary.
In addition, 3D printing technology is set to revolutionize not only manufacturing
but also research and teaching laboratories, with a potential impact on biotechnology and
chemical sciences, addressing a comparison between new 3D printed methods and other
traditional ones used in these areas. In biomedical engineering, for instance, 3D printing
has been an increasingly addressed tool for producing biocompatible and resorbable
materials, specifically tissue scaffolding, from bone and teeth, and still vascular and
organ scaffolding. Scaffolds usually consist of the individual’s own tissue (autogenous
tissue), because bio-resorption and biocompatibility (where it can be rejected or not by
the body) are the main constraints of a foreign scaffold. Therefore, the ability to produce
scaffolds through 3D printing for tissue regeneration avoids the use of the patient’s own
tissue. This is very valuable when large amounts of autogenous tissue are needed, to the
point of being infeasible by the patient [148, 221].
Moreover, in the biotechnology field, 3D printing has been an attractive pathway in
surgical preparation, through the printing of the patient’s anatomy, allowing a patient-
specific treatment plan and better preparation for surgery due to early study of body
anatomy [221]. Moreover, drug delivery devices have been widely manufactured, because
3D-printed drug implants make it easier for control drug release by providing a barrier
between drug and tissue through the binder printing, a solution capable of solubiliz-
ing a specific powder onto a matrix powder bed [282]. This ensures that the infection
will be treated locally and will not affect other tissues, as traditionally occurs with drug
treatments. As chemical applications, macro/microfluidic devices have been extensively
produced through 3D printing, with the potential for producing a complex microvascular
network with channels capable of diffusion-based mixing under laminar flow profiles, as
well as mixing from turbulent flow [259].
A highlight application of 3D printing in recent years is the customization of lab-
oratory material, producing customized parts to complement laboratory equipment of
different functionalities, through rapid prototyping, easily acquiring the necessary mate-
rial [66, 130, 145, 255]. It is about this application that this chapter focuses.
Recent approaches to 3D printing has been applied to chromatographic columns pro-
duction [76, 185, 186, 201, 231], mainly for liquid chromatographic separations. Porous
beds with perfectly ordered micro-structures, novel flow-distributors, collector, column
(walls) designs and standard liquid chromatography fittings were manufactured in a
single printed artefact, to achieve more efficient separations. Despite the adoption of 3D-
printing as a column production method, it is currently limited by several key challenges
such as: resolution, material choice and print times. This study can serve as a basis for
improving the piston operation, a subject that will be addressed in this chapter.
The popularization of 3D printers for different features comes together with the prices
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(a) (b)
Figure 5.1: Schematic of an SLA 3D printers. (a) Bath configuration SLA printer with a
direct curing method. (b) Layer configuration SLA printer with a projection based curing
process. Source: [97].
associated with the equipment, which has been decreasing sharply over the last four years.
Machines that once cost $20,000 can now be purchased for less than $1,000. This is
largely due to Chinese companies, which are investing their efforts in the manufacturing
of this technology [35]. The attractive pricing, and also the key advantages of 3D print-
ing, namely, simplicity in the manufacturing process, short production time, model and
manufacturing reproducibility, make this technology potentially envisioned in the most
diverse areas [269].
5.1.1 Stereolithography (SLA) Technology
Stereolithography (SLA) was the first patented 3D printing method, which occurred in
1986 by Charles Hull at 3D Systems [119].
SLA print technology is a light-polymerized type process, which uses a laser incident
on a liquid photopolymer resin, causing the monomer (liquid) to link together to form a
polymer (solid) [120], then the polymer composes the three-dimensional solid body.
There are two approaches to SLA, as shown in Figure 5.1, one based on direct/laser
writing (a), and mask-based writing (b) [97]. Both forms contain a movable base, a tank
of liquid resin, a UV light beam and a computer interface. The mask-based writing also
contains a digital mirror device (DMD) "mask"that allows curing a single layer at a time.
In the bath method, the oldest method for SLA, the platform is positioned just below
the surface of photoactive liquid resin and is thus submerged. The UV beam traces a 2D
section over the submerged base, causing the resin to polymerize when subjected to such
illumination. In this configuration, the laser moves line by line along the surface until
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the desired layer is completely cured. The stage is lowered slightly to a set height to start
a new layer so that a thin height of liquid resin is left over the previously cured material,
and then the curing process is repeated.
It is worth noticing that the thickness of the cured layer is dependent on the UV
light energy, more precisely the exposure duration, scan speed, and intensity of power
source [97]. In addition, between one layer and another, the resin surface is flushed with
a resin-loaded blade to ensure a uniform liquid layer.
In terms of limitations, this configuration is constrained by the tank size, which re-
stricts the height of the prototype to be printed, resin waste, and massive cleaning pro-
cedures. These drawbacks are overcome by layer configuration, so they are a better
alternative to SLA technology [48, 59, 159].
The layer configuration, unlike the previously explained configuration, has the stage
suspended above the resin tank, while the light source is below the reservoir. The reser-
voir has a transparent bottom that allows light to pass from UV to the resin. This change
of position allows the volume of resin needed to be reduced in the vat, where only a thin
layer of liquid is between the reservoir base and the submerged platform at the set height.
Therefore, the liquid is in contact with the platform when UV light is shone. Because the
reservoir base is transparent, the cure is done on the entire layer at once, giving a much
faster healing process than the bath configuration. When the curing process of a layer is
completed, the platform lifts along with the cured material adhered to it, and then the
process is repeated until the final object is achieved, with minimal cleaning stages [118].
The UV light source varies with the type of resin used [33].
A post-cure process is required for both configurations after part fabrication to strengthen
bonding in the final 3D prototype [274].
In SLA technology, the vertical resolution is determined by the thickness of the cured
layer. Reducing the layer thickness increases the curing efficiency, instead, the horizontal
resolution is defined by the diameter of the UV beam [106].
The drawbacks of SLA primarily involve resins, not only for the associated cost but
also because only one resin can be used at a time in a printing process, which limits
prototype design. In addition, most of the final material is brittle and may shrink after
polymerization as the resins are epoxy or acrylic based [106, 173].
Although SLA 3D printers are highly expensive, they feature high resolution (25µm
layers). In addition, efficient models (1.5 cm/h building speed) are already becoming
more accessible to labs, such as Formlabs printers [81].
5.1.2 Fused Deposition Modeling (FDM) Technology
Fused Deposition Modeling (FDM) was developed by S.Scott Crump, co-founder of Strata-
sys, in 1988 and the patent was awarded in 1992 [56]. The FDM print technology, the
most popular 3D process by the number of machines, is a process that uses a thermo-
plastic material as continuous filament [105], extruded from a moving, heated printer
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Figure 5.2: Schematic of an FDM 3D printer. Source: [197].
extruder head and deposited on the growing work, which is placed on a heated bed. The
head movement that defines the desired shape is performed by computational control.
Figure 5.2 shows the printer layout FDM.
In this printer type, the extruder has two ends, a hot and a cold one. The cold end
consists of the roller, which is responsible for pulling the material filament towards the
hot end and controlling the feed flow through a stepper motor. This represents the drive
mechanism in the material delivery system. The hot end is composed of a liquifier, an
essential component in this printer type, hosted in the heating chamber and a nozzle,
which are responsible for transforming the filament into a thin liquid that adheres to the
bed and the previously deposited material. For each material, a specific nozzle is used,
with different tip diameter, manufactured from different raw material, and working at a
different temperature.
Firstly, the head moves in two dimensions to deposit the extruded material in a hori-
zontal plane, thus forming a layer. Then the head is moved vertically to start working on
a new layer [32]. And so, the work begins again under the two dimensions of the plane.
This process continues until the final object is totally completed. The vertical height of the
layer defines the layer resolution, in this manner, as much lower height, better resolution
is obtained.
The speed of the extruder head must be controlled to stop and begin material depo-
sition to achieve an interrupted plane, in other words, without any binding between the
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Table 5.2: Materials used in the execution of the activities of Chapter 5.
Material Molecular formula Manufacturer
Clear Formlabs Resin - Formlabs
Pure Isopropyl Alcohol C3H8O LabChem
PEEK filament - Henan Suwei Eletronic Technology
Ethanol absolute CH3CH2OH Panreac
Sodium hydroxide NaOH Anko Nobel, EKA Chemicals
Hydrochloric acid HCl Carlo Erba Reagents
Fluorescent Tracer - -
sections of raw material. In addition, for the vertical layers of the process to bond suc-
cessfully, the ambient temperature must be controlled. Therefore, the system is kept in a
chamber, at a temperature slightly below to the material melting point being deposited.
In this printer type, the thermoplastic is rapidly cooled due to the low-temperature main-
tenance in the platform, where the material is deposited, and also the environment of the
system chamber. Since this kind of technology is the most commonly used in the field of
3D printing, a wide variety of filament materials are also already being used for extru-
sion, for example polylactic acid (PLA) [70, 107, 111],aliphatic polyamides (nylon) [158,
175, 243, 286], polyether ether ketone (PEEK) [64, 89, 117, 273], acrylonitrile butadiene
styrene (ABS) [36], and so on.
FDM, when it is compared to other 3D printing technologies, presents itself as an
inexpensive alternative [125], and is mostly used for prototyping and rapid manufactur-
ing, facilitating iterative tests and very short runs. They may also be used in the field of
human health in scaffolding prototypes for medical tissue engineering applications [172],
or for processing post-consumer plastic waste into filament, and other uses.
While it has the advantage of offering a low-cost solution over other technologies, the
FDM method’s drawback is the requirement for supports to deposit the liquid material,
in other words, it is impossible to create shapes with unsupported regions, which limits
the part shape to be printed.
5.1.3 Objective
In order to improve the fluid distribution in the recycle piston, the purpose of this chapter
is to develop flow distributors using 3D printing technology, addressing two distinct
printing methods: SLA and FDM. The numerous configurations produced will then be
analysed in an attempt to explore improvements.
5.2 Materials
The reagents and raw materials used in Chapter 5 are shown in Table 5.2.
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5.3 Methods
The 3D printing methods employed in this chapter were used at different times of the
thesis development. Therefore, although the following sections address the two different
methods, it should be borne in mind that the SLA method was worked on in advance, and
only after the results obtained with this method, the FDM method was further explored.
5.3.1 Production of New 3D Distributors
(SLA Technology)
The SLA printer used to produce 3D distributors was the Form 2 (Formlabs, Ger-
many)(Figure 5.3) with Clear Formlabs Resin (Standard Resin from Formlabs, Germany).
The Clear Resin is composed by methacrylated oligomers, methacrylated monomer and
photoinitiators [86].
The operating temperature is automatically controlled at 35◦C, the supports are au-
tomatically generated and easily removed, with auto-orientation for the optimal print
position. However, in the present work the supports were mostly generated manually to
improve their placement and minimize their number. The layer resolution is 0.025 mm,
the highest attainable with the current machine, the laser spot size is 0.14 mm and is
emitted with wavelength of 405nm [84].
The Open Source Blender software v. 2.79 (https://www.blender.org) was used to
generate the drawings, and the Preform program was used to send different shapes to the
printer. Blender is a free and open source 3D creation suite. It supports the entirety of
the 3D pipeline—modeling, rigging, animation, simulation, rendering, compositing and
motion tracking, video editing and 2D animation pipeline. The 3D drawings produced
in this thesis were always generated using the Blender scripting language programmed
in the Python scripting language and never produced by hand. Python is an interpreted,
interactive, object-oriented programming language. It incorporates modules, exceptions,
dynamic typing, very high-level dynamic data types, and classes. Python combines re-
markable power with very clear syntax.
Python scripts are a versatile way to extend Blender functionality. Most areas of
Blender can be scripted, including animation, rendering, import and export, object cre-
ation and automating repetitive tasks. To interact with Blender, scripts can make use
of the tightly integrated Application Programming Interface (https://docs.blender.org/
manual/en/latest/advanced/scripting/introduction.html).
To ensure that there is no monomer residue on the printed body and subsequent
danger of polymerization in contact with the light, the solid printed material should
immediately undergo two washing procedures, each bath with 10 minutes immersion in
pure isopropyl alcohol (LabChem, Zelienople-PA, USA). After the first 5 minutes of each
bath, the material is lightly subjected to shaking for 30 seconds. And then the piece is
put to dry. After being completely dry, it is subjected to post-cure, a process to improve
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Figure 5.3: Form 2 printer (from Formlabs) used to produce complementary piston parts.
This 3D printer uses stereolithography (SLA) as printing method.
the mechanical properties of the part, enabling to achieve their highest possible strength
(tensile strength) and stiffness (Young’s modulus). For post-cure of structures produced
with Formlabs Clear Resin, the supplier recommends subjecting the material to a 405
nm light for a fast and effective post-cure, at a temperature of 60 ºC, for 30 minutes [83,
85, 285]. In the laboratory, post-cure was performed using a 395nm LED flashlight (LE
brand), a VMS-C7 magnetic heating plate (VWR, Portugal) at 60ºC, for 30 minutes. The
post-cure process should be performed under the shelter of external light, i.e. the only
light affecting the material was the post-cure light, and should be ensured that the light
falls equally on all faces of the prototype.
(FDM Technology)
The FDM printer utilized was the CreatBot F160 Model (Henan Suwei Eletronic Tech-
nology, Zhengzhou-Erqi, China) (Figure 5.4) with PEEK as load filament. The operating
temperature is set for each print, the supports are automatically generated, the printer
has self-adjusting fan speed, the maximum layer resolution is 0.01 mm, and a single
martensite steel nozzle with 0.4 mm of extruder end diameter is used to generate the
structure of printing. The filament diameter is 1.75 mm. Paper glue must be applied to
adhere to the base of the print piece to the printer bed. The Blender software was also
used to generate the drawings, and the CreatWare V6.4.6 software program was used to
send different shapes to the printer.
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Figure 5.4: Form 2 printer (from Formlabs) used to produce piston distributors. This 3D
printer uses fused deposition modeling (FDM) as printing method.
5.3.2 Characterization of the 3D Printed Material
Some experiments were carried out to characterize the materials produced from each
resin/filament used.
i) Thermal Gravimetric Analysis (TGA): This test comprises the thermal stability study
of the 3D material. An analysis of degradation, or mass loss, of the sample under
different temperature was proceeded, using LABSYS evo platform (Setaram Instru-
mentation, Hong Kong) The atmosphere used for the experiment is argon, an inert
gas, which constantly passes through the sample during the experiment, to ensure
that there is no interaction of the sample with any gas. The temperature range used
in this experiment was 34.43 - 900 ºC for polymer from Clear resin, and 34.43 - 500
ºC for PEEK. Heating speed was set at 3 ºC/min.
ii) Solvent Compatibility Test: This test comprises the chemical stability study of the
3D material. The technical specifications provided by the manufacturer of each resin
do not inform its compatibility with the solvents that are used in biomolecules sepa-
ration/purification [80]. This experiment represents a test of absorption (interaction)
of the 3D form with a certain solvent. Therefore, it was performed compatibility
tests, through the analysis of percentage weight gain of one piece printed on the 3D
printers, after three days of immersion in three different solvents. The solvents cho-
sen are solvents with very high pH (0.1 M NaOH - pH 13.0), very low pH (0.001 HCl
- pH 3.0) and the solvent used for elution of nucleosides (ethanol 5% v/v in H2O).
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To work with the FDM method, it was needed additional characterization experi-
ments:
i) Printing Parameters for FDM printer: At FDM method, the printed material comes
out completely dry and no additional procedure is required. However, to start up
using the CreatBot printer, it is first necessary to calibrate the printer for each raw
material, in this case, the PEEK filament. Even with indication of the print parame-
ters in the literature and the manufacturer, optimum print conditions may change
depending on the desired part geometry as well as the print orientation. There are
three parameters to take into account for calibration:
a) Bed temperature;
b) Extrusion temperature;
c) Extrusion speed.
These parameters may differ from one feedstock to another, and analysis of the op-
timum printing condition is performed with the naked eye, observing whether the
printed material follows the minimum resolution required, such as the absence of
filaments between parts of the impression in different positions of the printing bed,
or overhangs, for example.
Conventionally, for calibration experiments, boat thumbnails (see Figure 5.5a) are
printed, as they contain a wide variety of shapes in their design [1, 260]: horizontal,
vertical and at different angles surfaces, at different heights (z), vertices, arcs, smooth
and rough surfaces, embossed printing (different printing plans), regions requiring
supports, among other variations. Therefore, the standard boat, also known as 3D
Benchy, was printed to calibrate the variables. Calibration by printing the part is also
important to understand machine limitations, whether in translation, extrusion, fan
cooling, and so on.
However, in addition to this part, calibration was also done using parts with the
design shown in Figure 5.5b.
After adjusted, the variables were kept constant for the distributors printing.
ii) Optimizing Part Dimensions: Metric specifications of the 3D printing part have been
optimized by varying the following dimensions: internal diameter (Di), external
diameter (OD), branches (or filament) thickness (e), crown thickness (Ec), workpiece
height (Ew).
iii) Deformation of PEEK part: The deformation of a specific piece (the shape will be
presented in the following sections), produced with PEEK filament, was developed
at furnace, controller B170 model (Nabertherm, Germany). The parameters ∆t1
(heating ramp time, min), ∆t2 (isothermal time, min) and Tiso (temperature to keep
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(a) 3D Boat thumbnail. (b) 3D circular part.
Figure 5.5: Designs used for FDM printer calibration. (a) 3D Benchy. Traditionally used
due to the diversity of shapes inside the design. Image source: [260]. (b) Spiral, printed
only in the XY plane. This design is similar to the 3D element required to insert into the
piston.
Δt1 Δt2
Tiso (ºC)
T (25 ºC)
Figure 5.6: Spiral Deformation Method. The original piece is subjected to the furnace
with a heating ramp of ∆t1 min from room temperature up to Tiso ºC and further ∆t2 min
in isothermal environment.
the material in isothermal conditions, ºC) were initially varied until the optimal
conditions of prototype deformation were found. See Figure 5.6. The variations
tested for each parameter were: ∆t1 = 15 and 30 min; ∆t2 = 15 and 30 min; Tiso =
155, 160, 165, 170 and 180 ºC.
5.3.3 Performance of the 3D Distributors
The distributor performance experiments presented below were developed by the stere-
olithography 3D printing method.
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5.3.3.1 Tracer Test
Each frit shape, among the various printed distributor models, was individually tested
by fluorescent and intense colour tracer injection for analysis of fluid behaviour within
the piston. A 395 nm LED Ultra-Violet Lamp (LE, Las Vegas, NV, USA) was used for this
purpose. The experiment is done by introducing the new 3D printed frit on the piston;
then, eluent injection (5 % v/v ethanol in H2O) is proceeded up to 20 mm and then 20 mm
of tracer diluted solution, causing the piston to go down. Then the piston is placed to
rise completely. The extent of fluorescent dye concentration profile, when introduced
into section area A of the device, was quantified by measuring yellow intensity across the
reflux piston.
5.3.3.2 Nucleosides Separation
The best performing dispenser was separated and used to replicate the prototype vali-
dation experiment described in the previous chapter, and compare to the results of the
original recycle container (with polyethylene frit). The solutes concentration profile was
also compared with gPROMS simulation already presented in the previous chapter, which
considered piston as dispersed plug-flow.
5.3.3.3 Pulse and Gradient Injection Test
The purpose of this experiment is to determine the concentration profile inside the recy-
cle piston for the final piston configurations, due to the different 3D printed frits plus
supports inserted between the inlet and outlet of section A (the section where the feed
and eluent passes, not just eluent) of the piston.
The experiment consists of pulse feed injection, full piston cleaning with eluent in-
jection during the time needed to return the absorbance signal to the reference, and
subsequent gradient injection increasing the concentration from pure eluent to pure feed
solution. The gradient concentration control was done by changing the flow rates of the
feed and solvent pumps every 0.5 s, with the sum of the two flow rates always remaining
constant. This was done automatically through Julia’s software. Thus, at the gradient
beginning, the eluent pump is at its maximum flow rate and the feed pump is at flow rate
equal to zero, opposite to what happens at the end of the gradient, where the feed pump
is at a maximum flow rate and the eluent pump is pumping nothing.
For each experiment, the feed and gradient volumes to be injected were proportional
to the volume of the piston (VP ), where each injection is inserted up to twice the internal
volume of the piston. At the end of the gradient, more feed solution is injected during
ten seconds to ensure it has reached the maximum absorbance level.
These experiments were performed using solutions of 0.05 g/L uridine in ethanol
5% v/v in H2O, at an absorbance of 260 nm, with Deuterium light only. The reference
solution for the UV detectors is ethanol 5% v/v in H2O. Two UV detectors were used:
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one at piston inlet and another at the outlet of the recycle device. Constant flow rates of
4 mL/min were used, with differences in the flow rates of both pumps (feed and eluent)
only in the gradient step.
5.4 Results and Discussions
5.4.1 Characterization of the 3D Printed Material
5.4.1.1 Thermal Gravimetric Analysis
The sample of Clear resin and PEEK polymers were analysed by TGA, done by recording
the weight loss as a function of temperature increase. The operating temperature of the
Single-column analog to SMB is 25 ± 5 ºC, therefore, the objective is not to ensure that
the 3d printed material is stable at the system operating temperature, once the ambient
temperature is a safe margin of stability for solid material produced from both Clear
resin and PEEK filament. It is highlighted the importance to know the behaviour of the
material when subject to high temperature variation.
Figure 5.7 presents the graphical results of the performed TGA test for both samples.
Results are expressed graphically as a percentage of weight loss as a temperature function.
It was observed that for the printed part using SLA technology, the structure is stable
up to approximately 250ºC, undergoing degradation process from slightly higher tem-
peratures. At 155ºC, for example, less than 2% of the initial mass was lost. Thus, at
this temperature, the material can be considered stable at the decomposition level as it is
still far from the steep slope of the curve (which characterizes the decomposition of the
solid). The slight loss of mass can be explained by possible moisture loss or evaporation
of remaining solvent used in the cleaning process or even remaining material (monomer)
adhered to the polymer walls.
Through the analysis, it was also observed that the heat deflection temperature (HDT)
indicated by the manufacturer (73.1ºC, at 4.5 bar, for post-cured material) [80] is sub-
stantially lower than that found in the analysis (318ºC). This is a positive factor once the
material has proven to have a higher temperature resistance than indicated.
The TGA decomposition profile for PEEK showed that there was no degradation of
the compound until 500 ºC, maximum temperature analyzed.
5.4.1.2 Solvent Compatibility
Most polymeric materials can absorb small organic molecules, and also can absorb or-
ganic or aqueous solvents, resulting in swelling of the bulk material [97]. Therefore, the
relevance of the solvent compatibility experiment.
The results for solvent compatibility test are depicted in the Table 5.3. The result
for Clear resin presents that the polymeric material achieves a <1 % mass gain for the 3
solvents after 3 days of immersion. In addition, it was noted that the polymer remained
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(a) Polymer formed from Clear resin.
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(b) PEEK Polymer.
Figure 5.7: Thermal Gravimetric Analysis. (a) Polymer produced by SLA method, with
Clear Formlabs resin. (b) Polymer produced by FDM method, with PEEK filament. Anal-
ysis made by the Analysis Laboratory (REQUIMTE - FCT/UNL).
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Table 5.3: Solvent compatibility test. After three days of material immersion in solvents
with different properties. The 3D printed polymers had less than 1% mass gain/loss,
showing to be compatible with the three solvents chosen.
3D Material Solvent Initial
Weight (g)
Weight After
3 Days (g)
Weight Gain
(%)
Clear Resin
0.1 M NaOH (pH 13.0) 0.1309 0.1319 0.76
0.001 M HCl (pH 3.0) 0.0949 0.0958 0.95
5% v/v Ethanol in H2O 0.1314 0.1326 0.91
PEEK
0.1 M NaOH (pH 13.0) 0.1700 0.1697 -0.18
0.001 M HCl (pH 3.0) 0.1657 0.1650 -0.42
5% v/v Ethanol in H2O 0.1238 0.1238 0.00
rigid, did not gain flexibility. However, in order to have more effective stiffness variation
results, a more accurate test would be required as this analysis was done only visually
when applying hand movements.
Therefore, this analysis showed that Clear resin polymer and PEEK polymer are com-
patible with the nucleoside separation solvent (5% v / v ethanol in H2) as well as solvents
similar to those used for purification of protein A resin monoclonal antibodies [30]. The
concern was to test solvents with very high or very low pH, it was used 0.1 M of sodium
hydroxide (NaOH, pH 13.0) and 0.001 M hydrochloric acid (HCl, pH 3.0). The NaOH
solution can be used in the cleaning-in-place (CIP) step for mAbs purification, while
the HCl solution suggests the low pH solutions used as elution buffer (20mM citrate, for
example).
5.4.1.3 Printing Parameters for CreatBot Printer
While the Form 2 printer (used for the SLA method) has well-defined print parameters,
the CreatBot printer required parameter adjustment to print well-defined parts, since the
information provided by both the manufacturer [112] and found in the literature [11], for
printing PEEK material, have ranges for operating parameters. Therefore, the optimum
printing conditions had to be well determined before starting to manufacture the desired
parts.
In this calibration test, the points evaluated in the 3D Benchy were: definition of
angles, vertices, surfaces definition (so that you can not notice the transition from one
layer to another) and dragging between different sections of the same plane. The points
evaluated in the circular piece were: formation of bubbles or grains in the 3D piece and
cohesion between layers (the piece must be solid and unique, without "unraveling"the
piece).
After printing samples with layout similar to the part desired for subsequent tasks
in this chapter (XY plane spiral part), manufactured under varying parameters, the op-
timum printing conditions found were: layer height = 0.1 mm (defines the quality, or
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Figure 5.8: Parts printed under optimal printing parameters of the CreatBot 3D printer.
This design is similar to one needed in a section of this chapter, which is explored later.
layer resolution), bed temperature = 120ºC, printing temperature (nozzle) = 420ºC, am-
bient temperature inside the printer = 150ºC, with print speed = 5 mm/s. The high air
temperature inside the printer has been set to prevent PEEK from cooling too quickly. In
addition, this temperature is adjusted by the printer through fan speed. Since the printer
inside never gets to 70ºC, because it is a too high temperature, the fact is that the fan does
not turn on, and that is the goal: keep the temperature too hot so that the fan speed is 0
%, to promote the correct material crystallization. For nozzle retraction, the nozzle travel
speed is 30 mm/s, with a Z distance (height) of 1.2 mm. The Figure 5.8 shows the spiral
printed under the best printing parameters.
The result for the latest PEEK 3D part characterization experiment, “Deformation of
PEEK part”, is presented below, along with the production results of the FDM part, to
facilitate understanding of the results.
5.4.2 SLA Method: Production and Performance of New 3D Distributors
The following tasks are separated by phases of work development, once the production of
new frits conformations was performed as needed as performance tests were continuously
carried out.
5.4.2.1 Phase 1: Massive 3D Confection and Tracer Experiment
At the end of the previous chapter, the idea of distributor adaptation was raised, to
improve as much as possible the radial and axial fluid distribution, in an attempt to
maintain the concentration profile not only in the ascension but also in the descent of
movable piston, implementing the “first in, first out method”. The improvement of the
flow distributor was done by 3D printing.
Very few approaches present in the literature explore 3D printing applied to chro-
matographic columns. The author S.H. Nawada et al. [76, 185, 186] has developed a
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(a) Web 3D frit. (b) Grid 3D frit.
Figure 5.9: Base design for 3D frits. These were the original (first) conformations.
Throughout the work, design complexity was introduced, changing several parameters.
(a) Web design; (b) Grid design.
study for complete chromatographic column design through 3D print, forming a single
monolithic entity, taking in consideration a porous bed, ancillary features such as col-
umn walls, flow distributors and external fittings, establishing different combinations of
specifications and geometries.
Thus, according to the literature and the previous studies cited, the interest here is
focused in gathering the 3D printer applicability in easily developing single pieces of
recycling device, specifically to produce and test different flow distributor arrangements
in an attempt to optimize flow dispersion performance as much as possible in our devel-
oped work, starting from a radial standard distributor geometry as considered by S.H.
Nawada [186] and a grid 3D frit, with similar structure of 3D printed monoliths (for
catalyst fabrication) found in the literature [201].
The SLA printer was chosen as the first 3D printing option because of its high resolu-
tion (XY/Z) [97], compared to other 3D technologies. The Form 2 delivers high-resolution
parts with footprint of industrial 3D printers, producing parts with precision and reli-
ability [82]. After post-curing, that helps 3D printed parts to achieve optimal material
properties, the resulting 3D parts consisted of strong and detailed models, with impres-
sive surface finish.
The first forms of 3D printed distributors produced were described in the literature,
with web (radial) and network (or grid) format. Figure 5.9 shows the basic constructed
layouts. However, countless parts conformations have been produced. First, simple parts
were produced, only in the XY plane. Secondly, the pieces complexity was increased by
introducing new frit layers with the channels ("pores") shifted from one layer to another
in the Z plane (height), in other words, one is never exactly overlapping the top layer
and/or lower, as shown in Figure 5.10.
The number of layouts was exorbitant (>30) (Appendix C.1). In addition, for each
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+11.25˚
+22.5˚
+33.75˚
Figure 5.10: Example of frit with multiple layers. The layers are always offset from each
other, i.e. there is no overlap of equal layers.
layout, the pore diameters were varied (for grid format, for example), or the spacing
between radial lines (at channels radial model), the number of layers (in the most complex
frits), the type of layer interleaving (varying between webs and grids for the same part),
the spacing between the layers, the lock diameter in the center of the radius, and still
other changes.
Due to the massive number of prototype fabrications, the first analysis of each distrib-
utor shape produced was performed by placing this part on the piston and performing
tracer injection tests, which has a strong yellow colouration. The visual analysis allowed
to rule out those inconsistent conformations, while the most acceptable prototypes, with
a better radial and axial fluid distribution were submitted to the following analyzes.
Among the 3D printed parts produced in this phase, the frit with the best configura-
tion was a distributor consisting of 4 layers in a radial format. (Figure 5.11 demonstrates
some 3D printed parts in phase 1, as well as the best performing distributor). The layers
have been arranged so that the web of a layer is uneven with respect to the web of the
lower layer.
Since the piston has neither perfectly stirred tank behaviour nor dispersed plug-flow,
several experiments have been carried out to study the hydrodynamic behaviour of the
fluid inside the piston. This is a video that shows an experiment of injecting eluent up
to 20 millimetres and then 20 millimetres of solution with tracer, causing the piston to
go down. Then the piston is placed to rise completely. What we see is the fluid travels a
preferred path to the movable plunger as it descends, while on the rise, the concentration
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4 layers in 
web format
Figure 5.11: The best 3D Frit design obtained in Production Phase 1. This result was
obtained by analyzing piston tracer injections with the various 3D distributors produced,
one at a time.
profile is maintained in the outlet of the device. This happened because the frit was not
homogeneous.
Figure 5.12 shows the result of tracer experiment, which presents a visual comparison
for fluid distribution within the piston between the presence of polyethylene frit and 3D
printed frit (the best design) at the top of recycling device. It is observed for the piston
with polyethylene frit that the fluid travels a preferred path to the movable plunger as
it descends, while on the rise, the concentration profile is maintained in the outlet of
the device. Meanwhile, performing the experiment with web format 3D printed frit,
it is noted that, although the tracer solution did not maintain the axial concentration
profile, fluid was distributed over the radial axis much more evenly than the original
piston configuration, as the fluorescent solution was injected and forced the piston down.
Therefore, a considerable improvement in piston performance has been achieved.
The 3D printed part conformation success in relation to the original frit can be ex-
plained by the radial centre blocking, where the tracer solution followed a preferred path,
and also by the difference in pore sizes in the 3D part itself. The pores enlarge as they
move away from the radial centre, giving a kind of blockage to the fluid, forcing it to dis-
perse more and more towards the ends of the piston as it travels between the innermost
layer of the frit to the outermost layer.
5.4.2.2 Phase 2: Nucleosides Experiment with 3D printed frit
The nucleosides separation experiment was reproduced under the same conditions as in
the previous chapter, by modifying only the frit to the 4-layer 3D printed frit. The result
for the concentration profile can be seen in Figure 5.13.The top graphic shows the results
for uridine, while the bottom one for guanosine. The blue line represents the result
for the dynamic process model simulated in gPROMS (presented at previous chapter)
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(a) Polyethylene Frit. (b) Radial 3D Frit, with four layers.
Figure 5.12: Comparison between the efficiency of (a) polyethylene frit and (b) the ra-
dial distributor, the best designed 3D printed frit. The polyethylene frit is the original
configuration used in the recycle piston. The analysis was performed visually due to the
number of pieces printed. Therefore, the feed solution was an intensely coloured tracer.
considering piston as dispersed plug-flow. The experimental curves are presented by
points: red, polyethylene frit piston; black, recycling device with 3D dispenser.
These graphs prove that the black curve, which uses frit 3D, approached more of a
plug-flow behaviour than the red curve, which uses polyethylene frit, for both compounds.
For both guanosine and uridine, the improvement could be seen mainly from the rise in
the concentration profile. Despite a slight approximation of the experimental curve to the
simulated model, it can be seen that the goal of this chapter has not yet been completely
achieved, so a new approach has been taken.
5.4.2.3 Phase 3: New Distributor Conformations and Pulse & Gradient Injection
Test
The 3D radial distributor chosen in the previous phase of the work, it was coupled to
the top of the piston throughout phase 3 of the experiments. In this last phase, the flow
distributors were no longer composed only of 3D printed frits, but also by a 3D printed
holder with different heights. Then the frits were interspersed with the equally spaced
brackets. The number of supports is always (N + 1) the number of frits, where N is the
number of frits. Figure 5.14 shows the 3D print configurations produced in this step. The
3D printed distributors used have a network format with a pore diameter of 0.1 cm.
Experimentally testing the residence time distribution profiles, the following experi-
ments were performed, with piston heights (z) ranging from:
1. z = 25 mm: without holders, and with four small holders;
2. z = 34 mm: without holders, with six small holders, and with three medium holders;
3. z = 45 mm: without holders, with four medium holders, and with two big holders;
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(a) Uridine.
(b) Guanosine.
Figure 5.13: Solute concentration profiles at the outlet of column for nucleosides sepa-
ration at one-column analog to SMB, using 3D printed frit. The top graphic shows the
results for uridine, while the bottom one for guanosine. Red points denote the exper-
iment with polyethylene frit, whereas black points represent the experiment with 3D
printed frit. The blue line represents the simulation of the dynamic process model con-
sidering piston as dispersed plug-flow. Replacing the frit with a 3D part resulted in a
slight approximation of the experimental profile to the simulated curve.
Figure 5.14: Different types of piston supports, that is, different heights and amounts of
grids. From left to right: z (height)  25 mm, z  34 mm, z  34 mm, z  45 mm, z  45
mm.
174
5.4. RESULTS AND DISCUSSIONS
The results of pulse and gradient injections are shown in Figure 5.15. UVA B is the UV
reader at the piston inlet, while UVA A is the UV cell at the outlet of the recycle device.
The results showed that related to the holder presence or absence, the presence of holders
with frits along the reflux piston caused a significant difference in the results. On the
unsupported piston, the feed solution is collected earlier, while solutes take longer to
exit the piston when holders have been inserted into the device. This indicates that there
was a larger radial scatter in the experiment with the holder, once the same feed volume
was injected. Moreover, in the gradient part of the curve, the concentration profile of the
product is much more stable (uniform), this was noted mainly for the two highest piston
heights. It was further noted that at high piston heights, when the piston is without
holder, product residues remained on the piston and came out with difficulty over time,
when in fact the piston should already be completely filled with eluent only, however, in
piston with holder the elution of uridine solution was successfully achieved.
Another interesting analysis was produced by comparing only the curves results that
considered holders, it was found that the greater the number of holders inside the re-
flux piston at a fixed height, the better the UV signal stability, which shows a better
approximation of the concentration profile of an empty column with axial dispersion.
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Figure 5.15: Pulse & Gradient injection at piston with different heights (25, 34 and 45
mm), and distinct 3D dispensers configurations. In this phase, the 3D dispersers are
composed by 3D printed frits + 3D printed holders. For each chart, the gradient starts at
the same time for the different curves. UVC B: UV cell at piston inlet; UVC A: UV cell at
piston outlet. As a result, the shorter distance between the Frits, and therefore a higher
amount of frits, improves the dispersion of the fluid inside reflux device. The difference
between the tested configurations is more significant as the piston volume increases.
5.4.3 FDM Method: Modeling and Production of 3D Spirals
From the previous experiment, it was seen that introducing grids along the piston im-
proved the fluid distribution within the piston. However, holders produced in SLA were
not flexible. Because of that, it was started the work with FDM 3D printing technology,
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in which spirals were produced.
Although the SLA printer has the ability to print material with smooth surface finish
and fine feature details, the material is brittle, not suitable for mechanical parts [9].
Therefore, the FDM printer was mainly chosen to work with a flexible material, in this
case, the PEEK. Along with this quality, the printer cost compared to other technologies
is attractive [97], as there are already a variety of Chinese brands investing efforts in
this technology where it is possible to buy printers around 100.00 dollars and may reach
values of 500,000.00 dollars for other technologies.
The new CreatBot F160 printer has been used to produce spiral holders made of
durable, and especially more flexible material than the aforementioned technology, in
a way to interleave frits along the length of section A of the piston. This clever spiral
configuration allows the piston to be completely closed by fully compressing the spirals.
For this, PEEK material appeared to be a good choice, since it supports high tempera-
tures to infer part deformation (as seen in the TGA test), while being quite flexible for
continuous movements in the part, serving as a kind of spring, but differing from the
latter by the advantage that when closed it occupies only the XY plane. This last quality,
the flexibility, is indispensable for the success of the 3D spiral, as the recycling device is
constantly varying its internal volume.
Therefore, the idea here is not to use the FDM method purely to improve piston fluid
distribution, but to combine the two 3D printing technologies to achieve the optimum
configuration. Thus, the 3D printed frits remained the same as the latest SLA design, but
now Clear resin rigid holders are replaced by highly flexible PEEK holders.
A disadvantage of FDM 3D printing is that the material must contain holders, that
is, it is impossible to deposit material without a holder to keep it in the desired position.
Therefore, the spirals produced with the CreatBot printer necessarily had to be produced
in a horizontal plane.
The production for the metric specifications optimization of the 3D spiral are pre-
sented in Figure 5.16. Optimal sizes for the new 3D holders conformation were: internal
diameter (Di) = 10 mm, external diameter (De) = 30 mm, spiral filament thickness (e) =
0.6 mm, crown thickness (Ew) = 0.5 mm, spiral height (Ec) = 1.2 mm.
Therefore, 3D printing production did not result in the final piece. Only after 3D
printing did the material undergo structural deformation to spiral out. For this, the
deformation conditions had to be tested, since slight changes could change not only the
Z-axis conformation but also the filament conformation by itself.
It is worth highlight that the temperatures tested should be above the glass transition
temperature (Tg ), i.e. reversible transition range where the polymer substrate changes
from a hard, rigid state and a soft, "rubbery"(not melted) state [31]. The temperatures
analyzed should also be below the PEEK decomposition temperature (obtained by the
TGA test). For PEEK polymer, Tg = 143 ºC [117], so the temperatures that made up the
test were slightly above 143 ºC.
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(a) Optimized parameters for 3D spiral.
(b) 3D printed spirals for metric specifications optimization..
Figure 5.16: 3D production for metric specifications optimization of the 3D spiral. The
final version of the 3D part, already optimized, is displayed at the right end of the image.
Optimized parameters: Di = 10 mm, external diameter De = 30 mm, spiral filament
thickness e = 0.6 mm, crown thickness Ew = 0.5 mm, spiral height Ec = 1.2 mm.
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Figure 5.17: Printed PEEK deformation tests, from XY plane for the 3D spiral. Opti-
mum furnace operating conditions were tested with the following parameters evaluated:
heating ramp time (gradual heating, ∆t1), time interval with stabilized temperature (∆t2)
and isothermal temperature (Tiso). In the picture above, ∆t1 = 15 min for all pieces. The
resulting optimal parameters are: ∆t1 = 15 min, ∆t2 = 15 min, Tiso = 155 ºC.
As a result of the optimal deformation conditions obtained for the spiral base piece
using the furnace equipment, temperatures of 155º and 160ºC have shown to be most suit-
able for shaping the spirals. Therefore, the lowest temperature, 155ºC, was established as
the ideal deformation temperature. It is worth remembering that when subjected to tem-
perature 155ºC, the mass loss can be neglected for materials produced from Clear resin
and PEEK filament, as could be analyzed from the TGA test discussed in the previous
section.
In addition, a 15 min heating ramp and a further 15 min submitted to 155ºC isother-
mal environment were the ideal times obtained. Thus, the spiral is perfectly shaped, and
the PEEK part comes into existence on the Z axis, not just on the XY plane. The conse-
quence of the spiral shape from the change of these parameters (ramp time, isothermal
time, and heating temperature) can be seen in Figure 5.17. Furthermore, it has been
found that the final 3D printed spiral is flexible enough to be compressed and extended
several times, always returning to the height Z defined in the furnace step, which defines
a long service life for the part. This further ensures that when inserted into the piston, the
spring effect extends over countless repetitions of separation/purification experiments.
After calibration of the FDM printer and determination of the furnace parameters
for spiral shaping, the standardization of fabricated spiral parts could be performed.
For this, a smart prototype was created to serve as the structure for the spiral in the
deformation process, which will be referred to as the Distortion Standard Equipments
(DSE). The prototype was also produced through 3D printing, but using SLA technology,
since the material must be hard and withstand high temperatures. Figure 5.18 shows the
constituent equipments of the DSE. It consists of a screw fitting that engages to the flat
spiral (XY axis) and is inserted into the glass container to proceed the first deformation
phase, a structural base (b), where the previously extended spiral is inserted to begin
the second deformation phase, responsible for height and diameter adjustment, and a
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(a) Screw fitting. (b) Base Structure.
(c) Net for spiral. (d) Spiral.
Figure 5.18: Distortion Standard Equipments (DSE) and spiral final version. The DSE,
built with SLA technology, consists of a screw fitting (a) to extend the flat spiral (XY axis)
in a first distortion phase, a structural base (b), where the spiral is inserted to adjust
its height (Z plane) and external diameter (OD), and a net-adapted to the spiral (c) that
serves as cover for the structural base and as frit for piston.
net with support to the centre of the spiral (c), which, while serving as a cover for the
structural base, is also the frit that will be inserted into the piston. The height of each
spiral has been set to 2.5 cm, so this is also the internal height of the fabricated SDR, while
the inside diameter (ID) of the equipment is 2.5 cm to perfectly fit the recycle device.
The steps for spiral deformation is shown in Figure 5.19. The first step for modifying
the single-layer spiral is to fasten the flat spiral to the screw fitting, insert it at a height of
5.0 cm and ID = 1.5 cm, and proceed to the primary modification of the part using the
furnace under conditions already mentioned. After cooling the new structure, the second
phase consists in the spiral distortion, where it is placed inside the structural base made
of Clear resin, which acts as a kind of "dome", its radial centre is attached to the network
that will serve as a cover to the dome. The material then goes back to the oven under the
same operating parameters. The part is cooled to remove from the frame and the finished
frame is ready.
The production and use of the SDR resulted in consistent, satisfyingly flexible and
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Figure 5.19: Deformation steps for the 3D printed spiral. The single layer spiral is at-
tached to the screw fitting, inserted into a small vial and placed in the oven to undergo
the first part modification step. Once cooled, the spiral already in three dimensions is
connected to the frit and inserted into the 3D ”dome”, where it will go back to the furnace.
Once cooled, the frit-spiral structure is ready.
easily reproducible spirals. Advantageously, the part has a very short production time
and is easily reproducible due to the manufacturing technology used. Thus, a clever fluid
distribution system composed of 3D printed frits (by SLA) together with spiral holder
(by FDM) was successfully manufactured.
5.5 Conclusions
The need to improve the axial and radial distribution of the fluid therein was analyzed.
Since the original piston had neither perfectly stirred tank nor dispersed plug-flow be-
haviour, several experiments had been carried out to study the hydrodynamic behaviour
of the fluid inside the piston. 3D printing technology was used to solve this task. 3D
printing has shown potential results in a variety of disciplines [97]. Therefore, this 3D
technology was used to solve this task.
Two 3D printing methods were used to print new piston frits: first, SLA print tech-
nology was used; the second printing method was based on FDM print technology.
It’s to note that, replacing the frit of the upper side of the recycle device with cus-
tomizable frits that can change the inlet profile, improves the hydrodynamic behaviour
inside the recycle device.
The samples characterization produced with the two 3D printing technologies was
performed. Thermal and chemical stability of the two raw material (Clear resin and
PEEK) were evaluated. TGA analysis has shown that the polymer resulting from Clear
resin has much higher thermal stability than the manufacturer had indicated, so the
heat distortion temperature (318ºC) is far above the temperature used in the last task
of this chapter (SLA mold for spiral production), 155ºC. For the PEEK filament, the
TGA showed that this material did not suffer degradation up to 500ºC. Therefore, the
furnace operating temperature is stable for both 3D materials. In addition, both polymer
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types are obviously stable at the operating temperature of the recycle piston (ambient
temperature).
Additionally, the two substrates used for the production of fluid dispersers have been
shown to be compatible with the solvent used for nucleoside separation, as well as very
acidic and basic solvents, a feature necessary for use in the purification process of other
biomolecules, such as in the process of capturing monoclonal antibodies in Protein A, for
example.
In the first phase of 3D distributors production, SLA technology was used and the
frits were produced in the most diverse configurations and doing the respective tracer
tests. From there, it was selected the frit that provided the best distribution of the fluid
so far and the experiment of nucleosides separation was repeated. The frit with the best
configuration was a frit consisting of 4 layers, each one offset from the next, in web for-
mat. Through this 3D part, the fluid distributed substantially more evenly in the radial
plane of the piston. In addition, using this 3D distributor for reproduction of nucleo-
side separation in the Single-column with Recycle Lag, a slight approximation of the
experimental concentration profile to the simulated one, which considers the dispersed
plug-flow model piston. In a new phase (phase 3) of 3D part productions, where both
radial 3D print frit and a new 3D print conformation (holders + grid frits) along the pis-
ton length were used, it was concluded that the greater amount of frits inside the piston,
with a smaller spacing between them, it results in a better distribution of the fluid inside
the piston.
The CreatBot printer, which uses FDM printing technology, is now being used to fol-
low the production of structural holders, but using a substantially more flexible material,
PEEK. The optimal printing parameters of PEEK material with the FDM 3D printer were
determined. Also, both the spiral parameters (dimensions) and the furnace parameters
for 3D part deformation were also analyzed. As a spiral distortion promoter, an ingenious
set of parts was produced in 3D, called DSE, which allowed the spirals to be sized to exact
needs (Z-extension, OD OD), as well as to standardize the parts produced.
This chapter is an ongoing work in which new 3D configurations are constantly being
produced and tested. In any case, the potential of 3D printing to complement piston
equipment is remarkable.
If improved piston parts, i.e. frits/distributors, are successfully developed to a greater
extend, the One-column Analog may win the same market share. This also enables
Single-column Analog to Recycle Lag to become the next generation of continuous chro-
matography, allowing not only to reduce the solvent consumption and increasing the
simplicity of the process, while, at the same time, maintaining extremely high levels of
purity and recovery of simple/easy biomolecules separation, but also mimics any type of
continuous multicolumn process. This can be achieved due to the introduction of cleverly
designed 3D distributors into the process.
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2nd Case Study: mAb Capture by Protein A
Affinity Chromatography
6.1 Introduction and Objective
In recent years, therapeutic drugs formed by monoclonal antibodies (mAbs) are the most
produced class of biopharmaceuticals [187], being applied in prevention and treatment
of cancers, autoimmune and infectious diseases, among several other diseases [189]. Due
to its high specificity and production capacity in large quantities, this biomolecule has
revolutionized the research and medicine areas.
Because of the high market demand, the optimization of production processes has
been increasingly required, seeking to reduce the time and cost of production for the
industries, but also aiming to facilitate access to these products not only in developed
countries, but also in countries with more difficult access to health.
Therefore, continuous manufacturing has gained space over batch processes. The
advantages include small equipment size, steady-state operation, low cycle times, high
volumetric productivity, streamlined process flow, and reduced capital cost [275].
The traditional method of mAb purification is composed of a stage of capture with
Protein A affinity chromatography using pH step elution, where the mAb is initially
retained and impurities flow-though the column (bind/elute mode), and two polishing
steps constituted by cation exchange chromatography (bind/elute mode) and still a anion
exchange chromatography (flowthrough mode) [123, 267].
In cases of biomolecule separation where it is possible to employ an affinity resin,
such as protein A for mAb purification, single-column batch processes can achieve high
purity [166]. However, this type of resin (protein A) usually exhibits strong mass transfer
limitations, facing shallow breakthrough curves, and therefore low resin utilization [104].
To overcome this limitation, a great number of mAb capture methods based on the
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Figure 6.1: Schematic diagram of one cycle of the twin-column CaptureSMB process.
Two identical columns are used, working in interconnected (IC) and batch (B) phases.
The feed stream is injected semi-continuously while the product is collected periodically.
Source: [30].
concept of sequential loading for affinity chromatography were developed. Among them,
in 2015, a novel twin-column counter current chromatography process was proposed
by Angarita et al. [14]. The twin-column CaptureSMB is used for the Protein A affinity
capture of mAbs.
Figure 6.1 shows the schematic diagram of one cycle of the twin-column CaptureSMB
process. Two identical columns are used, working in interconnected (IC) and batch (B)
phases. The feed stream is injected semi-continuously while the product is collected
periodically.
When the columns are connected in series, a longer feed is allowed comparatively
to a batch process, because the eventual breakthrough is caught by the downstream col-
umn instead of being lost. Therefore, the key feature of this process is that it works
by overloading a first column far beyond its DBC1% when a second column is intercon-
nected, improving the utilization of the stationary phase and allowing the first column
to be loaded much closer to its static binding capacity. The DBC1% is the typically used
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dynamic binding capacity (DBC) value (at a specific residence time), which indicates
the feed volume that can be loaded onto the column so that the percentage of 1% feed
concentration is reached at the column outlet [14].
Describing the process depicted in Figure 6.1, during the interconnecting phase, the
first part of the switch interval, the upstream column is being loaded with feed, with
flow rate QIC during the time tIC . Before the columns are disconnected, the washing
step begins for the fully loaded column, in order to catch any product that could elute
during this initial wash step. In this phase, the impurities traverse the columns and are
discarded in the waste (W) [30].
In the batch phase (proceeded during tB), the fully loaded column is further washed,
while more impurities are discarded. Then, the elution of pure product (P) is proceeded,
where it is collected. After, CIP and equilibration are done to prepare the column for the
next switch. In the meantime, in the other column is loaded more feed, at flow rate QB.
Thus, the first switch terminates before any product starts exiting the second column.
Then the columns swap function and a new switch interval begins, tSwitch = tIC + tB,
exactly equal to the previous one. When this second switch interval terminates, a cycle
has been completed, tCycle = 2(tIC+tB). Cycles can be reproduced as many time as needed.
Because of the already proved enhanced performance of the Twin-column CaptureSMB,
when compared with batch chromatography [30]—in terms of productivity and capacity
utilization—this method was suited chosen to be mimicked by the Single-column with
Recycle Device in order to compare process results.
6.1.1 Objective
The main objective of the present Chapter is the application of the Single-column Analog
to SMB in a second case study, the purification of monoclonal antibodies in protein A
resin, by mimicking the optimized Twin-column CaptureSMB process. The purpose is to
perform the comparison of the performance and efficiency of the new One-column system
with other chromatographic processes, different from that already covered in Chapter 4.
6.2 Chromatographic Column Model for mAb capture by
protein-A affinity chromatography
The model developed in this section is adapted from [30]. The modeled process is the
capture step by protein-A affinity chromatography of a protein or monoclonal antibody
(mAb) from a cell culture supernatant containing a group of impurities. It is assumed
that the impurities are not retained by the protein-A resin and for modeling purposes
they are lumped into a single pseudo-component.
The following notation is employed here: c(z, t) and c′(z, t) are the concentrations of
the mAb product and of the impurities in the liquid phase flowing through the column
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at axial position z and time t (i.e., the instantaneous axial concentration profiles in the
column), and pH(z, t) is the instantaneous axial pH profile.
By modeling the dynamic breakthrough behavior of the impurities in a chromato-
graphic column packed with protein-A resin, the differential material balance can be
written as
∂c′
∂θ
+
τQ
tVc
(
∂c′
∂x
− 1
Pe
∂2c′
∂x2
)
= 0 (0 < x < 1), (6.1)
where c′(x,θ) is the instantaneous axial concentration profile of the impurities in the
interparticle liquid along the column, x = z/L the dimensionless axial coordinate along
the column of length L and volume Vc, θ = t/τ is a reduced time coordinate scaled
by a reference time τ , Q the volumetric flow rate, Pe the axial Péclet number, and t =
+(1−)p the total porosity of the packed bed ( and p are the inter- and the intraparticle
porosities). The Péclet number, Pe = h/2 = vL/DL (v is the interstitial fluid velocity,
DL the axial dispersion coefficient, and h the dimensionless plate height), lumps the
contributions of molecular diffusion, hydrodynamic dispersion, and film resistance to
mass transfer.
Various values of the reference time τ can be selected for different purposes. For
example, setting τ = 1 makes θ = t, that is, the θ-coordinate is the same as the true time
coordinate t. On the other hand, if τ = 1/Q then the scaled time θ gives the volume of
eluted fluid through the column up to the present time instant t. Finally, given that the
time taken to fill an empty chromatographic column is Vc/Q, setting τ = Vc/Q gives the
time scale θ in terms of the number of eluted column volumes of fluid.
If desired, c′ can also be rendered dimensionless, that is, instead of working with c′
one works with w = c′/c′ref, where c
′
ref is a reference concentration, for example, equal to
the feed concentration, c′F. Note, however, that this change of variable does not alter the
material balance because all terms are linear operators of c′:
∂w
∂θ
+
τQ
tVc
(
∂w
∂x
− 1
Pe
∂2w
∂x2
)
= 0, (0 < x < 1). (6.2)
The typical boundary conditions for eq. (6.1) are
c′ − 1
Pe
∂c′
∂x
= c′in for x = 0,
∂c′
∂x
= 0 for x = 1.
(6.3)
where c′in is the concentration of the impurities in the inlet fluid. The boundary condition
at x = 0 is valid as long as there is liquid flowing through the column (Q > 0); if the flow
through the column is temporary halted (Q = 0), the correct boundary condition at the
column inlet is (∂c′/∂x)x=0 = 0. The above boundary conditions can be converted into
their dimensionless analogs by simply replacing c′ with w (and c′in by win).
The adsorption of the mAb product is assumed to be described by a Langmuir isotherm
model with the pH value as modifier [252]. In this case, the concentration of adsorbed
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mAb, q∗, in equilibrium with mAb concentration c in the liquid at a given pH can be
expressed as
q∗(c,pH) = Hc
1 + (Hc/q∞) , H(pH) =Href
(
pH
pHref
)ν
, (6.4)
where Href is the Henry constant at the reference pH value pHref, ν is a coefficient that
relates the change of Henry’s constant according to the pH value, and q∞ is the adsorption
capacity of the resin for the mAb.
It is convenient to scale the concentrations c and q, as well as the pH. Thus, c is
replaced by y = c/cref, q by Y = q/qref, and pH by s = pH/pHref. The choice of qref
is straightforward: qref = q∞, because this simplifies the expression of the adsorption
isotherm:
Y ∗ = q
∗
q∞ =
bsνy
1 + bsνy
, b =Hrefcref/q
∞. (6.5)
It is worth noting that if the choice for cref is cref = q∞/Href then b = 1 and
Y ∗ = s
νy
1 + sνy
(cref = q
∞/Href). (6.6)
The intraparticle diffusion, which is assumed to be strongly dependent upon the mAb
loading, severely limits the adsorption kinetics. A linear diving force approximation is
adopted to model the adsorption kinetics [99]. The expression reads
∂q
∂t
= km(q
∗ − q), km = k∞m
S1 + (1− S1)(1− qq∞
)S2 , (6.7)
where k∞m is the maximum value of mass transfer coefficient, km. The empirical correlation
used for km is done to approximate the effect of hindered mass transfer due to pore
blockage and other effects [30, 194]. S1 is a coefficient describing the maximum obstacle
to mass transfer, for which 0 <S1 6 1, the coefficient S2 >0 models the non-linearity of
the hindrance increase. S1, S2 are constant parameters. Introducing the above changes of
variable gives
∂Y
∂θ
= τkm(Y
∗ −Y ), km/k∞m = S1 + (1− S1)(1−Y )S2 . (6.8)
The differential material balance for the mAb can be written as
∂c
∂θ
+
(
1− 
t
)
∂q
∂θ
+
τQ
tVc
(
∂c
∂x
− 1
Pe
∂2c
∂x2
)
= 0 (0 < x < 1). (6.9)
If the concentrations are scaled as above, the following expression is obtained:
∂y
∂θ
+
q∞
cref
(
1− 
t
)
∂Y
∂θ
+
τQ
tVc
(
∂y
∂x
− 1
Pe
∂2y
∂x2
)
= 0 (0 < x < 1). (6.10)
The appropriate boundary conditions for eq. 6.10 are
y − 1
Pe
∂y
∂x
= yin for x = 0,
∂y
∂x
= 0 for x = 1.
(6.11)
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where yin = cin/cref is the dimensionless concentration of mAb product in the inlet fluid.
It is worth noting that the pH is also transported along the column; it behaves very
much like the impurities, that is, the pH is equivalent to a pseudo-solute that does not
interact with the resin. The transport equation for the solute is thus identical to that for
the impurities.
To summarize, the model is as follows.
• Impurity transport along the column:
∂w
∂θ
=
τQ
tVc
(
1
Pe
∂2w
∂x2
− ∂w
∂x
)
(0 < x < 1), (6.12)
(
w − 1
Pe
∂w
∂x
)
x=0
= win
(
∂w
∂x
)
x=1
= 1. (6.13)
• pH transport along the column:
∂s
∂θ
=
τQ
tVc
(
1
Pe
∂2s
∂x2
− ∂s
∂x
)
(0 < x < 1), (6.14)
(
s − 1
Pe
∂s
∂x
)
x=0
= sin,
(
∂s
∂x
)
x=1
= 1. (6.15)
• mAb-product transport along the column:
∂y
∂θ
+
q∞
cref
(
1− 
t
)
∂Y
∂θ
=
τQ
tVc
(
1
Pe
∂2y
∂x2
− ∂y
∂x
)
(0 < x < 1), (6.16)
(
y − 1
Pe
∂y
∂x
)
x=0
= yin,
(
∂y
∂x
)
x=1
= 1. (6.17)
• Adsorption kinetics of the mAb on the protein-A resin:
∂Y
∂θ
= τkm(Y
∗ −Y ), (0 ≤ x ≤ 1), (6.18)
• Adsorption equilibrium of the mAb on the protein-A resin:
Y ∗ = bs
νy
1 + bsνy
,
km
k∞m
= S1 + (1− S1)(1−Y )S2 . (0 ≤ x ≤ 1). (6.19)
6.3 Twin-column CaptureSMB Process
The process flow chart for the Twin-Column CaptureSMB process is shown more detailed
in Fig. 6.2. The process uses two identical columns, which we denote as column 1 and
column 2. A subscript is added to the concentration variables to indicate the column
they refer to; for example, y1 denotes the dimensionless mAb concentration profile in
column 1. To render the notation more compact the following shorthands for the outlet
concentrations are introduced: wout(θ) ≡ w(θ,x = 1), yout(θ) ≡ y(θ,x = 1), etc.
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Figure 6.2: Schematic of the Twin-column CaptureSMB process. The axial concentration
profiles in the liquid phase: red lines, mAb; green lines, impurity.
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Each half-cycle or switching interval is divided into two phases: an interconnected
phase (IC), where the columns are interconnected by connecting the outlet of the first
column to the inlet of the second column, and a batch phase (B) in which the second
column is disconnected from the first. The duration of the former phase is τIC and that
of the latter is τB.
Four different buffers were used in the experiments reported in [30].
Buffer A: 20 mM phosphate, 150 mM NaCl, pH 7.5, used for equilibration, washing, and
binding;
Buffer B: 20 mM phosphate, 1.5 M NaCl, pH 7.5, used as second washing buffer;
Buffer C: 20 mM citrate, pH 3.2, used as elution buffer;
Buffer CIP: 0.1 M NaOH, pH 13.0, used as cleaning-in-place (CIP) solution.
The important point about each buffer is its pH because it is the only parameter that
influences the mAb’s adsorption behavior: the lower the pH, the weaker the binding of
the mAb to the protein-A resin. Thus, from a modeling perspective, buffers A and B
behave identically because they have the same pH; so for all practical purposes we take
buffer A = buffer B = (pH)EQU = 7.5, where (pH)EQU is the pH at which the equilibration,
washing, secondary washing, and binding take place. Buffer C = (pH)ELU = 3.2 is the
pH at which the elution takes place. Finally, the real pH of the CIP solution is 13.0
(14 − pOH = 14 + log10[OH−]); however, this value is not meaningful for our model as
the CIP buffer is just a strong basic solution for cleaning the resin. The pH of the CIP
buffer should be set at a value smaller than (pH)ELU to mimic the cleaning effect of the
CIP solution; we arbitrarily set it to (pH)CIP = 2.5.
During step 1 and step 2 the two columns are interconnected (interconnected phase).
During step 1 feed is injected into the upstream column to move the mass-transfer zone
into the downstream column; this increases the loading of mAb in the upstream column
thus increasing the usage of the stationary phase. Note that no mAb is lost because
the mAb that breaks through from the upstream column is directed and trapped in the
downstream column. During step 1 the eluent of the downstream column is diverted to
the waste line.
The purpose of step 2 is to displace the impurities in the upstream column, which are
mostly present in the interparticle fluid, to the downstream column before starting the
collection of the purified mAb fraction. Thus, during this step the upstream column is
washed with a mild buffer able to wash out the impurities but desorb the mAb as little as
possible. But even if some mAb is desorbed, it is captured by the downstream column.
During this step the eﬄuent of the downstream column is diverted to the waste line.
Steps 3 to 5 are the batch phase wherein the two columns operate disconnected. Feed
is continuously injected into the downstream column until near breakthrough of the mAb
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Table 6.1: Boundary conditions for the first half-cycle of the CaptureSMB process.
Column 1 Column 2
Step IC/B Q1 y
in
1 w
in
1 s
in
1 Q2 y
in
2 w
in
2 s
in
2
Feed IC QIC yF wF sF QIC y
out
1 w
out
1 s
out
1
Wash IC QIC 0 0 sW QIC y
out
1 w
out
1 s
out
1
Elution B QB 0 0 sE QB yF wF sF
CIP B QB 0 0 sCIP QB yF wF sF
Equilibration B QB 0 0 sEQ QB yF wF sF
concentration profile, while the upstream column is first eluted to recover the purified
mAb, thoroughly cleaned, and then equilibrated to be ready for the next half cycle.
Table 6.1 lists the boundary conditions that apply to the first half-cycle of the Cap-
tureSMB process.
During the first half-cycle, column 2 is either connected to column 1 or connected to
the feed line; in the former case, the outlet eﬄuent of column 1 is directed to the inlet of
column 2. Thus,
{sin,win, yin}2 = {sout,wout, yout}1 for the IC steps, (6.20)
{sin,win, yin}2 = {sF,wF, yF} for the B steps. (6.21)
This can be written as
{sin,win, yin}2 = vIC × {sout,wout, yout}1 + (1− vIC)× {sF,wF, yF}, (6.22)
vIC =
1 for the IC steps0 for the B steps . (6.23)
Appendix D.1.1 shows how to implement the above equations in gPROMS software.
At the end of the first half-cycle, the two columns switch roles and go through another
half-cycle. At the start of the half-cycle (step 1’) the upstream column is fully loaded with
mAb (and impurity) from the previous half-cycle; the mAb’s axial concentration profile
in the liquid phase is about to break through, that is, the leading tail of its concentration
profile starts to appear the downstream end of the column. The second column is initially
clean and equilibrated with equilibration buffer.
There are two ways to model the columns switch. In one case, the steps above are
repeated but with column 1 in the place of column 2 and vice versa. The other alternative,
the one which was used, is to exchange the internal state (i.e., the axial concentration
profiles in the liquid and adsorbed phase) of the two columns at the end of each half-cycle
and redo the steps above.
In the first half cycle the purified mAb fraction is collected during step 3 (elution
step). The amount of component i (mAb or impurity), aPi collected in the product fraction
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during this step is
aPi =QB
∫
τ3
couti (t)dt. (6.24)
The implementation of the above equation in gPROMS software is explained in Ap-
pendix D.1.2.
Thus, the mAb purity in the collected product fraction, PmAb, is
PmAb =
aPmAb
aPmAb + a
P
w
. (6.25)
On the other hand, the amount of mAb injected into the system during the first half cycle
is
aFi = [QICτ1 +QB(τ3 + τ4 + τ5)]c
F
mAb, (6.26)
where cFmAb is the mAb concentration in the feed mixture. Thus, the product recovery,
RmAb, is
RmAb =
aPmAb
aFmAb
/. (6.27)
6.4 Replacing the Twin-column CaptureSMB System: Cycle
Design of the Single-column Process
The second case study that was applied to the new monocolumn chromatographic pro-
cess employed the isolation of a monoclonal antibody, a separation considerably more
difficult than that of nucleosides due to the similarity between the target product and its
impurities.
The method was applied to mAb capture with protein A affinity resin, a type of
highly specific resin to the target biomolecule. For this, an already validated multicolumn
counter-current process, the twin-column CaptureSMB, was used as reference and its
cycle was mimetized. The recipe for determining the Single-column process cycle based
on the multicolumn processes cycle has already been addressed in chapter 3.
Therefore, for the comparison, the cycle design of the single-column system was first
determined. The equivalence between the standard two-column CaptureSMB process
and the new one-column process is shown in Figure 6.3.
During the cycle’s first two steps, the outlet of the column is sent to section A of the
recycle device, which is the top section, forcing the movable piston to go down and thus
storing the fluid collected from the chromatographic column. During the other steps of
the half-cycle the chromatographic column is generating pure product or waste fractions
and the recycle device sits idle waiting for the start of the next half-cycle. During steps
1’-2’ of the cycle, the recycle device re-injects the fluid stored in section A back to the
inlet of the column by moving the piston up. The fluid is reinjected into the column
in the order into which it was collected from the column during the previous half-cycle.
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Figure 6.3: Schematic of the cycle of the One-column CaptureSMB process for mAb
purification. Axial concentration profiles in the liquid phase: red lines, mAb; green lines,
impurity.
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Figure 6.4: Schematic of the set of operating configurations of the plug-flow device.
An approximate “1st in, 1st out” method is thus being implemented for organizing &
manipulating the fractions of fluid from the chromatographic column.
Since the cycle for two-column processes comprises two switching intervals, mixed
fractions are reinjected into the one-column analog with a lag in time of one switching
interval based on the principle of recycle fractions with a lag in time of (N − 1)τ (or one
switching interval).
Figure 6.4 shows the different configurations of the plug-flow device during the stan-
dard operating cycle of the one-column CaptureSMB analog. In the schematics of Fig-
ure 6.4 the operation of the piston is manipulated via several one-way (i.e., on/off) valves:
the symbol  means that the on-off valve is open, whereas  means that the on-off
valve is closed.
Although the flow path configurations based on one-way valves are very flexible, their
assembly tends to be bulky because an one-way (or on-off) valve has only two positions:
open, which allows the fluid to flow through; and closed, which blocks the fluid flow.
For this reason, come two way-valves were replaced by a combination of injection valves.
Although these electrically-actuated, two-position 6-port/3-channel-injection valves also
switch between only two positions, each position is more flexible than those of the simpler
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one-way valve.
Note that Figure 6.3 shows that the eluent pump is not operated continuously over
the cycle—there are sub-steps during which the feed pump is turned off. However, it
might be of interest to operate continuously the feed pump. The simplest way to do this
is to direct the pumping fluid back to the eluent tank during the sub-steps during which
the eluent pump is supposed to be turned off. Actually, as shown in Figure 6.5 this leads
to a smaller set of operating configurations of the plug-flow device.
The cycle steps of a full cycle of the two-column CaptureSMB process and those of
its one-column analog are shown, in a simplified way, at Figure 6.6. Note that the one-
column CaptureSMB analog’s cycle can be simplified by merging identical, consecutive
steps. The resulting process is shown in Figure 6.7.
6.5 Data for Simulation: Operational Conditions and
Parameters
Using the dynamic process simulator gPROMS, ver. 4.0.0, the twin-column CaptureSMB
process was simulated for the present case study. gPROMS is a fast and effective tool
for performing simulation and optimization in steady and dynamic state, allowing the
user to make quick decisions about the process operation. In addition, process mod-
elling and simulation has been a key tool to gain understanding of processes that require
broad time and resource consumption, as is the case of protein A chromatography for
monoclonal antibodies, where both the feed and the column resin are usually extremely
expensive [146].
Therefore, after the operation cycles were well defined, the simulations were carried
out. The parameters used in the simulation were exactly the same as those provided by
the author of this purification process [29, 30]. The operational conditions and parameters
used can be seen in Tables 6.2 and 6.3.
The simulation of the single-column process described at previous section, that mim-
ics the twin-column system, was also created, and two different piston operational models
were considered: a simulation approached the recycle tube as a perfectly agitated tank,
while another considered the reflux device as axially dispersed plug-flow model. The
mathematical models used for the piston were the same as those presented in Chapter
3. The two reproductions were also submitted to the same conditions of the experiment
done with the twin-column chromatographic system.
The operating conditions and parameters used in the simulation were based on the
purification of the monoclonal IgG1-type antibody, at concentration cF = 1.2 mg/mL,
contained in a supernatant cell culture, using Protein A resin in columns of dimensions
0.5 (OD) x 10 (L) cm, system equivalent to that addressed by Baur et al. [29, 30]. The
parameters used at the three simulations are expressed in Table 6.2 and Table 6.3.
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Figure 6.5: Schematic of the reduced set of operating configurations of the plug-flow
device for the case when the eluent pump is operated continuously.
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------------------------------------------------------------------------
Two-column Process One-column analog
Step Flow-path Flow-path
---- ------------------------------------ -------------------------
(1st half-cycle)
S1 F ----> COL1 ------------> COL2 -> W F -------> COL --> Piston
S2 EQU --> COL1 ------------> COL2 -> W EQU -----> COL --> Piston
S3 ELU --> COL1 --> P F --> COL2 -> W ELU -----> COL --> P
S4 CIP --> COL1 --> W F --> COL2 -> W CIP -----> COL --> W
S5 EQU --> COL1 --> W F --> COL2 -> W EQU -----> COL --> W
(2nd half-cycle)
S1’ F ----> COL2 ------------> COL1 -> W Piston --> COL --> W
S2’ EQU --> COL2 ------------> COL1 -> W Piston --> COL --> W
S3’ ELU --> COL2 --> P F --> COL1 -> W F -------> COL --> W
S4’ CIP --> COL2 --> W F --> COL1 -> W F -------> COL --> W
S5’ EQU --> COL2 --> W F --> COL1 -> W F -------> COL --> W
------------------------------------------------------------------------
Figure 6.6: Steps of a full cycle of the twin-column Capture SMB process and its one-
column analog.
---------------------------------------
Step Flow path
---------------------------------------
S1 F -------> COL --> Piston
S2 EQU -----> COL --> Piston
S3 ELU -----> COL --> P
S4 CIP -----> COL --> W
S5 EQU -----> COL --> W
S1’+S2’ Piston --> COL --> W
S3’+S4’+S5’ F -------> COL --> W
---------------------------------------
Figure 6.7: Steps of a full cycle of the one-column Capture SMB process after merging
identical, consecutive steps.
The three simulations, one for twin-column process and the two others for single-
column process, allows comparing the performance of purification processes when sub-
jected to the same parameters of operation. The analysis was done in terms of solute
concentration profile evaluation, purity and recovery values at steady state cycles, and
specific productivity.
6.6 Results and Comparison with the Twin-column
CaptureSMB
With the simulation results of the multicolumn system and single-column systems, the
efficiency of the processes can be compared. In a first analysis, the concentration profile
at the chromatographic column outlet was analyzed for the Twin-column process and the
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Table 6.2: Parameters of Protein A Column used at simulations, based at Baur et al [29,
30] case study.
Parameter Symbol Units Value
Interparticle porosity  - 0.368
Intraparticle porosity p - 0.0
Peclet number for axial dispersion Pe - 400
Maximum mass transfer coefficient k∞m min-1 0.180
Pore blockage coefficient S1 - 0.6245
Pore blockage coefficient S2 - 2.071
Power exponent of Henry coefficient v - 16.6
Saturation capacity per resin volume qsat or q∞ mg/mL 94.72
Henry’s constant at reference pH Href - 246.8
Reference pH pHref - 7.5
Reference mAb concentration cref mg/mL 1.2
Reference impurity concentration wref mg/mL 0.12
Reference impurity concentration wref mg/mL 0.12
Table 6.3: Operating conditions for the different simulated CaptureSMB processes. The
parameters QIC , QB, and tstepi , were optimized by J.P.B.Mota using AMPL software.
Parameter Symbol Units Value
Flow rate of interconnected step QIC mL/min 1.4
Flow rate of batch step QB mL/min 1.4
Equilibration, loading and washing pH pHEQU - 7.5
Elution pH pHELU - 3.2
CIP pH pHCIP - 2.5
Sub-step 1 duration (IC, Feed) tstep1 min 10.1617
Sub-step 2 duration (IC, wash) tstep2 min 2.0
Sub-step 3 duration (B, elute) tstep3 min 30.7583
Sub-step 4 duration (B, CIP) tstep4 min 2.0
Sub-step 5 duration (B, EQU) tstep5 min 2.0
One-column Analog with piston as axially dispersed plug-flow. It is worth noting that, for
the two-column process, the output concentration of column 1 is the only one analyzed,
since in terms of simulation the columns are not exchanged at each switch interval, but
the concentration profiles are exchanged. Consequently, this indicates that the product is
always being withdrawn in the output stream of the same column (i.e. column 1 in the
gPROMS implementation).
Figure 6.8 shows the graphic result, where the black curve represents the multicolumn
system and the blue dots represent the data for the single-column process with axially
dispersed flow model for the piston. In addition, each time unit represents a sub-step,
therefore, as one cycle has ten sub-steps, ten time units indicate a complete cycle. With
the graphic result, it is seen that the profiles of monoclonal antibody concentration in
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Figure 6.8: Concentration profiles of column outlet stream, for two mAb CaptureSMB
processes: Twin-column and One-column Analog with axially dispersed plug-flow model
for the recycle device. Black curve, twin-column process; blue dots, one-column analog
with piston as dispersed plug-flow model. The curve was plotted with dimensionless
time (α, or θ at mathematical model), where each ten units of time represents one full
cycle. The two processes had similar concentration profiles at steady-state operation, and
presented the same specific productivity, proving the effectiveness of the monocolumn
system in mimicked the twin-column process
the liquid phase have very similar behaviour comparing the two processes, being slightly
different only in the transient state (i.e. approximately the first three cycles), which does
not infer significant impact on the desired analysis. In addition, the two processes show
the same specific productivity, i.e. feed processed per time unit per resin volume. These
two analyses have proven the ability of the single-column system to effectively mimic the
process of monoclonal antibody capture that uses to two identical columns.
Secondly, the concentration profiles of the two simulated one-column processes (pis-
ton as dispersed plug-flow or perfectly stirred tank) were compared, as shown in Fig-
ure 6.9, where it is shown that, for this case study, the fluid behaviour within the piston
does not condition the smooth functioning of the chromatographic process developed in
this thesis.
We have already addressed this issue in Chapter 4. When the adsorption isotherm
is strongly favorable, as is the case of protein A, the concentration front of the adsorbed
product is compressed as it travels along the column. Hence, under these conditions,
the effect of fluid mixing in the recycle piston has less influence on the shape of the
breakthrough curve than when the adsorption isotherm is less concave and closer to a
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Figure 6.9: Concentration profiles of column outlet stream, for the two simulated mAb
CaptureSMB processes: Piston as dispersed plug-flow or perfectly stirred tank. Blue dots,
one-column analog with piston as dispersed plug-flow model; Red curve, one-column
analog with piston as perfectly mixed tank. The two processes identical concentration
profiles, proving that the effectiveness of the monocolumn process is not put into question
by the type of hydrodynamic behaviour of the fluid within the piston.
linear shape.
With the purpose of analyzing only steady periodic cycles for the Single-column, the
graph for cycles 9 and 10 (Figure 6.10) were plotted, a safe region to be in the cyclic steady-
state regime. The concentration profiles for the product (red line) and for impurities
(black line) are presented. The colored regions indicate the sub-steps of the cycle, so
that the yellow block represents the sub-steps that the column outlet stream is being
redirected to the piston (S1 + S2), the gray area indicates the elution sub-step, or product
collection (S3), and the blank region expresses the remaining sub-steps of the cycle (S4
+ S5 + S(1:5)’). This graph shows that part of the product coming out of the column is
mixed with impurities. This mixed fraction is redirected to the piston, avoiding the loss
of mAb. Moreover, the recirculation of impure product allows a better use of the column
resin, since more product can be loaded without risk of being discarded at the column
exit. It is also seen that very little product is discarded in the waste stream, resulting in a
high recovery of mAb. Finally, it was verified that the moment when the impurities are
eluted does not interfere in the purity of the collected product.
It is important to note that the two impurity fractions that come out in the white region
of the graph are similar, in the twin-column system, to the impurity concentration profile
of the downstream column (represented by the first impurity step curve) plus upstream
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Figure 6.10: Cycle 9 and 10 of the One-column Capture SMB with dispersed plug-flow
piston behaviour. The red line indicates the mAb concentration profile at the outlet of the
chromatographic column. The colored regions of the chart, indicates different sub-steps.
The yellow area indicates the S1+S2 sub-steps, showing the concentration profile of the
mAb that is directed to the piston. The gray area shows the elution step, S3, with product
collection. In the blank space, it shows the remaining sub-steps of the cycle. In this last
region, impurities are discarded at the outlet of the column.
column (represented by the second impurity step curve), since in this process the rejection
of impurities occurs at both downstream and upstream column waste streams, depending
on the cycle sub-steps.
Finally, the purities and recoveries were then calculated for the simulated processes.
Figure 6.11 and Figure 6.12 show, respectively, the purity and recovery graphs. The Ta-
ble 6.4 reveals the calculated values for the cycles in steady-state condition. The values of
100% indicate that the impurities came out completely in the waste stream, not showing
remnants in the elution stream (S3) or the stream passing to the next column, or piston,
(S1 + S2), i.e. when the devices are interconnected. In the analysis of monoclonal anti-
body recovery, very similar values were obtained for the three simulated processes, close
to 99.5%, differing only in the second decimal place.
In addition, the three systems take just a few cycles to achieve cyclic steady state:
three cycles for the multicolumn process and six cycles for the analogous single-column
process. However, through the analysis of the recovery graph for the One-column process,
it is seen that, before reaching the steady state, high recovery values were already being
obtained from the second cycle, showing that this difference of three cycles between the
two processes is not a determinant factor that disqualifies the process.
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(a) mAb purity for Twin-column CaptureSMB.
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(b) mAb purity for One-column CaptureSMB.
Figure 6.11: mAb purity per dimensionless time unit, at (a) Twin-column process and
(b) One-column process, considering the case of piston with axially dispersed plug-flow
behaviour. Purity of 100 % was achieved for both processes with steady-state operation,
indicating that there are no traces of impurities leaving in elution step S3+S3’, for twin-
column, or S3, for one-column, of the cycle.
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(a) mAb recovery for Twin-column CaptureSMB.
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(b) mAb recovery for One-column CaptureSMB.
Figure 6.12: mAb recovery per dimensionless time unit, at (a) Twin-column process and
(b) One-column process, considering the case of piston with axially dispersed plug-flow
behaviour. In (a) the steady-state was reached from the fourth cycle, with recovery of
99.48 %, while in (b) the stationary state was reached in the seventh cycle, with recovery
of 99.47 %. This shows that the two systems are very competitive in terms of efficiency.
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Table 6.4: Comparison of Purity and Recovery in different operating systems.
Twin-column One-column with Recycle Lag
Dispersed
plug-flow
Perfectly
mixed tank
Purity (%) ∼ 100 ∼ 100 ∼ 100
Recovery (%) 99.5 99.5 99.5
The high purity and recovery results obtained showed that the Single-column Cap-
tureSMB system is a potential candidate for the purification of monoclonal antibodies,
since it presents advantages over the existing multicolumn process, present in the liter-
ature [30]. Since the resin is a major component of the overall production cost of bio-
pharmaceuticals, especially in cases where the resin is expensive (as the case of protein A
resin) [116], working with the limit case of only one chromatographic column is a broad
step towards the introduction of this process in the manufacture of these bioproducts,
as well as an opportunity of great visibility to the market, taking into consideration the
substantial reduction of production costs. Furthermore, the smallest number of equip-
ment implies a simpler, more flexible system and with lower pressure drop, decreasing
the chances of setup damage.
6.7 Conclusions
After the system has shown its efficiency for simple separations, the second case study
was performed, this time a more complex separation. The purpose of this chapter was to
replace the standard Twin-Column CaptureSMB process, which employs two identical
chromatographic columns, by a Single-Column chromatographic analog that employs
a special type of plug-flow device for recycling mixed fractions to the chromatography
column with a lag in time.
The comparison was proceeded, using gPROMS simulation tool, evaluating the per-
formance and efficiency of the single-column with recycle lag, for the purification of a iso-
form of monoclonal antibody, and comparing with the multicolumn countercurrent SMB
process already studied and validated in the literature, the Twin-column CaptureSMB [14,
29, 30]. The Twin-column Capture SMB process showed (in studies presented by the re-
spective author) to have a better performance than the batch system applied to the same
mAb capture, obtaining capacity utilization and specific productivity superior to the
batch system, with constant values of purity and yield. A higher productivity of the
twin-column CaptureSMB, against the Batch system, means that fewer cycles are needed
to obtain the same amount of product, implying a slower deterioration of the resin and,
consequently, a decrease in the resin costs. Therefore, this process was considered a good
case of study to be mimicked.
Hence, the process model was implemented to the capture of monoclonal antibody in
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protein A, considering piston as a perfectly mixed tank and piston with axially dispersed
plug flow behaviour. When dealing with a new process, gaining understanding of the
process is crucial in designing an efficient and robust process, and determining the opti-
mum conditions of the process [30]. Thus, the cycle design was first planned and, then,
the validation for this application was done by gPROMS simulation.
The Single-column with recycle lag analog to SMB was evaluated in this case study
through purity, yield, specific productivity and concentration profile evaluation.When
comparing the concentration profiles in the product outlet stream, for the three processes
simulated CaptureSMB: Twin-column, One-column with perfectly mixed tank model for
the piston and other considering the device as axially dispersed plug-flow; the results
showed that the curves, after the transient state, had very similar performance, conclud-
ing that the fluid behaviour within the piston does not restrict the mimetization capacity
of the new process. In addition, the specific productivity obtained for the three processes
were exactly the same.
Still, for the twin-column, the monoclonal antibody was recovered in 99.48 %, while
the single-column recovered 99.47 % of the desired product. The purity was 100 % for all
processes. This proves the efficiency of the One-column CaptureSMB process, either with
or without perfect mixture inside recycle device, to isolate monoclonal antibody with
protein A resin in affinity chromatography.
Despite achieving comparable purity and recovery levels with the twin-column Cap-
tureSMB, the Single-column with Recycle Lag analog features valuable advantages. The
price of protein A resin is almost one order of magnitude higher than stationary phases
of non-affinity [90]. This indicates that, reducing from two to one column in monoclonal
antibody isolation process, it drastically reduces the purification costs of this biomolecule
and consequently the total costs of production. In addition, the reduction of columns
number brings flexibility to the system, simplicity, and reduction of operating pressure.
No less important, the change from one mixture to another, i.e. the preparation to start a
new purification, is faster, since only one column needs to be cleaned. Especially for mon-
oclonal antibodies, the latter quality really makes sense, since the process of monoclonal
antibodies purification usually takes a long time. Therefore, with all these qualities, the
Single-column CaptureSMB chromatographic process is a visioned alternative process to
be established in the industry.
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Final Considerations
The increasing acceptance of biopharmaceuticals, their ability to treat previously un-
treatable diseases, and their huge market demand, are the major factors driving the
exponential growth of the biopharmaceutical market. However, increasing demand for
affordable biopharmaceuticals, high-end manufacturing requirements, and complicated
and cumbersome regulatory requirements are hindering the market growth.
The pressure to increase process performance and reduce costs spreads over the whole
development and manufacturing chain, encompassing research, analytics, clinical trials,
and production. The production of a biopharmaceutical can, in turn, be divided into
upstream and downstream processing, which are both under slow but continuous im-
provement. The focus of this thesis is on the contribution of chromatography to down-
stream processing. In order to increase the performance of a chromatographic separation
unit beyond traditional batch technology, several continuous countercurrent processes
for distinct applications have been developed and many of them patented [207, 248].
The overall objective of the present work was to develop a new chromatographic unit
as effective as the existing multicolumn systems for the capture and polishing steps in
downstream processing of biomolecules, but simpler, cheaper and with a smaller foot-
print, using just a single chromatographic column and a new developed recycle device.
Three specific objectives guided the research direction:
• Establish the design, mathematical model, and assembly of the prototype;
• Experimentally validate the set-up, through the mimetization of a multicolumn
separation process;
• Improve the operation of the set-up, using 3D printing as a tool for the process
optimization;
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• Apply the newly developed biomolecule purification process in another case study,
seeking to certify the effectiveness of the set-up.
7.1 Main conclusions
Chapter 3 described a new single-column set-up capable of mimicking multicolumn
SMB processes and other existing countercurrent continuous processes to perform down-
stream biopurification. The recipe of how to mimic multicolumn continuous chromatog-
raphy with just a single-column apparatus, the conceptual set-up design, its mathematical
model, and the assembly of its prototype, as well as their operational capabilities, were
presented. As result, it was shown that with a clever implementation of single-column
chromatography with recycle it is possible to mimic the operation of the continuous mul-
ticolumn process, obtaining a system as compact and simple-to-operate as the standard
single-column batch process. The new apparatus can be used both in the capture step as
polishing stage of a purification train and the valuable advantages of the process were
explored, such as reduction of the total amount of equipment used and consequent total
size of the installation, reduction of required resin quantity and decrease of the total pres-
sure drop. In addition, because only one chromatographic column needs to be repacked
when switching from one mixture to another, changing separations is easier and takes
less time than with a multicolumn SMB system. Furthermore, system automation helps
avoiding operational errors and expenses with additional human operators, since the
process requires skilled labor. As consequence, a considerably simpler, more flexible and
stable system is obtained, in addition to being more economical.
Chapter 4 focused on the experimental proof-of-concept of the developed set-up, us-
ing the linear separation of nucleosides, uridine and guanosine, by reversed phase as case
study to demonstrate the effective use of the proposed chromatography apparatus. Before
the biomolecules separation experiment, preliminary experiments were performed to test
the recycle device operation, as well as the functionality of the different possible con-
figurations operated by the set-up. The recycle piston, operates with small-to-moderate
mixing of fluid between the sections and with the mobile plunger in perfect operation,
giving a pressure drop of only 6 bar when traveling the length of the device, implying
the process of opening and closing the piston. In the initial tests, the piston seemed
to comply with the plug-flow dispersed model. The characterization of the prototype,
for this separative process, was performed through experiments, prior to the execution
of the separation. For the chromatographic column, the interparticular porosity, the
Henry’s constants and the Péclet numbers were determined. The values obtained were
very similar to those found by the authors of the mimetized system, a two-column, open-
loop, SMB system [228]. For the piston, the dead volumes, which gave very low values
(V0 = VL = 0.273) cm3, and the axial dispersion coefficients were calculated. For the
nucleosides separation process, the concentration profiles of each biomolecule demon-
strated that the hydrodynamic fluid behaviour inside the recycle device was between
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the dispersed plug-flow model and a perfectly agitated tank. But, although the exact
hydrodynamic behaviour within the piston has not been exactly determined, this is not
a determinant limitation, because the One-column Analog to SMB system overcome the
separation challenges and separated the nucleosides very efficiently, obtaining very high
values of purity (99.57 % for guanosine and 97.03 % for uridine) and recovery (97.76 %
for guanosine and 100 % for uridine), in addition to low solvent consumption.
Based on previous chapter results, in order to improve the operation of piston de-
vice, in Chapter 5 it was developed new piston distributors and collectors configurations
through 3D printing, which was explored a broad range of frit layouts for the dispenser.
Two 3D methods were used: SLA and FDM. Chemical and thermal stability tests were
made with 3D printed material made by each method, which proved to be stable both for
the solvent used in the nucleosides separation, as solvents with similar pH to the solvents
used in the purification of monoclonal antibodies. Through experiments with the 3D Frits
produced from the Clear resin (experiments with tracer, separation of nucleosides and
evaluation of the residence time distribution profiles), it was obtained a improvement
of the fluid distribution within the piston when compared to original polyethylene frits.
The presence of brackets inside the reflux piston, preferably higher number of distribu-
tors and consequently smaller height of each bracket, proved to be substantially better
than the use of the original polyethylene frits, which had shown concentration profiles
at the piston outlet with minor disturbances and even closer to a dispersed plug-flow
model. Due to this result, the FDM method has been used to overcome the limitation of
the Clear resin holders, the high rigidity of the 3D material, becoming brittle. Therefore,
with the PEEK material was achieved substantially more flexible 3D brackets, enabling
the movement of the mobile plunger inside the recycle tube. It is important to note that
considerable improvement has been achieved, however, additional geometric designs
are being constantly produced using 3D technology, in the perspective of further opti-
mization of the prototype by achieving the really desired plug-flow operation inside the
recycle container, since the only thing that can compromise the product purity and pro-
ductivity of this process comparing to the analogous SMB is the efficiency of the plug-flow
device.
The results obtained with the case study approached in Chapter 6, the purification
of a monoclonal antibody through protein A resin, showed that, although it is a desire to
maintain a dispersive tubular behaviour within the piston, it is not a restricted condition
for the proper functioning of the facility. The Single-column chromatographic system
mimicked the Twin-column CaptureSMB process operation with the same specific pro-
ductivity (feed processed per unit time per resin volume), or absolute productivity (feed
processed per unit time) divided by the number of columns. The monocolumn process
reached mAb purity of 100% and recovery of 99.47%, values exactly the same as those
obtained with the simulation for the twin-columns process mimetized. With this, it was
concluded that the newly developed platform is capable to imitate more complex sepa-
ration processes (than approached in Chapter 4), and mainly, this platform shares the
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benefits of SMB chromatography in that it not only gives significantly higher yields of
purer product, but also enables processing more feed and thereby increasing the overall
throughput when compared with batch chromatography. However, the process developed
by this thesis uses just a single chromatographic column.
It is expected that the work presented in this thesis has scientific repercussions and
is an important step for the optimization of chromatographic processes applied to the
biopharmaceutical industry, where product quality and operating costs are constantly in
question to meet the health needs worldwide.
7.2 Suggestions for Future Work
Single-column Chromatography with Recycle Lag, as already exposed throughout this
document, has the potential to mimic continuous multicolumn chromatographic process
for separation and/or purification of biomolecules, reducing equipment costs and increas-
ing simplicity of operation, while maintaining the same specific productivity, as well as
high values for product purity and recovery. In addition, the proposal of this thesis en-
ables the use of 3D printing in a field still very little explored by this technology, 3D
parts for chromatographic processes. Some important steps were given in the technical
feasibility and validation of the system, but there is still a path to be travelled.
It is suggested to analyze the hydrodynamic behaviour of the fluid at piston equipped
with the new spiral configuration in PEEK plus grids in Clear resin equally spaced inside
the piston. The analysis can be through:
1. Pulse and gradient solute injection tests, proceeded at piston device, experimentally
testing the residence time distribution profiles;
2. Proceed with the separation of nucleosides and compare with the results obtained
in this thesis.
It is also suggested the continuity of the use of 3D technology to address more models
of distributors and piston collectors, to approximate as much as possible the dispersion
of the fluid to the dispersed plug-flow model.
In addition to these suggestions, it is plausible the experimental validation of the
simulated process presented in Chapter 6, experimentally mimicking the Twin-column
CaptureSMB.
Finally, it is still suggested the application of the prototype to mimic other purification
processes approached in the literature, recently developed and already validated, such as
the twin-column MCSGP process, developed by Steinebach et al. [250], for purification of
monoclonal antibodies, or the Gradient with Steady State Recycle (GSSR) three-column
process, developed by Silva et al. [242] and apply for purification of peptides (another case
of reversed-phase purification), showing the effectiveness of the process developed in this
thesis when applied solvent-gradient and when mimicking processes more complex than
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two columns. The validation of the new monocolumn process can still be accomplished
through adenovirus purification using size-exclusion chromatography, based on the two-
column process developed by Nestola et al. [193]. This would show the effectiveness of
the process when applied to different types of chromatography, and not only to reversed
phase chromatography with protein A, and to different types of biomolecules.
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Appendix A
A.1 Publications Regarding Monocolumn Chromatographic
Processes Similar to SMB
Evolution of the publications about the processes development for biomolecules separa-
tion and purification that use only one chromatographic column to mimic SMB operation,
where it is observed that only two research groups have already approached systems of
just one chromatographic column analogous to SMB, and the investigations occurred in a
short period of time, from 2003 to 2007.
The Analog
• 2003
• 4 articles
• Abunasser, N. et al.; 
Kim, K. et al.*
The Single-
column Analog
with Recycle Lead
• 2005
• 2 articles
• Araújo, J. et al.** 
The Single-
column Analog
with Recycle Lag
• 2005
• 2 articles
• Mota, J. et al.; 
Araújo, J. et al.** 
The Unmixed
Analog
• 2005
• 2 articles
• Abunasser, N. et
al.
Alternative
Version of the
Single-column
Analog with
Recycle Lag
• 2007
• 2 articles
• Rodrigues, R. et
al.**
Figure A.1: Publications regarding monocolumn chromatographic processes similar to
SMB for biomolecules separation/purification. They are separated by developed process,
initial publication date, number of articles published about this method and respective
responsible author. Data obtained from research done in b-on. *Author belongs to the re-
search group of Professor Dr. Nadia Abunasser (School of Chemical Engineering, Purdue
University, West Lafayette, IN, US). **Author belonging to the research group of Profes-
sor Dr. José Paulo Mota (Department of Chemical Engineering, Faculdade de Ciências e
Tecnologia, Universidade Nova de Lisboa, Caparica, PT).
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A.2 Piston Mounting Protocol
Recycle-device assembly steps assist the researcher in avoiding mounting errors, as well
as facilitating the execution of this task. The steps are as follows:
1. Fit the frits: For this purpose, the acetal parts that receive the frits (top cover and
movable piston) must be heated on the heating plate, in order to dilate these parts,
and the frits should be placed in the freezer for about 20 minutes, in order to
contract them;
2. Place the movable piston at the top of the device, with the glass column completely
empty of any liquid. The movable piston hole must be closed with a fitting that
prevents liquid from passing from section A to section B;
3. After being able to fit the movable plunger and unable to push it further by hand,
due to the frictional resistance between the o-rings and the column glass, fill section
A with a fluid (usually ethanol 5% v/v in deionized water) until the upper edges of
the column and ensure that no bubbles remain in this section;
4. Close the device top and turn on the liquid pump in order to push down the movable
plunger to a height that will allow to connect the capillary from the movable plunger
to the bottom of the device;
5. Check that there is no leakage at both ends of the capillary;
6. Fill the bottom (section B) of the piston with the same 5% ethanol solution;
7. Close the bottom of the piston, ensuring that there is no bubble inside the section.
To close the inner and outer parts, the outer fittings should be removed to reduce
pressure and consequent force to be exerted by the person that is closing them;
8. If any bubbles are left in Section A, reopen the top, add 5% ethanol and ensure
there are no internal bubbles.
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A.3. RELATIONSHIP BETWEEN RELAYS AND PNEUMATIC VALVES
A.3 Relationship between Relays and Pneumatic Valves
The two OptoRLY88 relay boards are addressed by matching each relay to a pneumatic
valve. There are 16 on-off valves successfully installed to the boards. However, only 7 are
currently required for the setup.
Su
p
p
ly
C
ab
le
Valve 8 7 6 5 4 3 2 1
Board #1 #1 #1 #1 #2 #2 #2 #2
Relay 2 4 6 8 2 4 6 8
Valve 16 15 14 13 12 11 10 9
Board #1 #1 #1 #1 #2 #2 #2 #2
Relay 1 3 5 7 1 3 5 7
Figure A.2: Schematic of correspondence between Relays and Pneumatic Valves. The
setup has two boards, even though only one is required. Each board has eight relays, and
each relay corresponds to one on-off valve.
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A.5 Pumps Calibration Protocol
Isocratic pumps connected to the One-column setup can be calibrated via the command
interface in Julia software. The calibration protocol contain the following steps:
1. Start Julia software: ( julia1 ; using ChromatographyStudio );
2. Choose the setting that the stream will obey: ( @step );
3. Calibrate to desired flow rates: ( cal=calibrate_pump... );
4. Then do ( cal.fit[4].p) : Provides the terms of the calibration equation. What’s
inside the bracket means the degree of polynomial you want to generate;
5. Get the inverse calibration data: ( cal.fit_inv[4].p ). Reverse calibration allows
transformation of calibrated flow rates to original pump flow rates;
6. Write the equations coefficients into the devices.jl file and save it;
7. Finally, do the calibration once again with the same flows. The flow values to be
obtained in this step should be closer to the desired values, so the pump will be
calibrated and ready for use;
8. Four graphs will be generated by the system:
• Calibration curve (desired flow rate vs. actual flow rate) prior to using the
calibration equation (example in Figure A.3);
• Calibration curve after using the calibration equation;
• Weight vs. time graph for each chosen flow, before using the calibration equa-
tion (example in Figure A.4);
• Weight vs. time graph for each chosen flow rate, after using the calibration
equation;
9. Turn off Julia software: ( exit() ).
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Figure A.3: Example of pump G calibration curve.
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Figure A.4: Example of pump G weight curve.
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A.6 Valves Position
Table A.2: On-Off and switching valves position. 1 = opened valve, 0 = closed valve.
Configuration On-Off Valves Switching Valves
V1 V2 V3 V4 V5 V6 V7 COM2 COM8
F+R=>COL=>R 1 0 0 1 1 1 0 A A
R=>COL=>R 1 0 0 1 0 0 1 A A
E=>COL=>R 1 0 0 1 1 0 1 B A
E=>COL=>P/W 1 1 1 0 0 0 1 B A
F=>COL=>P/W 0 1 1 0 1 1 0 B B
F=>COL=>R 0 0 0 1 1 1 0 A B
F+R=>COL=>P/W 1 1 1 0 0 1 0 B B
R=>COL=>P/W 1 1 1 0 0 0 1 B B
A.7 Implemented Steps in ChromatographyStudio.jl
Prototype operation steps, implemented at ChromatographyStudio.jl Julia’s package cre-
ated to automate the setup. The following schemes were generated using Adobe Illus-
trator image editor. Each feed tank has a corresponding fluid color. The colors in the
tubes indicate where each fluid is passing, while the gray paths indicate that there is no
fluid passing through it in this step. F, E, P, W, R are the feed, eluent, product, waste,
and recycle stream; COL, RP, UVi, Vi refer, in this order, to the column, recycle piston,
UV detector and on-off valve apparatus; the 2-pos-6-port valves are represented by the
circles with their fluid passage position inside, which can be A, B, IN or BY; COMi is the
communication ports for each equipment.
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Figure A.5: Configuration F+R => COL => R.
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Figure A.6: Configuration R => COL => R.
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Figure A.7: Configuration E => COL => R.
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Figure A.8: Configuration E => COL => P/W.
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Figure A.9: Configuration F => COL => P/W.
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Figure A.10: Configuration F => COL => R.
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Figure A.11: Configuration F+R => COL => P/W.
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Figure A.12: Configuration R => COL => P/W.
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Appendix B
B.1 Hydrodynamic Experiments Julia Commands
The experimental script submitted to Julia software for the preliminary hydrodynamic
experiments, the “Exps.jl”, is presented below:
Listing B.1: Exps.jl
1 @uvc A wavelengths=[260.0]
2 @uvc A set:dark
3 @uvc A set:ref
4 @uvc A plot:all
5 monitor_balance(bal, 1.0);
6 @pump F = 2.0; @pump E = 2.0
7 @monitor file = "uridineafter.mon"
8 @sequence begin
9 include("Exps.jl")
10 end
11 @monitor stop
12
13 % Exps.jl: (For UV after piston)
14
15 @step F => COL => W
16 @valve +V4
17 @valve -V2
18 @valve -V5
19 sleep(200.0)
20
21 @step E => COL => W
22 @valve +V4
23 @valve -V2
24 @pump E = 2.0
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B.2 Ideal Wavelength for Blue Dextran Compound
Ideal wavelength (λ) for detection of Blue Dextran compound. For blue dextran solution
at c = 0.24 g/L, the Absorbance Spectrum (Graph (a)) was read in the ( approximate)
range 260 < λ < 750 nm during a step injection. Therefore, 5 wavelengths were tested
in this range: 285.0, 290.0, 305.0, 600.0, 620.0 and 630.0 nm. From the chromatogram
obtained for each wavelength (Graph (b)), the λ = 620 nm wavelength was chosen to
perform the experiments with blue dextran solution, due to the low disturbance of the
UV signal. It is important to point out that the blue dextran experiments were performed
using the USB4000 spectrometer, with only deuterium light turned on, and that for this
spectrometer the ideal Integration Time (IT) is 65000 µs.
(a)
(b)
Figure B.1: UV detection for Blue Dextran solution (c = 0.24 g/L). (a) Absorbance Spec-
trum (–) and Intensity Spectrum (–); (b) Chromatogram for five wavelengths (285.0,
290.0, 305.0, 600.0, 620.0, 630.0 nm). The λ = 620 nm is within the detection range of the
Absorbance Spectrum and showed a stable absorbance signal, therefore, this wavelength
was chosen for the experiments to be performed with blue dextran.
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B.3 Henry.jl
Script run at Julia software for Henry constant determination, the “Henry.jl”:
Listing B.2: Henry.jl
1 @pump G = 0.0
2 @pump F = 0.0
3
4 println("\n Feeding during 40 s \n")
5 @step E+F => COL => P
6 @pump F = 3.0
7 sleep(40)
8
9 @pump F = 0.0
10 @pump G = 3.0
11 println("\n Eluent till end \n")
12 readline()
13 @pump G = 0.0
14
15 @monitor stop
16 sleep(1.0)
17 @valve -all
B.4 Components Absorbance Spectrum
Ideal wavelength (λ) for detection of Uridine and Guanosine compounds. For each com-
ponent solution at c = 0.05 g/L, the Absorbance Spectrum (Graph (a)) was read in the
approximate range of 210 < λ < 300 nm during a step injection. Therefore, 3 wavelengths
were tested in this range: 260.0, 280.0 and 285.0.0 nm. From the chromatogram obtained
for each wavelength (Graph (b)), the λ = 260 nm wavelength was chosen to perform the
experiments with uridine and guanosine solutions, due to the intensity of the UV signal.
It is important to point out that the uridine and guanosine experiments were performed
using the USB2000 spectrometer, with only deuterium light turned on, and that for this
spectrometer the ideal Integration Time (IT) is 37000 µs.
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(b)
(a)
(i=1) Uridine.
(b)
(a)
(i=2) Guanosine.
Figure B.2: UV detection for uridine (i = 1) and guanosine (i = 2) solutions (ci = 0.05 g/L).
(a) Absorbance Spectrum (–) and Intensity Spectrum (–); (b) Chromatogram for three
wavelengths (260.0, 280.0, 285.0 nm). The λ = 260 nm is within the detection range of the
Absorbance Spectrum and showed a stable absorbance signal, therefore, this wavelength
was chosen for the experiments to be performed with the nucleosides.
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B.5 Isotherm.jl
Script run at Julia software for Adsorption Isotherms determination, the “Isotherm.jl”:
Listing B.3: Isotherm.jl
1 println("\n***Beginning Test now***\n")
2
3 println("\n***F = 1.0 E = 4.0***\n")
4 @step E + F => COL => P
5 @pump F = 1.0
6 @pump G = 4.0
7 sleep(1080)
8
9 println("\n***F = 2.0 E = 3.0***\n")
10 @pump F = 2.0
11 @pump G = 3.0
12 sleep(1080)
13
14 println("\n***F = 3.0 E = 2.0***\n")
15 @pump F = 3.0
16 @pump G = 2.0
17 sleep(1080)
18
19 println("\n***F = 4.0 E = 1.0***\n")
20 @pump F = 4.0
21 @pump G = 1.0
22 sleep(1080)
23
24 println("\n***F = 5.0 E = 0.0***\n")
25 @pump F = 5.0
26 @pump G = 0.0
27 sleep(1080)
28
29 println("\n***Done***\n")
B.6 ColExps.jl
The experimental script submitted to Julia software for the uridine-guanosine separation
test, the “ColExps.jl”, is presented below:
Listing B.4: ColExps.jl
1 % Cycle 1 (Just for cycle 1):
2
3 @step F => COL => P
4 sleep(236.6322)
5 @step E => COL => P
6 sleep(240.5298)
7
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8 % Cycle 2 to N:
9
10 @step E => COL => R
11 sleep(609.282)
12 @step R => COL => P
13 sleep(368.7534)
14 @step F => COL => P
15 sleep(236.6322)
16 @step R => COL => P
17 sleep(+-240.5298)
18
19 % At the end of the N cycle, there is a cleaning command:
20
21 @step E => COL => P
22 sleep(609.282)
23 @pump F = 0.0
24 @pump E = 0.0
25 sleep(1.0)
26 @valve -all
B.7 Simulation Building Blocks
B.7.1 Dispersed plug flow
Model representing the two frits of the recycling device:
x = 0 : Qci −DiL∂ci∂x = (Qci)in, (B.1)
0 < x < 1
∂ci
∂θ
=
τ
Vf
(
DiL
∂2ci
∂x2
−Q∂ci
∂x
)
, (B.2)
x = 1 :
∂ci
∂x
= 0, (B.3)
where Qi,in and ci,in are the inlet volumetric flowrate, and inlet solute concentration.
The material balances to nodes between chromatographic units (admixing or splitting of
streams) are easier to write in terms of solute molar (or mass) flowrates. Thus, we shall (i)
drop the subscript ’in’ inQin and letQ stand for the working volumetric flowrate through
the cell, and (ii) lump Qin and ci,in into the solute molar (or mass) flowrate, (Qci)in.
Vf is the dead volume present in each frit.
Hereafter the time scale is scaled by τ : the dimensional time coordinate t is replaced
by a dimensionless time coordinate θ = t/τ .
And
DiL =D
(1)
iL +D
(2)
iL Q (B.4)
is the dispersion coefficient.
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B.7.2 Adsorption column (linear isotherms)
Model representing the chromatographic column:
x = 0 : Qci −DiL∂ci∂x = (Qci)in, (B.5)
0 < x < 1
∂ci
∂θ
=
τ
[+ (1− )Hi]Vc
(
DiL
∂2ci
∂x2
−Q∂ci
∂x
)
, (B.6)
x = 1 :
∂ci
∂x
= 0, (B.7)
where Hi is the Henry constant of solute i,  is the interparticle porosity, Vc is the column
volume.
B.7.3 Recycle piston
Piston volume is variable, so:
∂V
∂θ
= τ(Qin −Qout) (B.8)
1. Model representing the recycle device as dispersed plug flow:
x = 0 : VQinci −DiL∂ci∂x = V (Qci)in, (B.9)
0 < x < 1
∂ci
∂θ
=
τ
V 2
(
DiL
∂2ci
∂x2
−V [Qin − (Qin −Qout)x]∂ci∂x
)
, (B.10)
x = 1 :
∂ci
∂x
= 0, (B.11)
where ci,in = c
Frit
i,out.
2. Model representing the recycle device as perfectly mixed tank:
V
dci,out
dθ
= τQin(ci,in − ci,out). (B.12)
Brief model explanation:
As the volume of liquid inside the recycle device, V , changes with time, the global
material balance is
dV
dt
=Qin −Qout, (B.13)
where Qin and Qout are the inlet and outlet volumetric flowrates.
The solute material balance is
d(ci,outV )
dt
= ci,inQin − ci,outQout, (B.14)
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V
d(ci,out)
dt
+ ci,out
d(V )
dt
= ci,inQin − ci,outQout, (B.15)
where ci,in and ci,out are the inlet and outlet solute concentrations. Taking into
account eq. (B.13), and substituting dVdt at previous equation:
V
d(ci,out)
dt
+ ci,out(Qin −Qout) = ci,inQin − ci,outQout, (B.16)
V
dci,out
dt
=Qinci,in −Qinci,out). (B.17)
Hence, the solute material balance can be rewritten as
V
dci,out
dt
=Qin(ci,in − ci,out). (B.18)
As the dimensionless time coordinate θ = t/τ , the final equation is
V
dci,out
dθ
= τQin(ci,in − ci,out), (B.19)
which is valid even if V changes with time. This equation gives ci,out(θ) as a function
of V (θ),Qin(θ), and ci,in(θ). The molar flowrate of solute exiting the cell is ci,outQout.
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Appendix C
C.1 3D Printed Distributor Designs
Examples of designs explored in the SLA method for producing 3D fluid dispensers. Due
to the wide variety of conformations, only a few are shown in the image for illustrative
purposes.
Figure C.1: Examples of designs explored in the SLA method for producing 3D fluid
dispensers.
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Appendix D
D.1 gPROMS Implementation
Brief explanations of implementation in gPROMS are given below. Each section is in-
tended to perform a different task.
D.1.1 Connections between Chromatographic Columns
The below equations (already discussed in Chapter 6):
{sin,win, yin}2 = vIC × {sout,wout, yout}1 + (1− vIC)× {sF,wF, yF}, (D.1)
vIC =
1 for the IC steps0 for the B steps, . (D.2)
can be implemented in gPROMS via one easy mechanism. It is necessary to simply
introduce a new SELECTOR, the vIC, which is a special type of variable that can only hold
a discrete number of values. For example, in the model we add the following section:
SELECTOR
vIC AS (OFF, ON)
Then, in the EQUATION section we introduce the following block:
EQUATION
...
CASE vIC OF
WHEN OFF:
Column(2).sIN = sF ;
Column(2).wIN = wF ;
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Column(2).yIN = yF ;
WHEN ON:
Column(2).sIN = Column(1).sOUT ;
Column(2).wIN = Column(1).wOUT ;
Column(2).yIN = Column(1).yOUT ;
END # CASE
D.1.2 Amount of Component i Collected in the Product Fraction
Note that equation, explained in Chapter 6, that describes the amount of component i
(mAb or impurity) collected in the product fraction
aPi =QB
∫
τ3
couti (t)dt, (D.3)
is difficult to calculate in gPROMS as is. However, this equation can be recast as
follows:
daPi
dt
=QBc
out
i (t) for t ∈ step 3 s.t. aPi = 0 at the start of step 3. (D.4)
In practice, the actual equation implemented in gPROMS is
daPi
dt
= vPQBc
out
i (t), v
P =
1 t ∈ step 40 t < step 4 , (D.5)
where aPi is reset to zero at the start of every half cycle.
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Annex A1
ChromatographyStudio.jl is the custom-made central program that calls all of the devel-
oped drivers, created by J. Antunes & J.P.B. Mota [16], for Single-column Analog process
automation and data acquisition.
Figure I.1: Hierarchical diagram of programs created for Single-column Analog to SMB
process automation and data acquisition. Programs are condensed in an unique easy-to-
use interface, the ChromatographyStudio.jl module. Source: [16].
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